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Abstract  
Background 
The Royal Stoke Pharmacy Workforce Calculator (RSPWC) was developed to meet 
a local need of identifying clinical pharmacy staffing levels, not described 
nationally. This study demonstrates the validity and transferability of the RSPWC 
and its application to other settings. 
Methods 
A two-round Delphi consensus study was conducted to confirm the activity 
standard (tasks, times and frequencies) for clinical pharmacy services.  An 
operator evaluation was undertaken to demonstrate the reliability of the tool by 
multiple operators and a series of qualitative interviews explored the utility of the 
tool in different settings.  These research strands ran concurrently from April 2016 
to December 2016. 
Results 
Participants from 21 sites across the UK were recruited, including district general 
hospitals (nine), teaching hospitals (eleven) and one mental health trust.  A wide 
range of staffing levels, across all staff groups, was reported.  Consensus was 
achieved for 68% of components of the algorithm that drives the RSPWC. For a 
further 21% of components, ‘nationally-representative’ figures were identified 
from the data.  Eleven percent of the components, those relating to elements 
dependent on individual patient responses to medicines, failed to achieve 
agreement.  A pragmatic approach was taken in the derivation, from study data, of 
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these activity frequencies for typical patient groups.  Content validity of the tool 
was demonstrated.  The ‘operator evaluation’ demonstrated reliability in its use by 
different operators.  The application of this tool to a variety of settings was 
identified through the qualitative data. 
Discussion 
The results of the study demonstrate the validity, transferability and utility of the 
RSPWC.  They capture, for the first time, a consensus on the required service 
components for the delivery of pharmaceutical care, across multiple hospital sites 
nationally in the UK. Through this study a clinical pharmacy workforce calculator 
for acute hospital settings has been developed and validated. 
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Preface 
This thesis charts the course of the development of a pharmacy workforce calculator, from 
its inception at the Royal Stoke University Hospital to its national validation as part of this 
Doctoral study.  As a tool conceived from a practical, local need, the Royal Stoke Pharmacy 
Workforce Calculator, as it is now known, facilitated the growth of a pharmacy workforce at 
the Royal Stoke University Hospital.  Its validation for application by pharmacy managers in 
acute hospital sites across the UK comes at a time when the attention of hospital Chief 
Executives across the country has been drawn to their pharmacy departments, with a 
previously unprecedented level of scrutiny.   Through the NHS Benchmarking project and 
the Lord Carter report, the issue of pharmacy staffing levels and productivity has become a 
key work-stream for NHS managers.  Having clarity on the capacity of their workforce will be 
paramount for pharmacy managers over the coming years and the Royal Stoke Pharmacy 
Workforce Calculator is a novel tool to support them in this task.  
Chapter 1 of this thesis introduces the subject in the context of the historical development 
of clinical pharmacy services, the identification of a local need to calculate accurately 
workforce need and details the current political context.   This is followed in Chapter 2 by an 
in depth review of the literature pertaining to workforce planning in general terms and 
more specifically in healthcare.  Published evidence from the pharmacy profession is 
considered from the perspectives of workforce planning, productivity, outcomes and time 
and motion data.  From this review the research questions, aims and objectives of the 
research project are crystallised in Chapter 3.   
The methodological approach of the World Health Organisation for identifying healthcare 
staffing resource, it’s ‘Workload Indicators of Staffing Need’ (WISN), was adopted for the 
delivery of this project. Chapter 4 explores the methodological considerations for the 
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establishment of calculating workforce, developing consensus, confirming validity and 
conducting of research using questionnaires and interview processes, all of which are 
required to implement a WISN approach.  The concept of reflexivity is explored and its 
influence on practice research is described. 
Moving into Chapter 5, the feasibility study, which informed the main Doctoral research, is 
reported.  This element of the research identified practical and methodological challenges 
which were addressed to improve the delivery of the main study, and also confirmed that 
the proposed data collection methods were realistic. The methods used for the main study 
to recruit participants, collect and analyse data are described in detail in Chapter 6.  The 
main study had three distinct parts. Part 1 was a two-round Delphi consensus study, which 
determined the ‘activity standard’ for clinical pharmacy i.e. it confirmed a national view on 
the scope of the job of the clinical pharmacy team.  Part 2 was an Operator Evaluation to 
assess the transferability and reliability of the Royal Stoke Pharmacy Workforce Calculator in 
the hands of other operators.  The final part of the study consisted of qualitative interviews 
with pharmacy managers to explore the utility of the tool in different settings and to 
understand the reasons behind outlying data sets from Parts 1 and 2.  The methods used for 
each of these parts are detailed and justified. 
Results of the study are reported in Chapter 7 and describe the consensus achieved and the 
activity standard defined by the data returned.  The applicability of the Royal Stoke 
Pharmacy Workload Calculator to other settings is described, with the limitations identified.  
The final part of this chapter is the analysis of the qualitative data which enriches the 
quantitative results of the first two parts.  The development of a nationally validated tool for 
calculating pharmacy staffing requirements is discussed in detail in Chapter 8.  The criteria, 
by which the Royal Stoke Pharmacy Workforce Calculator can be considered to demonstrate 
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the various elements required for validity to be proved, are identified from the results.  A 
validated version of the calculator, suitable for distribution through pharmacy networks 
nationally, is published.  
A wider discussion of the findings of this research, the degree to which the aims and 
objectives were met, their place in the published literature and implications for practice is 
presented in Chapter 9. 
Chapter 10 concludes the study, highlighting the key findings and giving recommendations 
for further work and actions for practice.   
The final Chapters of this thesis (11 and 12) are for the reader’s reference.  These include a 
full list of references used in its construction, a glossary of terms used, copies of all relevant 
study documentation for their examination and a list of participant sites, so the reader has 
an understanding of the population from which the consensus was drawn and can identify 
the presence of key stakeholders. 
In summary, this thesis presents the evidence for the validation of the Royal Stoke 
Pharmacy Workforce Calculator and its applicability to pharmacy departments across the 
UK. 
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1. Introduction 
1.1 Background 
For many years the disciplines of industry and commerce have recognised the need to 
identify appropriate staffing resource.  In order to be competitive and generate a profit, 
staff resource needs to be carefully managed. In this time of financial austerity and with a 
growing elderly population with increasing reliance on health services, healthcare delivery is 
increasingly driven by cost containment and tight budgetary management and there is much 
that can be learnt from established approaches in industry in terms of staff resource 
calculation and productivity.  This challenge falls to all professions within healthcare and 
pharmacy is no exception. This study explores the validity of a staffing calculator tool 
developed to identify clinical pharmacy staffing resource requirements within an NHS 
hospital trust. 
1.2 The evolution of ‘clinical pharmacy’ 
The role of the hospital pharmacist has changed significantly over the past 40 years. The 
initial focus of the role was on dispensing and manufacturing of medicines within the 
confines of the pharmacy department.  The first steps were taken to working on the wards 
in the late 1970s by supporting nursing teams with stock management and safety checks of 
prescribed medicines.  Subsequently, through the 1980s, the focus moved towards one of 
direct patient-specific care. This was  initially delivered in the ward environment and now 
often in out-patient or domiciliary settings.  This ‘new’ (late 1970s) form of pharmacy 
practice was initially described as ‘ward pharmacy’ to distinguish it from that of dispensary 
based activities, but is now referred to as ‘clinical pharmacy’ which has been defined as 
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‘that area of pharmacy concerned with the science and practice of rational medication 
use’(1).  More specifically the delivery of ‘clinical pharmacy’ has been described as the 
provision of pharmaceutical care.  This expression was first coined by Hepler and Strand in 
their seminal 1990 paper ‘Opportunities and responsibilities in Pharmaceutical Care’(2).  
They defined pharmaceutical care as ‘the responsible provision of drug therapy for the 
purpose of achieving definite outcomes which improve the patient’s quality of life’.  They 
challenge the pharmacists to manage or prevent ‘drug related problems’ (‘drug’ referring to 
medicines use rather than illicit substances).  These ‘drug related problems’ were previously 
defined in an earlier paper by Linda Strand et al.(3) and these are summarized in Figure 1.1.  
How this should be delivered was not described, but pharmacists would need to access 
patient specific information to be able to identify and address the problems listed. 
Figure 1.1 ‘Drug related problems’ adapted from Strand et al. 1990(3) 
Drug related problems 
 
Untreated medical indication requiring drug therapy 
 
Too little of correct drug prescribed 
 
Patient not receiving the prescribed drug 
 
Too much of the correct drug is prescribed 
 
Adverse Drug reaction 
 
Drug interaction 
 
Drug treatment with no valid indication 
 
Wrong choice of drug 
 
Compliance with prescribed regimen 
 
 
 Lack of early clarity or direction from either Government or professional bodies regarding 
how pharmaceutical care should be delivered has resulted in a diverse and varied array of 
3 
 
services across the UK and other countries.  Service development has often depended on 
the success of various managers in resourcing and delivering specific services and then 
building on a successful service model(4). 
Through the first decade of this century a substantial body of literature became available to 
demonstrate the benefits of a ‘clinical pharmacy service’, in terms of both financial (cost-
effectiveness)(5-7) and patient care (morbidity and mortality)(8-10)  outcomes.  As the 
benefits of clinical pharmacy services became clear,  the need to deliver these services 
became more pressing and identifying, securing and maintaining the workforce to deliver 
‘pharmaceutical care’ has become a challenge faced by Chief Pharmacists and other hospital 
managers.  There is, however, fairly limited published work in this field and little national 
guidance.  An exception is in the specialty of intensive/critical care.  Critical care pharmacist 
groups, as part of the Faculty of Intensive Care Medicine have identified through consensus 
of experts from the United Kingdom Clinical Pharmacy Association (UKCPA) and the Royal 
Pharmaceutical Society (RPS), both standards of practice within this patient cohort and a 
pharmacist/patient ratio required to deliver these(11).  This group recommends 0.1 WTE 
pharmacist should be employed for every level three bed (providing care to patients 
requiring respiratory support or have two failing organs) and 0.1 WTE pharmacist for every 
two level two beds (providing care for patients requiring detailed monitoring, stepping 
down from critical care or require increased levels of monitoring). Aside from this much of 
the published literature focuses on the targeting of limited pharmacy resource in the most 
efficient way. This includes identifying ways of prioritising patients to receive 
pharmaceutical care to a level appropriate to their needs, along with the need to 
demonstrate productivity and value for money. 
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However, as other hospital services expand, it is essential that pharmacy resource grows 
alongside, otherwise increasingly a smaller proportion of patients will be able to receive 
pharmaceutical care as the staff will not have the capacity to see all patients and the need 
to prioritise services becomes more important.  When hospital business cases are submitted 
for funding of new or expanded clinical services, hospital pharmacy departments are often 
asked to submit their required resource needs to service this expansion.  With no nationally 
accepted service model or staffing guidance, the figures submitted are often ‘best guess’ 
and  due to the relatively expensive employment costs of the pharmacy workforce, 
substantial.  As a result, local experience demonstrates these often get rejected or 
arbitrarily reduced in the final submission and pharmacy resource effectively shrinks on 
each occasion, as existing staff have to deliver pharmaceutical care to a greater number of 
patients.  This suggests that a robust and objective means of identifying adequate staffing 
levels, that is evidence based and nationally validated is required. 
1.3 Reflections of a pharmacy manager 
 This section describes the challenge of identifying and securing adequate workforce 
resources in a changing clinical environment. 
Over the course of the past 14 years the delivery of healthcare in the area has undergone 
substantial transformation.  The acute Trust originally operated from three sites in a half 
mile radius of each other, which fragmented the delivery of care and resulted in many 
operational challenges and inefficiencies.  An ambitious building project was commenced to 
centralise services in a modern, state of the art premises on the largest of the three sites.  
The premise for its design was a focus on acute general and specialist care, with a clear plan 
to move routine services into expanded community based locations, both for rehabilitation 
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in-patient purposes and for out-patient clinics. As a result there was a substantial reduction 
(circa 300) in bed capacity in the design of the new premises.   During the course of this 
project the global economic downturn occurred and the resultant financial challenges for 
local government services and private businesses resulted in the planned community 
services not being developed.  This had a number of consequences.  There was not sufficient 
capacity for ‘step-down’ or rehabilitation patients in the community resulting in ‘bed-
blocking’ and negative impact on patient flow through the Trust.  As a consequence wards 
which should have closed when their service transferred into the new building remained 
open or shortly after closure, re-opened, to provide additional capacity.  The healthcare 
managers in these situations considered the need to employ additional nurses and doctors 
but made no provision for pharmacy resource.    Repeatedly requests for service delivery 
were received by phone, typically at the end of the day or working week for imminent 
implementation.  Initially, the expectation was for the pharmacy team to simply stretch 
resources, with no additional funds being requested.  Eventually the message that the 
resource could not simply be stretched indefinitely was understood by the business teams 
and pharmacy resource requirements began to be requested.  Our main challenge was that 
the staff numbers we were requesting were instinctively based on experience and because 
of the short timescales allowed for response, limited evidence to support the figures could 
be accrued and so the justification for the figures was limited and difficult to defend. As a 
consequence these values were challenged or arbitrarily reduced.   For a pharmacy manager 
this was increasingly frustrating and there was a very real risk that the staff resource would 
begin to fall short of that needed to deliver a safe service.   These challenges led to the 
development of the pharmacy workforce calculator (see Appendix 2). This calculator now 
referred to as the Royal Stoke Pharmacy Workforce Calculator (RSPWC) is an Microsoft 
Excel® spreadsheet (the development of which is described in more detail in the following 
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section) which calculates the pharmacy staffing requirement for a whole ward per annum.  
The development of this tool resolved issues for us initially – the objective spreadsheet-
based nature of the tool, appealed to the sensibilities of the business managers and led to 
much more successful requests for increased resource.   
The capacity challenges described were largely due to supporting the emergency admissions 
to the Trust.  Elective services had to develop different approaches to managing bed 
shortages, by introducing new procedures which substantially reduced length of stay.  In 
addition, to support the finances of this new premises additional income had to be sought 
and cases were developed to bring new business from neighbouring geographical areas e.g.  
the establishment of a major trauma centre covering parts of north and mid Wales in 
addition to Staffordshire and bariatric surgical patients from Shropshire.  This increased 
activity within the Trust, more patients to review, with no impact on bed numbers.   
Pharmacists provide care to patients not beds and this insidious creep in activity needed to 
be addressed so the workforce calculator was developed from its original prototype to allow 
its application in these circumstances.  The business managers required a little more 
convincing by the pharmacy team on this concept, but eventually it was accepted and 
application of the calculator over a period of time allowed the pharmacy resource to grow in 
line with the rest of the Trust.   
As a pharmacy team in Stoke-on-Trent we were keen to share our success with colleagues 
nationally and this work was presented at a national conference.  This generated much 
discussion and interest. Many colleagues recounted similar experiences and challenges and 
we were being asked to share the calculator widely.  This however, generated a level of 
concern for the developing team and those of us who used it.  The service delivery model 
that existed in Stoke was resourced on the basis of the calculator. We had no idea if this 
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would translate to other sites and whilst this could be a caveat in its use, if proved to not be 
transferrable and therefore discredited, we may lose the benefits we had gained locally.  
This was a risk we were not prepared to take.  So ‘to share or not share’ was the question.  
The answer was to validate and then to share, but the process of validation required time 
and led to the identified need for a focused project. 
1.4 Staff resources for clinical pharmacy services in Stoke-on-Trent 
The need for a robust and objective method of calculating staff resource was identified by 
pharmacy managers at the Royal Stoke University Hospital (RSUH) and the absence of 
national guidance as described earlier, led to their development of the ‘Royal Stoke 
Pharmacy Workforce Calculator’ (RSPWC).  This was based on time and motion data 
collected on a range of staff of differing grades and specialty i.e. junior and senior 
pharmacists (Agenda for Change Bands 6-8a) on a range of wards (excluding paediatrics, 
critical care and renal medicine) completing tasks that are required to deliver 
pharmaceutical care(12,13).  The calculator uses these task times, and the frequency with 
which the standard operating procedures of the department specify they should be 
completed, to calculate the pharmacy time required to deliver pharmaceutical care to one 
patient. Using the average length of stay data, bed numbers and average patient 
throughput, the resource required to support the whole service is identified in a more 
consistent and transparent way, than the ‘best guess’ approach.  
This tool has been used successfully within RSUH and is now accepted as part of its 
pharmacy business planning process.  It was internally validated by comparing the resource 
it calculated for a specific ward area, to that identified by more traditional and time 
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consuming methods of benchmarking with other organisations i.e. comparison between 
service specification and staff available to deliver this (see Table 1.1). 
This benchmarking exercise took several months, requiring multiple visits to several other 
hospitals to establish the pharmacy staffing resource needed for the unit, based on how 
similar services were delivered at these other hospitals. Apart from being a time consuming 
process, the output remained entirely subjective and open to challenge. In contrast, the use 
of the calculator resulted in a more objective assessment of the staff resource required as it 
was based on specific measurable activity necessary for patient care. This comparison 
resulted in local acceptance that the data that the tool had generated was reasonable and 
realistic.  
Table 1.1 Comparing existing staffing levels for Acute Medicine with Benchmark and RSPWC 
Ward Area Benchmark* Resource tool 
calculation 
Current staffing Shortfall 
Clinical Decision 
Unit 
1 x Band 8a 
1 x Band 6/7 
1 x Band 5 
 
1 x Band 8a 
1 x Band 6 
1.5 x Band 5 
1 x Band 8a 1 x Band 6 
1.5 x Band 5 
Acute Medical 
Unit 
1 x Band 8a 
1 x Band 7 
2 x Band 6 
2 x Band 5 
1 x Band 8a 
2 x Band 7 
0.55 x Band 6 
2.96 x Band 5 
1 x Band 8a 
1 x Band 7 
0.5 x Band 6 
2.0 x Band 5 
1 x Band 7 
1.46 x  Band 5 
*Benchmark – UHNM service compared with other equivalent Trusts – regional and national 
The RSPWC can be applied to a range of scenarios; the opening of new beds, for specific 
additional patient case numbers, for simple increases in throughput due to reduced length 
of stay and appraisal of existing resource for current activity.  It only calculates the staff 
resource required for the direct delivery of pharmaceutical care activities to patients, and 
excludes activities such as medicines information, staff development, and clinical audit. This 
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is because it is assumed that these activities will be funded as part of the core pharmacy 
service.  It is also not applied to areas such as critical care where nationally accepted 
pharmacist/patient ratios exist and already form the basis of staffing resource 
requirements(11). Finally the RSPWC identifies resource required across a 7-day service.  
This is not universally delivered across the Trust and as such for wards with lengths of stay 
less than 72 hours, a reduction to 5/7 of the value is used. There will be a proportion of 
patients for whom the service cannot be delivered if the pharmacy service is Monday-Friday 
only and the value adjusted accordingly. 
Examples of the use of the RSPWC in identifying required staff resource at UHNM include 
the conversions of a small ‘winter pressures’ ward with ad hoc pharmacy cover into a 
permanent medical ward with a greater number of beds. At around the same time a medical 
ward with a pharmacy service was converted to a short stay unit (SSU) with a much higher 
turnover of patients. Application of the RSPWC to the business data calculated the required 
resource and allowed successful negotiation of 1.0 whole time equivalent (WTE) Band 7 
pharmacist and 1.0 WTE Band 5 technician for these reconfigured services Monday to Friday 
(see Table 1.2). 
Table 1.2 Staffing requirements (WTE) identified by RSPWC for reconfigured wards.  
Ward Area RSPWC 
Calculation 
(for a 5 day 
service) 
Current 
Staffing 
Shortfall 
SSU 
1.26 x Band 7 
1.06 x Band 5 
0.5xBand 7 
0.5 x Band 5 
0.76 x Band 7 
0.55 x Band 5 
New Medical 
Ward 
0.28 x Band 7 
0.24 x Band 5 
Ad hoc cover 
0.28 Band 7 
0.24 Band 5 
 
The RSPWC has also been used to determine the pharmacy staff requirements for several 
surgical business cases that involved increases in patient throughput. In these cases the 
additional patient numbers were small and so the calculator generated small extra staff 
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requirements, such as 0.2 WTE for example.  However, to date, through consistent and 
persistent application of the calculator to successive business cases, 2.0 WTE pharmacists 
have been funded in this piecemeal way at RSUH, whereas without the workforce 
calculator, this service would have had to been delivered with no additional funding.  
1.5 Current approaches to identifying workforce needs in the NHS 
The RSPWC is based on local services and a local approach to staffing resource calculation.  
It needs to be considered in the context of a more general approach to workforce planning 
and more specifically in the context of NHS guidance.   
A Google® search of ‘workforce planning’ generated over 11 million results and amongst 
them are many management consultancy firms advertising their services to solve this 
problem for their clients.  One such company, the Hay Group, in their brochure ‘Strategic 
Workforce Planning’(14) identify the ‘five rights of workforce planning’.  The first of these is 
the ‘right size’, knowing that you have the right number of people in the right roles with the 
right time to deliver the job. The other four are ‘right shape’ relating to organizational 
structure and skill mix, ‘right place’ ensuring staff are available where and when they are 
needed, ‘right skill’ covering the need to have appropriately trained staff and the 
overarching ‘right cost’.  These are fundamental principles and apply to clients in all sectors. 
With the NHS workforce estimated at 1.4 million(15), placing it in the top five of worldwide 
employers, the number of Google® results directly linked to NHS workforce planning is 
unsurprising.    The King’s Fund recently published ‘Workforce Planning in the NHS’(16).  This 
explores workforce planning experiences and aligns these with the NHS strategic policy in 
three key areas – mental health, general practice and community services. In each of these 
the shortfall of staffing is identified and the future pressures that will arise.  It concentrates 
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largely on training and recruitment and retention issues generally rather than specifying 
methods of calculating the workforce required.  
Monitor, the regulator for independent Foundation Trusts, produced their ‘Strategic 
Workforce Planning Tool’(17).  This suggests that ‘strategic’ planning is ‘long term’ (defined 
as three years ahead). It identifies a four stage process.  Firstly to identify each staff 
‘cluster’, then to model the workforce demand i.e. workload to be completed by which 
groups, then to model workforce supply (including sickness absence).  Managers should 
then identify the gap between the last two stages and finally in stage 4 plan how to build 
the model of future workforce delivery.  It follows the same principals of the ‘five rights’ of 
the Hay group(14) at a very high level, leaving a significant amount of detail to be agreed 
and identified by individual managers in individual services. 
If the NHS Employers website is explored, workforce planning tools(18) are identified that 
were commissioned by the Department for Health with the aim of supporting managers to 
identify health science workforce requirements.  Three professional groups were considered 
pathology, physiological sciences and physical science and engineering. That most closely 
aligned to pharmacy is pathology and closer examination of this explains the process and 
application of this tool. Managers are asked to gather data about their available staff 
including grade, contracted hours and overtime.  They need to include services drivers e.g. 
numbers of tests, numbers of samples. Then they must describe time allocated to 
processes, activities or tasks, the list of which have been agreed through consultation with 
people delivering the service and is fixed in the calculator.  This is referred to as the ‘PAT list’ 
and time data collected for each activity on the list.   These data are then entered in to a 
spreadsheet which can be manipulated to model different scenarios.  This tool reflects that 
developed by Monitor above.  It gives greater clarity and indeed fixes the tasks to be 
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completed by different staff groups, but still requires a significant amount of localised time 
and motion data for individual managers if they are to use this tool in practice. 
The largest staff group in the NHS is that of nurses(15) and the Royal College of Nurses 
website has a link to a ‘Skills for health’- nurse workforce planning tool(19)  to guide 
decision makers as to the most effective level and mix of staffing. This is a comprehensive 
spreadsheet document with a separate workbook for different wards.  The user can enter 
the numbers of patients of different categories expected in an average hour and their 
opening times and the calculator works out the staff required from a list of timed activities, 
generated from work by Hurst et al.(20) (this is described in more detail within the literature 
review, see section 2.4.1).  This is a simple to use tool, applies the principles described 
above but requires little data collection by the user other than service metrics which are 
likely to be already known.  It has caveats in the text though that some sheets are driven by 
small data sets and that it is undergoing further development and cautions the user that the 
results should be ‘indicative only’.  
When considered in this context, the approach taken in the development of the RSPWC 
would appear to follow the principles outlined in documents produced for other allied 
health professions and the nursing workforce.  However, a similar document for Pharmacy 
has not yet been developed. 
1.6 The Lord Carter Report and the current political context 
In February 2016 Lord Carter of Coles(21) published the report of his investigation in to the 
‘unwarranted variation’ in service delivery within the NHS, with a resultant variation in the 
cost to the tax payer in delivering an apparently similar service.  There were a number of 
work streams within this project including clinical staffing, estates and procurement, 
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medicines expenditure and the pharmacy workforce.  It is explicit in the report that these 
latter two are seen to be interlinked. 
 “The delivery of hospital pharmacy services and the optimisation of medicines 
are intrinsically interwoven and, from a value perspective, can’t be separated” 
[Lord Carter page 30](21).  
With this in mind the report states that more pharmacists need to be deployed in patient 
facing clinical roles, rather than in doing tasks considered to be ‘infrastructure’ e.g. supply of 
medicines, education and training, medicines information and manufacturing of medicines. 
The percentage of pharmacists who are prescribers must be increased and that where 
possible the ‘infrastructure’ elements of the service should be delivered either 
collaboratively or through outsourcing to non-NHS partner providers. 
It recommends that each Trust developed and approved a ‘Hospital Pharmacy 
Transformation Plan’ by April 2017, to outline the process by which the pharmacy 
department would move to address the required changes in pharmacy services by 2020. 
It proposes a method of making more direct comparisons by the introduction of the terms 
‘weighted activity unit’ (WAU) – one WAU is equivalent to one inpatient admission – and 
the adjusted treatment cost (ATC) which defines the cost envelope expected for each WAU.  
This cost envelope includes staff resource to deliver the service, but it stops short of 
specifying numbers for each cohort of staff. 
The report is based on a series of benchmarking exercises run across the NHS with 
participant sites reporting on various elements of their service(22).  The metrics considered 
were developed from focus groups run nationally to identify priorities and “what good looks 
like” [Lord Carter of Coles, page 69](21).  The detail of the specific Pharmacy NHS 
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Benchmarking project is critically reviewed within the literature review (see section 2.5), 
where limitations and challenges are identified. However, the reality is that regardless of 
perceived shortcomings in its methodology or findings Lord Carter’s report is gathering 
political momentum. As a consequence, the attention of NHS Chief Executives across the 
country has been focused on the pharmacy workforce in their hospitals and there seems to 
be both a greater level of scrutiny and expectation of delivery from this profession than ever 
before.  Pharmacy departments are challenged to identify their productivity in delivering 
the existing clinical pharmacy services, whilst at the same time there is an explicit remit for 
expansion of the roles of pharmacists in supporting other professional groups.  With the 
required base-line staffing levels having not been established, this expansion may require 
additional staff.   Alternatively existing services may be delivered by a skill-mixed team, 
thereby releasing pharmacists into these new roles.  The development of a validated 
pharmacy staffing calculator would facilitate a more objective review of staffing needs and 
deployment. 
1.7 Summary 
Hospital pharmacy has evolved over the past 40 years and in its latest incarnation of ‘clinical 
pharmacy’ is seen to have many beneficial outcomes, in both patient safety and financial 
savings.  There is a political drive to develop and extend the role of the pharmacy workforce, 
but no nationally accepted tool exists with which to calculate the size of the required 
resource to deliver existing services as a baseline to these proposed developments. 
The RSPWC was developed by pharmacy managers at the RSUH for local staffing 
calculations.  Its wider application nationally requires validation of the elements of its use.  
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This study seeks to explore this validity or otherwise and its place in the context of current 
service delivery priorities. 
The next chapter considers the literature on workforce planning generally and specifically 
for healthcare and pharmacy and seeks to identify what evidence exists to support the 
components (tasks, times and frequencies) which drive the RSPWC.  
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2. Literature Review 
2.1 Overview 
The purpose of this literature search is two-fold.  Firstly, it reviews the literature to identify 
if other researchers have explored the issue of pharmacy staffing and to review the RSPWC 
in the context of this information. Secondly to identify if evidence already exists to support 
the components (tasks, times and frequencies) that are included in the RSPWC. 
The first section of this chapter describes the search strategy in detail.  This is followed by a 
review of the literature pertaining to workforce identification in general, learning from 
other disciplines and reflecting on the relevance of this to hospital pharmacy practice. The 
next section reviews the pharmacy literature to explore whether the challenge of identifying 
the necessary pharmacy resource has been addressed by other studies and to identify the 
evidence that already exists to support the underlying elements of the RSPWC.  Finally the 
implications of this review on the proposed study are considered 
2.2 Literature Search Strategy 
A search of the literature was performed in November 2015, and repeated at regular 
intervals (most recently June 2017) to identify literature relating to the methods used and 
proven for the identification of workforce requirements generally, as they apply to the 
healthcare industry and specifically in the pharmacy profession.  There were three strands 
to this literature review 
Firstly, a search of the ‘grey’ literature using Google® as a search engine with general search 
terms of ‘workforce planning’, ‘staffing levels’, ‘time and motion’, ‘hospital’  and ‘pharmacy’.  
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The broad search on ‘workforce planning’ generated results in the millions, with many of 
the top results relating to NHS healthcare.  The top ten hits relating to healthcare and 
published in the last fifteen years were reviewed.  These formed the starting point for the 
contextualisation of the study and the key findings from this review have been outlined in 
the introduction.  
Secondly the academic literature was searched for papers on identification of workforce 
requirements.  Health care databases were searched including Medline, Embase, CINAHL 
and Web of Science to identify work on this subject in allied health professions (AHP).  This 
ensured that learning from other disciplines was included in the development of this specific 
pharmacy tool.  The search strategy used accepted Boolean operators and equivalent Mesh 
browsers or thesaurus terms were used wherever possible.  Searches were limited to 
English language and published since 2000 (post Hepler and Strand(2)).  Combinations of the 
following words were used in searches across all identified databases. 
‘workload’, ‘time and motion’, ‘staffing resource’, ‘workforce’, ‘resource allocation’ 
The criteria for selection of papers was that they should discuss approaches to identifying 
required staffing levels for clinical care and description of the methods used to do so. 
Thirdly a search focused on the pharmacy specific academic literature was also conducted.  
This used the same database selection described above, with the same limitations applied.  
The keywords once more were combined using Boolean operators and Mesh browsers or 
thesaurus terms appropriate to the database were used.  Combinations of the following key 
words were used. 
‘pharmacy’, ‘hospital’, ‘clinical’, ‘ward’, ‘benefits’, ‘workload’, ‘time and motion’, ‘staffing 
resource’, ‘workforce’, ‘resource allocation’, ‘services’. 
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Inclusion criteria were research papers or journal articles reporting the deployment of 
pharmacy staff, the benefits of this deployment in financial and patient safety terms, those 
where time and motion figures were reported and those where staff deployment and 
productivity were described. 
Searches were repeated in different databases and combinations until no new relevant 
papers emerged.  Further literature was identified from the references of relevant papers, 
through routine scanning of contents pages of key journals as they were published and from 
personal communication with other parties working in this field.  The papers identified 
through this series of literature searches are discussed over the following pages and the 
implications of these findings for the development of the RSPWC are identified. 
2.3 Identification of healthcare workforce requirements 
The need for adequate human resources to deliver healthcare has been recognised by the 
World Health Organisation (WHO) and it recently updated its Workload Indicators of 
Staffing Need (WISN) tool(23)  which provides a framework for the provisions of healthcare 
utilising principles long used in industry.  It can be applied to specific services or whole 
health care systems and there is published literature supporting its use for example in 
Namibia, India and Uganda(24-26).  This can be considered to be the ‘gold standard’ 
approach to healthcare workforce resource calculation, but there is no published report on 
its application to a pharmacy workforce.   
The application of the WISN tool requires the gathering of experts in the field to define 
‘workload components’, the standard to which these should be delivered and the workload 
it is reasonable to expect one health care worker to achieve.  It includes recognition of 
‘unavailable’ time during the working year (e.g. annual, sick and study leave).  When all this 
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information is available it provides a calculation to identify required resource and where 
shortfalls or overstaffing exist in current provision.  It is a robust and established method of 
calculating resource but requires a significant time and operational commitment from a 
wide range of senior professional staff to deliver.  This approach is reflected in that of the 
Hay group(14) and also the Kings Fund(16), Monitor(17) and Skills for Health(19), with only 
the latter completing the full cycle for a specific staff group and none of them for pharmacy. 
The existence of the WISN tool and the reflection of its approach across a range of NHS and 
non-NHS workforce guidance would appear to suggest that this ‘methodology’ of identifying 
staffing resource is well established and accepted.  The literature was further explored to 
find reports of applications of this type of approach, rather than specific application of 
WISN, in healthcare settings.  The largest staff group in healthcare, the nursing profession, 
generated most literature, though one paper applying these principals to AHP was found.   
2.4 Identifying staffing requirements in the nurse and AHP workforce 
2.4.1. The nursing workforce literature 
The papers presented here are a selection of the literature post 2000 in which nursing 
approaches to the issue of workload calculation are describe.  The purpose of this section is 
to establish a context for the review of pharmacy literature and the development of the 
RSPWC.  It is not intended as a comprehensive review of the nursing literature as the 
nuances of acuity and workload of the nursing profession do not translate to that of 
pharmacy and would therefore not add relevant detail. 
Ghosh and Cruz(27) presented a pragmatic paper on this subject. They recognised the 
benefits to patient care of adequate nurse staffing levels and that, in developed countries, 
standard nurse-to-patient ratios have been established.  However, the affordability and 
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achievability of these ratios is questioned for services in developing nations, such as Oman, 
where this team are based.  Whilst acknowledging that the debate on the ‘right’ nurse-to-
patient ratio is ongoing and further research is required, they identified a problem for the 
here and now, namely that hospitals need some sort of tool to determine the nursing 
resource required to deliver care in their setting.  They highlighted a review that considers 
five different methods for workforce planning and conclude that a combination of methods 
may generate improved accuracy in the prediction of staffing requirements. They argued 
that the complexity of available staffing models puts the task of resource identification into 
the ‘too hard’ category and as a result either genuine requests are ignored or resource 
allocated on an ad hoc basis. The paper then described the development of a computer 
programme designed to model nursing staff requirements for hospitals in the Sultanate of 
Oman Ministry of Health hospitals.  This programme identified nursing numbers for a variety 
of care settings.  It was based on bed numbers, bed occupancy, available nursing working 
hours (taking factors such as annual leave and sickness into consideration) combined with 
an assumed nurse-to-patient ratio depending on acuity. It should be noted that this ratio is 
not referenced.  Finally a ‘workload factor’ was applied which recognised that there is lower 
workload during afternoon and evening shifts, but how this was calculated was not 
explained. Individual ward areas could then be applied to the calculator and a total 
organisation requirement identified by combining results. The computer programme 
developed to calculate the resource based on this model requires substantial local data 
collection and entry and the authors did not describe any validation process for this model, 
nor the experiences of its implementation.  It is suggested that this tool is only applicable for 
medium-term planning rather than day-to-day rostering, but that it allows managers to 
model different scenarios.  It also recognised that numbers alone do not ensure the quality 
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of the service and asserts the need to continue with adequate training and development of 
staff.   
In 2008 a UK team lead by Keith Hurst, described the development of a similar calculator 
tool for NHS hospitals(20).  They recognised that though tools were available to calculate 
staffing requirements they were complex to use and therefore often ignored and instead 
managers employed their own ‘professional judgment’. The project was intended to 
develop the existing Association of UK University Hospitals (AUKUH) ward staffing 
multipliers, which were workload and nurse to patient ratio based. These original multipliers 
were devised through professional judgment alone and it was unknown what standard of 
care they generated.  It was therefore determined by the research team, made up of senior 
nurses from across the UK, that a more evidenced based approach was required. Their 
method for validating and developing their calculator was to take the AUKUH multipliers, 
adjust them with evidence from the literature, alongside new patient dependency (i.e. 
patient acuity with respect to nursing care) workload data collected and validate their 
calculator by comparison with the more established, but time-consuming to use, Leeds 
University Acuity-Quality Staffing System. Their literature review identified a range of tools, 
recognising that none was perfect – but that if used, they needed to be valid and reliable for 
the specific setting for the output to be acceptable to the nursing team.  Data collection was 
led by experienced local practitioners at 3 AUKUH sites and reviewed the care of around 
2,800 patients, well in excess of that needed for statistical significance to be proved.  Data 
included rating of patient dependency using the two scales, time taken in delivering care 
and 135 quality standards which included timely assessment post-admission, speaking to 
patients and carers, inspecting the ward environment.  The ability of different nurses to use 
the tool reliably was proved in a smaller validity study.   Following detailed data correlation, 
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an algorithm for calculating direct care hours per day was constructed.  This was based on 
bed numbers and patient dependency ratings.  These were derived from observing around 
3000 hours of nursing care, documenting activities completed and time taken and finally an 
adjustment for non-available time (which they identified as 0.22 WTE, from the study 
attendance on nurses from 83 wards). For statistical significance of the comparison between 
the two calculators to be demonstrated the care of 200 patients needed to be reviewed.  
The data set achieved exceeded this and equivalence to the established but time-consuming 
method was proved.  Use by individual managers in real-life settings requires only the entry 
of either bed occupancy or acuity data to generate a staffing resource requirement for the 
ward on a daily basis. They conclude that this is an evidence based easy to use tool which 
has been made freely available for use by other sites via their website and subsequently 
through adoption by the NHS Skills for Health website(19) (see section 1.5).   
A different approach to workforce planning was taken by Twigg and Duffield(28).  They 
identified that nurse staffing levels in Australia at the time were at crisis point, with many 
nurses leaving the profession due to the pressures of under-staffed work environments. 
They proposed a new staffing model to address this issue.  Like Hurst et al.(20) they 
completed a literature review and identified 5 approaches to nursing workforce  
 Professional judgment 
 Top down – nurses/occupied bed or hours of care/patient approaches 
 Acuity-quality models such as the AUKUH model(20) 
 Timed task activity models 
 Regression analysis 
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The failings of each were discussed. For Hurst et al.(20) the challenge was that the model is 
based on nurses’ assessment of dependency which might be over estimated to achieve the 
level of care that the nurse thought appropriate, rather than actual need.  They then 
established a working party to develop a new model called the ‘nursing hours per patient 
day’ model (NHPPD). This group undertook two further tasks, in addition to the literature 
review, to develop the model.  They benchmarked current staffing nationally and they 
exercised professional judgment through consensus amongst senior nurses, though they 
note that this was “prone to significant variation” (Twigg et al., 2009 pg 136).  They then 
established a set of seven categories of ward e.g. a category ‘A’ ward has a stated NHPPD of 
7.5.  This is assumed to be the number of hours of nurse time per occupied bed per day but 
this is not stated explicitly in the paper, nor is there any detail as to how this has been 
calculated.  From the methods it would suggest that it is based on professional judgment, 
benchmarking and literature. A category ‘A’ ward would typically have one or more of the 
following characteristics: 
 high complexity patients,  
 have a high dependency beds within a ward,  
  be a step down ICU,  
 be a high intervention level specialist unit/ward,  
 have tertiary paediatric patients,  
 have mental health patients with a high risk of self harm and aggression,   
 have patients frequently on 15 minute observations.  
 
By contrast for a category ‘D’ ward with an NHPPD of five, characteristics would typically be: 
 moderate complexity patients, 
 acute rehabilitation ward 
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 emergency patient admissions >40%  
 moderate patient turnover >35% 
 mental health patients with medium to low risk of self harm and aggression.   
 
A senior nurse then appraised the hospital wards against the seven categories and identified 
the nursing requirements.  There is no validation of the tool reported and its application is 
subjective on the part of the senior nurse conducting the review.  Application of this tool to 
hospitals in Western Australia resulted in an increase of 313 nurses across the state’s public 
hospitals.  The author’s identify in their own appraisal of the tool that it removes 
subjectivity of assessment but this is not apparent in their description of the tool’s 
application.  They also identify two limitations of the tool.  Firstly that it does not fully deal 
with the issue of acuity as it relies on the judgment of the senior nurse and would benefit 
from an acuity appraisal as per Hurst et al.(20), i.e. the same element of that paper which 
was earlier described as its shortfall and that there was no evidence for the effectiveness of 
this tool in improving patient care. 
The team addressed this second element in later work(29).  They explored the patient 
outcomes that resulted from changes in staffing levels generated from the use of the 
NHPPD. Application of this tool generated increased requirements for staff numbers across 
all wards and the increased cost associated with this approach had been approved in 
budgetary terms.  The output of this investment was intended to be improved patient care 
which needed to be demonstrated.  They reported on a study conducted over a 4 year 
period in the state capital Perth.  Data collected from 3 hospitals with 1449 beds in total 
included staffing data on nursing time available for shifts and patient data extracted from 
the hospital coding systems.  This allowed analysis of nursing related outcome measures e.g. 
wound infection, urinary tract infections, pressure ulcers, pneumonias, and deep vein 
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thrombosis (DVT). The results demonstrated that after the implementation of the NHPPD 
staffing levels (requiring over 300 more nurses) mortality rates reduced by 25% and other 
patient safety measures also improved e.g. lower rates of pneumonia, pressure ulcers and 
DVT. The authors suggested that mandatory staffing levels should be implemented 
nationally as an evidence based approach to improving patient care.  
An American perspective was presented by Hughes et al.(30).  In their recent paper they 
described ‘traditional’ methods of calculating nurse staffing based on midnight census i.e. 
number of occupied beds at midnight (the details of this calculation are not presented).  
They proposed that this was an underestimate of staffing requirements as it did not take 
into account ‘patient churn’ i.e. admissions, discharges and transfers all of which are more 
labour intensive than looking after a single patient for a shift. The aim of their study was to 
compare workload estimates of patient churn using three different measures and the 
different nurse staffing levels to deliver this care.  Workload data (details not specified) was 
collected from 183 wards over 32 hospitals for a two week period, along with staffing levels.  
The adult care wards were grouped into three categories, general medicine/surgery, 
intermediate care and critical care to allow different rates of patient churn to be 
established.  Using the data collected the different methods of calculating staff 
requirements were applied to calculate and compare the staffing numbers generated. The 
full calculation is not provided, only the element related to patient churn and its impact on 
final staffing numbers, so full appraisal of this approach is not possible.  In both cases the 
methods that included patient churn generated statistically higher staffing levels than 
midnight census.  The authors concluded that to accurately forecast staffing needs it is 
essential to include patient churn to identify workload.   
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Finally work on this topic by the Nursing and Midwifery Workload and Workforce Planning 
Programme for Scotland was described by Flynn, Kellagher and Simpson(31).  In a guidance 
paper published in 2010 they suggested an approach to nursing workforce identification 
that does not depend on a single tool but instead triangulates requirements using a number 
of approaches (see Figure 2.1)  
Figure 2.1 Triangulation in nursing and midwifery workload and workforce planning  
 
 
 
 
 
 
The speciality specific calculation tool refers to the use of a calculator that has been proven 
to be applicable to the speciality in question.  The Hurst et al. model(20) is established for 
acute care settings but may not be applicable to community or mental health units for 
which other methods may be more valid. Flynn, Kellagher and Simpson go on to identify 
four tools which can be used.  All these tools specify a 22.5% predicted staff absence rate 
and include varying degrees of acuity assessment.  The staffing levels calculated should be 
triangulated with clinical outcomes as defined by care quality indicators e.g. falls and 
pressure ulcer prevention and finally reviewed with the professional judgment of the 
relevant manager.  They also identify the need for education of practitioners in the use of 
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the tools so that they are applied consistently.  This paper does not provide details on the 
calculations.  It is more a guide to their practical use and implementation.   
In summary this selection of the nursing literature illustrates a number of points. Firstly, it 
identifies the benefit of a simple, easy to use calculator tool, based on objective 
measurement of workload. Secondly, there is a need to consider acuity and ‘patient churn’ 
if workload is to be accurately assessed. Thirdly, any staffing model should be used 
alongside quality outcome markers to demonstrate effectiveness of the staff in delivering 
patient care.  Finally, we are reminded by Flynn, Kellagher and Simpson of the need for 
managers to triangulate staffing calculations and quality indicators with the pragmatism of 
professional judgement(31). 
2.4.2. The AHP workforce literature 
Only one paper was identified through the literature search to complement the information 
already discussed in the NHS employers workforce planning tool(18)(see section 1.5).   
Adrian Schoo and colleagues presented results from an Australian study conducted in the 
state of Victoria(32).  This study had three objectives, namely to identify from the literature 
current methods of quantifying workforce requirements amongst the AHP, to identify the 
potential use of these with their state and to identify the potential barriers to use of these 
tools.  Pharmacy is not included in the list of AHP specified in the objectives but the 
profession is represented in one of the focus groups conducted and in the literature (two 
papers from 1980 and 1995, predating the limit for the literature review).  Their literature 
review analysed 78 papers which met their inclusion criteria and the initial comment was 
that there was a lack of consistency in use of descriptors within the literature which made 
identification of suitable papers and direct comparison between them difficult. They 
conceptualised the topic through a simple relationship of service activity or demand to 
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workload and the labour required to deliver it.  From the literature on deriving workforce 
they identify four main types of methods for calculating workload capacity (see Figure 2.2) 
and a fifth approach of mixed methods was also identified.  Which of these is most 
‘accurate’ was not established from the literature.  They also reported that the application 
of these tools had been demonstrated in local settings, for specific professions, rather than 
as a strategic, regional or national approach for AHPs.  The lack of progress with 
development of robust workload calculation was summarized from the literature in three 
categories. 
Figure 2.2 Methods for calculating workload capacity (adapted from Shoo et al.(32)) 
 
 
 
 
 
 
 
 These included that activity could not be accurately captured within single professions, let 
alone across the range of AHP, due to the lack of specified performance measures; the 
difficulties associated with difference in approaches to service delivery in different settings 
e.g. hospital v community and finally the suspicion that a rigorous tool would not allow 
space for professional judgment.   
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Following their literature review a series of focus groups were held to discuss the issues 
identified.  The findings relating to small, site-specific application of tools were upheld, with 
a variety of measures being reported.  The impact of patient acuity was not discussed.  This 
might have been included in the reference for the need to triage patients for service 
provision, though at face value this appeared to relate to managing workload by seeing 
patients appropriately, rather than a variation in workload because of acuity.  The need for a 
tool to be practical for use was identified in both the literature and focus group discussions. 
Four main considerations when choosing a calculator tool were identified 
 That it should be simple to operate, requiring minimal time by user i.e. using 
available data 
 That it had technical acceptability i.e.  it is seen as valid by the healthcare 
practitioners 
 That it’s output is comprehensible i.e. results accepted and understood by non-
clinicians 
 That it is flexible, in that it can adapt to changing models of service delivery 
The authors acknowledged the complexity and challenges of developing a fully functional 
resource calculator.  However, this is countered within their discussion where they 
identified a trend within state government to standardize workforce planning approaches 
and cautioned that unless there is investment in this process there is a risk that a sub-
optimal solution may be forced upon professions.  
In summary this paper adds little detail to the process of workforce calculation but concisely 
summarises the challenges faced when trying to develop and implement such tools, key 
features to include the success of implementation and a warning of the urgency of investing 
in this for the AHP.  
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2.5 Review of the pharmacy staffing workforce literature 
  Within the pharmacy profession the ‘dilemma of establishing effective pharmacy staffing 
levels’ is recognised and debated(33,34).  There are a small number of papers that describe 
in detail the development of methods of identifying the pharmacy workforce resource to 
deliver the service, but the focus of much of the literature is on prioritisation of resources, 
rather than the establishment of the required levels of staffing to deliver that service and 
the productivity of the pharmacy team.  In recent years the global economic crisis has 
resulted in reductions in healthcare funding and pharmacy departments are often faced 
with using staff reductions as their only way of meeting the required saving targets(35), so 
there is need to prioritise resources to deliver greatest effect and demonstrating the 
benefits or outcomes of the service is necessary.  This review of the pharmacy literature will 
consider the relating to the identification of staffing resource requirements, prioritisation, 
productivity and service benefits. 
It has already been identified that there is no specific guidance as to the delivery of 
pharmaceutical care and service models have developed in localities based on historical 
funding(4).  The challenge of quantifying the staff to deliver the service in multiple different 
settings was recognised by Schoo et al.(32,35) and it may not be possible to produce a 
universal calculator because services are too different.  A description of the delivery of 
pharmaceutical services has been produced by a London-based team(36).  Onatade, Miller 
and Sanghera report on a quantitative comparison of ward-based pharmacy services across 
seven acute NHS hospitals in the UK. They recognised that whilst some guiding principles 
exist it is not clear if clinical pharmacy services are provided in the same way at different 
hospitals, so the aim of their study was to quantitatively compare key clinical pharmacist 
activities across a number of Trusts.  The study was based across three NHS trusts in Greater 
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London and included seven different hospital sites (four teaching hospitals and three district 
generals) with bed bases ranging from 180-1000.  Only one site had full electronic 
prescribing.  At each hospital, pharmacy teams (pharmacists, technicians and support 
workers) visited the wards on a daily basis and the activities they completed included the 
review of patients’ clinical status and assessment of prescriptions to ensure safe and 
effective use of medicines.  In addition they ensured a supply of medicines was available, 
provided information and guidance on the use of medicines, discussed treatment with 
patients and completed medicines reconciliation (MR). The latter is the process of ensuring 
an accurate and up to date record of current medicines is recorded on transfer between 
settings and particularly on admission to hospital.  The variety of activities was consistent 
across the seven sites, however the detail and scale of their delivery varied across the 
settings.  The Monday-Friday (9am-5pm) service comparisons identified that some sites 
have high percentages of wards with pharmacists present for the full day i.e. 9-5pm and 
others have many wards which have a time-limited service of around 2-3 hours per day.  
Clinical verification of prescribed medicines is routinely undertaken by the ward based 
pharmacist, but, in their absence, this duty falls either to a ‘discharge team’ or the 
dispensary.   Data collection for this study was done using data collection forms developed 
following a ‘brain-storming’ session to ensure that the main duties were captured.  The 
duties listed in this paper reflect those tasks included in the RSPWC.  Following a pilot on 
each site, data collection was undertaken for five consecutive weekdays.  Data was collected 
on over 13,000 patient encounters (review of drug chart) and 40,000 activities took place. 
There were a number of activities for which there was no statistically significant difference 
in their delivery across the seven sites. These included MR, transcription checks, 
confirmation of allergy status, supply and checking of discharge medication and 
consultations with patients.  Those activities with statistically significant differences in 
32 
 
frequencies across the sites included, checking notes and blood results and making 
interventions.  Another statistically significant difference between sites was the time spent 
per patient.  Pharmacists at two hospitals spent more than eleven minutes per patient (in 
one of these hospitals 99% of wards have full time pharmacist cover and also registered the 
most interventions).  At the remainder, pharmacists spent less than ten minutes/patient. 
Explanations for some of the differences in service provision were suggested.  These 
included use of technology and specialities provided e.g. high numbers of ‘calculations’ in a 
hospital with high numbers of neonatal and paediatric beds and low numbers of ‘check of 
blood results’ in a site with the least acute patients, suggesting treatment was more stable.  
No patient outcome measures were described.     The authors believed that the multi-site, 
multi-organisation, large scale data collection makes this work generalisable.  They did 
recognise the absence of data collection by technical and support staff, the self reported 
nature of the data collection and the London focus of the study which might have 
influenced the results.  The bed/pharmacist ratio was not reported in this study, though it is 
possible to extrapolate this from the data presented.  It suggests that there is a narrow 
range, with six of the seven sites having between 16.6-18.5 beds/pharmacist and the 
seventh, less acute site, having 22.5 beds/pharmacist.  However, the pharmacist time/beds 
ratio will be substantially different due to the range of pharmacist hours per day per ward 
that is described.  From the available data, it is not possible to extrapolate this, but the 
extremes of the data set serve to highlight the ‘unwarranted variation’ in service delivery.  
In two neighbouring hospitals the pharmacists might have twice the amount of time 
available to deliver care to broadly the same number of patients. The difference in the 
service provided by those sites relates to those activities which were done at statistically 
different rates.  It is not known which is right or whether there are patient outcome 
differences.  This is the first published, quantitative comparison of the delivery of 
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pharmaceutical care and serves to describe the phenomenon being explored in this 
validation study.  What this illustrates is a difference in available resource and from the 
literature review published methods of calculating this requirement are few. 
If we turn our attention to the literature relating to the identification of pharmacy staffing 
levels, a small number of papers exist.  Within the UK such projects have been undertaken 
in the past and much of it has focused on dispensary(37,38) or oncology services(39). In 
2004 Acres(37) described an approach to reviewing required staffing levels in his pharmacy 
dispensary, but this is not directly relevant to clinical pharmacy services and so is reviewed 
for context purposes.  He used a simple process to calculate capacity and demand and from 
this identified the shortfall in his service.  The capacity of his team was calculated as the 
total number of hours available to the service each week (this included consideration of 
annual leave, sickness absence and study leave).  The demand was the number of items 
dispensed (using retrospective data from previous financial year) divided by dispensing rate 
items/hour to identify how long the workload should take.  The shortfall in his service was 
calculated by subtracting capacity from demand.  It was reported as a 35% shortfall in 
capacity against demand.  This process followed the principles of WISN(23) but it was small 
scale, one Trust, and only for dispensing activities.  No data was collected for clinical 
checking of prescriptions or accuracy checking of final items.  He recognised that it did not 
solve his staffing problems or directly improve morale but allowed an objective review of his 
service and provided answers to challenges relating to delays and he suggested that it 
would illustrate the impact of any investment. 
Low et al.(39) reported a year earlier on a similar project undertaking to support capacity 
planning for cancer services.  They established a working party in Scotland, chaired by a 
chief pharmacist, to consider the subject.  They recognised the absence of workload data for 
34 
 
clinical practice and they established a focus group to discuss and identify the required 
resource.  This two person focus group identified the resource required for clinical 
pharmacy services for a cancer unit as 1.0 WTE as lead for unit (0.4 WTE if not a specialist 
centre), 1.0 WTE per 30 inpatients and 1.0 WTE per 20 outpatients.  They used Purkiss(38) 
figures for dispensing and aseptic services as these were felt to be reasonable and 
subsequently produced a list of WTE staff requirements for a range of pharmacy services 
required for the delivery of Cancer treatments.  This paper has a number of limitations, 
some identified by the authors, namely that the grade of staff is not identified nor the acuity 
of the patient illness and their need for pharmaceutical care.  In addition the methods used 
to calculate the WTE for clinical pharmacy are not explained and the focus group was very 
small, which leaves the output open to challenge as simple opinion not consensus. 
The paper by Purkiss(38) is worth review, despite it being outside the criteria for inclusion 
by means of its date (1997).  The model proposed by him at that time is still referred to 
twenty years on whenever pharmacy staffing levels are discussed by pharmacy managers in 
networking settings.  Therefore understanding its concept and output is an important basis 
for current work.  He starts by quoting a previous commentator  
“It has been the dream of many hospital pharmacy managers that a formula 
would be derived which could be used to predict staffing levels and that health 
authority members and managers would see the logic behind the statistics and 
provide appropriate funds”  [Riley in Purkiss, 1997 pg 393](38) 
He identified that computer models developed at that time for the purpose of calculating 
staff resource required comprehensive data sets to be gathered which was time consuming.  
Furthermore, whilst benchmarking was becoming fashionable, the process had inherent 
limitations and risks.  He identified the limitations due to data quality issues in self reported 
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data sets, and the potential of bias in data submitted by managers with different incentives.  
Risks associated with benchmarking were outlined and included that all would be driven to 
the average, rather than the weakest aspiring to the best and that there was a presumption 
that managers had their current staffing levels correct.   He therefore proposed a simple 
model which would allow calculation of staff resource for all elements of a pharmacy 
service.  The dispensing WTE were calculated using JAC® data.  The aseptic services data 
provided the evidence for that WTE requirement, similarly with medicines information.  In 
none of these categories are the calculations provided.  For the clinical service he identifies 
the need for 1 WTE pharmacist (AfC 8a equivalent) per speciality e.g. respiratory medicine.  
There is no indication how many wards, beds, patients this might cover.  Other staff groups 
were allocated based on reasonable ‘judgement’.  Within the paper examples of application 
of his model were given and these included the expansion of existing services and the use of 
‘fractions’ of WTE e.g. 0.2 WTE being used to grow a service incrementally.  He concludes 
that the ‘dream’ had become a reality.  This paper demonstrates that the need for simple 
methods of calculating workforce requirements has been relevant to pharmacy 
management historically and, whilst the ‘solution’ may have been identified by the team in 
Sheffield at that time, there is a need for an update on this model to reflect current working 
practices. 
In the more recent published literature, work by an Australian team comes closest to 
describing a method of identifying the resource required to deliver pharmacy services(40).  
This work is based on a PhD study of around 4000 patient admissions and detailed time and 
motion work on the 20,500 pharmacist activities completed for these patients, analysed by 
patient group(41).  Their calculation method had three components 
 The data from Stutchberry et al.(41). 
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 The frequency with which tasks should be completed as specified in the national 
Standards for Clinical Pharmacy Services(42) 
 The knowledge of the ‘unavailable pharmacist time’, which related to the mean 
non-clinical time spent at work, rather than the out-of-work unavailable time 
identified by WISN(23) 
 
Using this approach the team calculated the number of patients for which an individual 
pharmacist can care, by patient group.  This work reflects and supports that done already on 
the RSPWC since several of the clinical activity timings identified cross-reference with those 
suggested in the RSPWC (see later Table 2.1 page 55).   The national standards though 
require daily patient review, so frequencies of many activities are greater in this model than 
in the RSPWC. Another difference is that in this Australian model, only pharmacist time is 
considered, as there was less routine use of technician staff in current practice(42).  
Pharmacist time per patient is, therefore, greater than that identified in the RSPWC, as 
pharmacists delivered all elements of the service provided.  The RSPWC includes 
calculations of various grades of support staff resource required to deliver the supply and 
distribution of medicines for use by this patient cohort, as well as the clinical element, of 
direct patient care.  This is omitted from the Australian model. Whilst its application in the 
identification of pharmacy resource for a specific cohort is demonstrated, it is not apparent 
if this model could be applied to the business case process, particularly, for example, the 
incremental growth of commissioned services in surgery.   
With little guidance available on the required number of staff to deliver a clinical pharmacy 
service, managers have recognised that they have to use the staff resource they do have to 
deliver care to those patients who need it most.  They have to prioritise their service and it 
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is this prioritisation of services that is the focus of much of the published literature.  Much 
of this is American as the privately financed nature of the service drives closer and more 
detailed scrutiny of what services are being provided and therefore charged. 
Granko et al.(34) describe a tool developed to allocate clinical pharmacist resources(34).  
This development involved a process of consensus amongst a number of groups of clinical 
pharmacy leaders. They scored scores service areas based on patient throughput, severity of 
illness or clinical condition by historic patient group characteristics, teaching activities, drug 
costs and high risk medicines for example anti-coagulants, anti-epileptics and anti-biotics.  
The composite score achieved for each service area is then ranked and allows prioritisation 
of resource to the most high risk service.  They do not describe what pharmacy service is 
delivered to those areas whose priority falls below their identified top 20 high risk services.   
Similar work to prioritise service delivery according to risk was presented by Bednall et 
al.(43).  This is similar in its methods (with the exception of teaching commitments) and 
conclusions as that described by Granko et al.(34).  No patient outcome is demonstrated in 
either paper and the validity of these ranking models is unconfirmed. 
The East and South East England Specialist Pharmacy Services team have produced a 
resource for managers to support the prioritisation of pharmaceutical care(44).  This is a 
comprehensive guide on methods of delivery of care, to support managers in the planning 
and delivery of service. On the subject of prioritisation they recognised that it is not possible 
to review every patient every day (cf SHPA standards(42). They then identified three areas 
to consider when prioritising patients.  These are the drugs the patient is prescribed, the 
underlying health of the patient and the operational priorities of the organisation.  They go 
on to suggest the activities necessary to identify such patients which include MR, screening 
ward lists for new patients, reviewing notes, charts and blood results and in liaison with 
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ward staff.  In addition they considered skill mix in detail and outline anticipated 
competencies of differing grades of staff, suggesting clinical areas where they maybe most 
acceptably deployed.  Once more this paper focuses on doing the best you can within the 
resources available rather than identifying the resources needed to deliver the service. 
The accuracy of prioritisation of services by the allocation of a ‘risk score’ has been 
investigated by a team at University Hospital Birmingham(45).  Their work, at a single 
hospital with full electronic prescribing, involved the review of almost 59,000 patient 
admissions over a two year period to establish if it was possible to allocate a ‘risk score’ to 
patients based on demographics, types of drugs prescribed and blood results, which would 
then allow direction of staff resource to the most needy patients.  This work demonstrated 
that a ‘risk score’ could be calculated, but when this was compared to actual pharmacy 
intervention data it was found not to be either specific nor sensitive enough to accurately 
predict need for pharmacy intervention.  There was a positive correlation with increased 
age i.e. patients over 80 years old were most likely to require pharmacy intervention and a 
paradoxical decrease in interventions for those patients with renal or liver dysfunction.  
They suggest that prediction of the level of pharmaceutical care need in a patient cannot be 
predicted by metrics alone but requires an element of professional judgment which is not 
well defined. 
Within Scotland’s pharmaceutical services a ‘pharmacy triage’ process has been established 
– again to prioritise limited resource by using the professional judgment of a pharmacist 
following initial clinical review.  They use a red-amber-green (RAG) approach to identifying 
patients requiring further pharmacy input(46).  This is once more based on various patient 
characteristics e.g. patients requiring MR, drugs requiring therapeutic drug monitoring and 
patients with liver or renal impairment.  The frequency of subsequent review is dependent 
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on this initial triage process, which is repeated on subsequent reviews and the RAG scored 
amended.  The method of compiling these characteristics is not reported and the evidence 
from Suggett and Marriott(45) would suggest that the presence of renal or liver impairment 
is not necessarily a good marker of need for pharmaceutical intervention. The Scottish team 
report a reduction in pharmacist time spent on ‘low risk’ patients as a result of using this 
tool but again no patient outcome data is presented 
In another recent British paper, published in the European Journal of Hospital Pharmacy(47) 
the evaluation of the implementation of a pharmaceutical assessment screening tool used 
to identify pharmaceutical acuity of patients on admission is reported.  This was a small 
study (35 patients), using a similar RAG approach to the Scottish model.  All pharmacy staff 
were trained on the use of the prioritisation tool and six months post implementation was 
evaluated by a team who independently verified the priority assigned to the study patients. 
The results failed to demonstrate acceptable validation, in that pharmacists using the tool in 
practice did not assess patients’ acuity to the same level as the assessment panel.  A 
number of reasons for this were discussed including training and compliance of staff using 
the tool, but also whether it accurately identified the patients most in need of 
pharmaceutical in-put.  The authors suggests that clinical experience and judgement of 
individual pharmacists on individual patients plays as significant part. 
This literature suggests that much time and effort is being expended in the search to 
identify methods to prioritise pharmaceutical services, with little robust evidence of success.  
There is a need to identify what resource would be needed to see every patient according to 
their actual pharmaceutical need and, as suggested by Acres(37), even if the funding or staff 
are unavailable to meet this need, at least the gap would then be known and allow 
appropriate acknowledgment  and mitigation of risk. 
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As well as trying to prioritise patients for pharmaceutical intervention another focus of the 
literature is the productivity of clinical pharmacy services, to justify the investment of staff 
time in delivering pharmaceutical care. 
Krogh, Ernster and Knoer describe a method of delivering staffing-to-demand as a way of 
providing a cost-managed service(35). Their model is based on a ratio of actual 
activity:staffing against budgeted activity:staffing, aiming for 100% productivity at all times.  
Their work identified a strong correlation between unit of service (UOS) and daily patient 
census and by monitoring daily patient census early in the working day it is possible to 
calculate the staff required to deliver care over the 24 hour period.  Where census is down, 
staffing is reduced either by voluntary or compulsory reduction in working hours and calling 
in additional staff if census is higher than normal, or staff sickness occurs. This model is 
dependent on the budgeted staff-to-work ratio being correct but Krogh, Ernster and Knoer 
give no suggestion as to how this is calculated.  In addition there is also the need for a 
flexible workforce, available at short notice for additional shifts and prepared to work fewer 
hours than planned.  This model proved effective in reducing staffing costs, but there is no 
evaluation of service quality or patient outcomes.  Human resource issues such as job 
satisfaction, pay and benefits also had to be managed.  In addition the UOS monitored do 
not include clinical activities; this maybe because of the lack of availability of robust 
workload data for clinical pharmacy services. The authors suggest that this might not be 
transferrable to other sites due to different patient cohorts and services delivered, but there 
is a need to ensure that staff levels match activity.  In addition they point out that it is only a 
mathematical model and not a substitute for sound judgement, echoing the guidance from 
Flynn , Kellagher and Simpson(31).  
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Naseman and colleagues(48) describe another approach in the US to developing a pharmacy 
productivity model.  This was based on units of activity rather than basic metrics such as 
doses dispensed, which are often used in external benchmarking.  They capture activity 
from all staff groups i.e. pharmacists and technicians.   Their method was to use an ‘expert 
panel’ representing all elements of the workforce to identify the key activities for each staff 
group and the associated time standards.  For pharmacists the key activity was clinical 
verification of prescribing and the process was weighted by drug i.e. chemotherapy would 
take longer than a laxative to verify.  For the technician group time standards were created 
by analysis of historical workload by drug category and then observation of process to 
determine timings for each category.  These time values were then applied to data reports 
from the electronic system relating to verification and dispensing on a monthly basis.  To 
these figures were added fixed routine commitments and then the final figure was 
compared with actual work hours to establish productivity.  This model was compared with 
others used in external benchmarking and found to be comparable.  The main advantage 
cited in the discussion being the timeliness of data availability.  Their approach used in-
hospital data rather than being based on financial charges post-discharge which often result 
in time lag.  This allows a more responsive adjustment of staffing to activity.  The 
transferability of this model is not proved.  This paper identifies a methodology for 
identifying time standards for pharmacy activities.  It is however limited to single activities 
for both pharmacists and technicians, rather than the breadth of professional practice and 
patient outcome data which is not recorded.   
 Another common measure of relating staffing costs to out-put is that of benchmarking, i.e. 
comparing individual departments with the group results of their peers.  In an attempt to 
describe a more general staffing picture, Fitzpatrick and Sanders(49) reported on a 
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benchmarking exercise undertaken to compare staffing establishments across the UK 
relative to hospital admissions.  This was an update of a previous paper(50). The mean 
percentage whole time equivalent (WTE) pharmacist per admission to acute hospital was 
identified as 0.114%.  A wide variability in this figure was noted both nationally and 
regionally, ranging from 0.095 WTE/admission in the South West and 0.135%/admission in 
London.  It would be reasonable, therefore, to assume that there is an accompanying 
variability in the service delivered, which would suggest that this is being done based on 
utilisation of available resource rather than identification of need.  This variation had 
remained unchanged since the previous paper although staffing levels had grown along with 
activity over the intervening years. 
Much interest has been generated in the size and deployment of the NHS pharmacy 
workforce by the NHS Benchmarking project which recently reported on its review of 
hospital pharmacy services(22) and is the evidence base for much of the Lord Carter 
Report(21). Trusts were invited to participate by entering their own data against an array of 
categories, from number of staff in individual staff groups, to whether the directorate is 
independent or part of a large section of the organisation; from existence of service level 
agreements to antimicrobial policies.  This was a wide ranging study across all aspects of 
hospital pharmacy with clinical pharmacy included as one of the sections.    Categories of 
data included numbers of pharmacists per 100 beds, time spent on wards per 100 beds, 
numbers of ward rounds attended per week, numbers of clinics attended per week.  
Results, available to participants only via password protection on the website, reported as 
bar charts against an identified ‘benchmark’ which is the mean or median depending on the 
data set.  Much has been made about the position of a Trust against a benchmark.  The data 
is anonymous except for the users own data and relative position above or below the line 
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can be subjectively judged as ‘good’ or ‘bad’.  The reality is that it can be ‘spun’ either way.  
This is a powerful tool and used by decision makers to form judgements as to whether a 
department is delivering relative to its national peers.  The data does not clarify activity 
delivered at each site and as demonstrated in the paper by Onatade, Miller and 
Sanghera(36) the pharmacists/bed metric does not necessarily represent pharmacist-
time/bed.  Another comparison between these papers is of note.  They both identify the 
same figure for the mean percentage of pharmacist time spent on a ward each day as 66% 
(equivalent to approximately 5 hours/day) and yet Onatade, Miller and Sanghera’s paper 
identified a substantial number of wards within their study that had pharmacists allocated 
for only 2-3 hours/day. There appears to be a mis-match between workload and resource. 
This benchmarking data gives numbers but little in the way of outcomes; however this 
review has started to define the priorities for the service and shape key performance 
indicators for clinical pharmacy. Do you attend ward rounds? How many active prescribers 
do you have? Do you MR your patients within 24 hours? What percentage of patients do 
you see each day?  It describes what different Trusts are saying they deliver with the 
resource they currently have. It does not describe what pharmacists should be doing when 
they see those patients, what tasks need to be done and how long they take and how many 
staff might be needed to deliver this service.  
The pitfalls of external benchmarking identified by Purkiss(38) were further expanded in a 
series of papers by Rough, McDaniel and Rinehart(51,52), along with suggestions as to how 
to avoid them. In the first paper they identified that benchmarking is only effective if 
services are compared like for like and that for clinical pharmacy there is no accepted 
standard for measuring productivity(51).  A series of limitations of pharmacy benchmarking 
processes were identified.  These included: 
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 Definitions not being aligned between participants and so answers are not 
comparable 
 Questions often do not reflect best practice 
 Drug expenses not categorised e.g. sites with Cancer services will have much higher 
spend 
 Acuity measures not sensitive enough  
 Clinical activity not accurately captured 
 Contractual differences are not  recognised 
 ‘Gaming’ in the reporting (i.e. shaping the results by the responder to suit purpose) 
In the second paper the team suggested strategies for the effective use of benchmarking 
tools(52).  They advocated the value of ‘internal’ benchmarking i.e. developing performance 
metrics for individual services that are more representative of the service.  Their approach 
to developing this benchmark is to first identify the core activities that should be measured 
and methods for capturing that data.  To establish the time-standard for these activities 
they suggested, either ‘borrowing’ from another department or running a ‘Delphi’ approach 
amongst pharmacist practitioners internally to identify how long the tasks should take. The 
mean time from this response should be fed back and participants given the chance to 
amend their response.  They suggest this should then be followed by a small sample 
confirmation by direct observation.  Once these measures are agreed and accepted data 
should be collected on a routine cyclical basis.  The authors recognised that this is a time 
consuming activity for individual sites but that its value is in demonstrating the quality and 
outcome measures of a service which are rarely addressed by external benchmarking. 
The issue of the need to effectively capture clinical activity is one that is identified and 
addressed by Pawlowski, Cusick and Amborn(53). In their 2102 paper, they identify that, 
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over a three year period, patient numbers in their organisation grew, but pharmacy staffing 
remained static.  External benchmarking was not effectively capturing the clinical elements 
of their service.  They recognised that they were unable to describe the clinical pharmacy 
workload in a manner that reflected its importance to the delivery of safe, effective and cost 
effective care and that without this justification existing and future services would be at risk.  
Their first step was to commence manual tracking of pharmacist activities such as 
clarification or confirmation of orders, antibiotic regimen change, formulary conversion, 
monitoring of renal doses.  The workload associated with this manual tracking they believed 
to result in under-reporting of activity and so they collaborated with their IT department to 
establish an electronic reporting system incorporated into the electronic medical record.  
Through a consensus process they established a weighted metric for each variable to 
identify the relative time each took.  Consensus was defined as full agreement between 
manager and staff.  Data was collected electronically in real time, the activities were 
counted and weighted accordingly and a sum total and average was reported monthly and 
quarterly to the hospital authorities.  In addition to a productivity report a variance report 
was also created to support deployment of staff to high work-volume areas and targeting 
those team members who might require additional support or training. Throughout their 
discussion the authors identified the known benefits of clinical pharmacy(5,8,10) and 
therefore the importance of being able to capture activity to support them.  
This is another example of a ‘single-site’ solution for describing clinical pharmacy activity.  
The argument that this has to be done site by site because of operational differences is 
repeatedly offered(32,35) and should be challenged.  Why should there be such differences 
if the benefits of specific activities are known and if there are differences in services can the 
known benefits be presumed? 
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For clarity and context a number of papers outlining the benefits of clinical pharmacy 
services are reviewed. Bond and Raehl have published a series of papers on the subject of 
the benefits of clinical pharmacy services. Their early work(5,8) demonstrated that 
increased levels of clinical pharmacist staffing and the presence of four clinical pharmacy 
services (clinical research, medicines information, admission drug histories and participation 
in cardiopulmonary resuscitation) were associated with reduced morbidity and mortality.  
This was reprised in 2006/7(9,10) and demonstrated that benefits identified in the first 
papers had been sustained over a period of years.  They reported results of a US national 
survey of pharmacy services and staffing were correlated with mortality data from Medicare 
hospitals.  Results were reported for 885 hospitals (93% response rate) and over two million 
Medicare admissions.  Statistical analysis demonstrated that provision of all of these 
services reduced mortality. For eleven of the eighteen service and staffing variables that 
were considered, these analyses are statistically significant.  The top five services associated 
with reduced mortality (p≤0.007) were adverse drug reaction (ADR) monitoring, drug 
protocol management (advising or changing therapy in response to blood results), drug use 
evaluation, CPR participation and admission drug histories.  For each of the clinical 
pharmacy services clear definitions are provided enabling pharmacy managers to identify 
the value added activities of their staff.  In terms of pharmacy staff groups, the numbers of  
clinical pharmacists (at least 50% of employed time spent on ward based duties) was most 
highly associated with reduced mortality (p=0.003).  This is compelling evidence, both for 
which services should be delivered and for the need for the staff to do so.  A limitation of 
this paper (and of those in the series) is that they are based on historic data (1995 and 1998) 
i.e. with seven to eight years between data collection and report.  The authors cite that this 
is due to the time lag in the national mortality data becoming available.  In reality services 
may have changed in the interim period. 
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Bond and Raehl’s paper the year earlier(10) considered the impact of clinical pharmacy 
services on the frequency of ADR using the same data set described above.  Again this 
confirmed that the presence of clinical pharmacy services was statistically associated with 
reductions in the frequency of ADR which also translated into reductions in patient LOS, 
‘Medicare’ charges and drugs costs.  These financial aspects have more recently been 
confirmed by a number of teams in smaller site specific studies. Gallagher et al.(6) reported 
on a study of a full year’s worth of pharmacist intervention data in an 850 bedded, Irish 
university teaching hospital.  They define a pharmacist intervention as: 
 “an action taken by a pharmacist that aims to change patient management or 
therapy” [Gallagher et al., 2014].  
They conducted a retrospective review of all interventions recorded by the 13.8 pharmacists 
employed to provide a clinical service, using a paper based data collection system that was 
transcribed on to a database.  Their analysis of the cost of the service was done by 
calculating the time taken to complete the interventions (not the full time employment) and 
the hourly rate of employing a pharmacist.  The cost avoidance achieved was done by the 
recorded interventions being allocated a ‘score’ based on the chances that a patient would 
have suffered harm had the treatment continued unchanged.  A sample of the score 
allocation was reviewed by two independent academic pharmacists with hospital pharmacy 
experience and found to correlate.  This figure was then multiplied by an ADR avoidance 
value, identified from recent European literature.  Their results included review of 4,257 
interventions conducted on 2,147 patients (NB 32,000 admissions were recorded for the 
hospital that year i.e.only 6% of admissions) and showed a net cost avoidance of over 
600,000 euros.  This was analysed using a variety of ‘worst  and best case scenarios’ e.g. 
lower values associated with cost avoidance, lower acceptance rates of interventions, more 
48 
 
expensive pharmacist salaries and the converse.  All variations still generated substantial net 
values (0.6 to 3.7 million euros).  There were some short-comings in this analysis.  Key issues 
include the subjective nature of the appraisal of the interventions, the cost being that of 
time delivering the interventions rather than employment costs and the measure being cost 
avoidance rather than cost saving.  Cost avoidance is not a tangible financial metric and one, 
which local experience suggests, is not fully acceptable to healthcare managers.  The 
authors argue that ongoing cost-avoidance will lead to cost-savings but this is a long term 
view which does not always help short term financial management.  Another reflection on 
this study is the number of pharmacists employed to deliver the service that was being 
examined.  With 850 beds having 13.2 WTE clinical pharmacists, corresponds to 64 beds per 
pharmacist.  This should be compared to the study by Onatade, Miller and Sanghera(36) 
who reported a range of 16-22 beds per pharmacist.  It could therefore be argued that 
intervention rates would be much higher if staffing levels were higher and it should be 
noted that pharmacy interventions were made for only 6% of the hospitals patient 
population that year.  No comment was made as to the acceptability of this situation nor 
the actions taken to mitigate the risks for patients not reviewed, the number of which is not 
identified. 
Whilst the evidence continues to exist relating to the benefits of clinical pharmacy, not all 
studies are as positive.  Work by a Swedish team(54) investigated the cost-effectiveness of 
introducing a new clinical pharmacy service on two wards at a university hospital, through a 
prospective randomised (method not described), controlled study.  This clinical pharmacy 
service had three elements, a medication review including feedback to the physicians, a 
discussion of medicines use with the patient and a medication report sent to the GP.  The 
‘normal’ service was not described.  Once more costs were associated with the pharmacist 
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time required to complete the intervention and in addition this study included cost of other 
healthcare contact during a six-month follow-up period.  Effectiveness data related to 
improvements in quality of life metrics.  Patient characteristics in the control and 
intervention groups were equivalent.  Data relates to 164 intervention and 181 control 
patients and the results of this study found that the intervention was not cost-effective.  The 
authors discuss this in detail and postulate a number of reasons for their findings which 
contradict other studies e.g. its implementation by relatively inexperienced pharmacists in a 
pharmacy naive service – it was too big a step change, data collection too early in the 
implementation of the service, the delivery of the service, estimation of cost and length of 
follow up.  They also note a high rate (66%) of exclusion of patients deemed unable to 
participate in the medicines use discussion.  Fundamentally, the results of this study are not 
comparable to the previous studies, as neither the service delivered, nor the costing 
methods are equivalent.  Their interventions were not in the top five services identified by 
Bond and Raehl.(9).  Their outcome measures were based on patient subjective quality of 
life reporting, not population data and their costs elements (e.g. out-patient appointments, 
GP contacts, drug costs and hospital admissions costs for six months post intervention) 
which inflate the value, and will be influenced by factors in addition to the pharmacist 
intervention.   
This issue of non-comparable data was discussed by Gammie, Vogler and Babar(7) in their 
systematic review of the recent (2010-15) literature pertaining to the economic evaluation 
of pharmacy services.  They recognised that differences in methodologies prevented a 
meta-analysis approach.  This review included both community (ten papers) and hospital 
(four papers) services.  The hospital services reported represented discrete specific 
intervention e.g. HIV pharmacy services, pharmacy led self management programs for 
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patients with obstructive pulmonary disease, improved diabetes medicines education of 
doctors and nurses and therapeutic drug monitoring, rather than delivery of clinical 
pharmacy services to in-patients.  They noted in summary that the majority of studies 
 “indicate minor to significant clinical benefits and are cost-effective” [Gammie, 
Vogler and Babar, 2017 pg 64]. 
This review of the literature has demonstrated paucity in the availability of practical 
methods of calculating clinical pharmacy staffing resources.  It identifies a focus on 
prioritising limited resource for those patients who need it most, though the success of this 
approach is not proved and there is a need to be able to demonstrate productivity or value 
for money of the investment in a pharmacy service.  There is evidence that certain clinical 
pharmacy activities are both cost and clinically effective, but demonstrating this at local 
level remains challenging.  
The next section will consider the literature that contributes to the validation of the RSPWC 
in terms of the timings of the activities included in its algorithm. 
2.6 Evidence to support timings of activities in the RSPWC 
There are three key elements which drive the algorithms in the RSPWC – the tasks 
completed by pharmacy staff, how long they take and how often they are completed.  The 
tasks are not well defined in the literature, though there is evidence that some core 
elements are common to a number of sites(36).  Many of these core elements are based on 
the findings of Bond and Raehl(9,10) and the principles of pharmaceutical care identified by 
Helper and Strand(2,3).  How often these tasks should be completed is also not well defined, 
though a number of approaches have been explored to address this with limited success(45-
47) However, amongst the literature there are reports of timings of patient care activities 
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conducted by pharmacists and these begin to provide support for the validity of the timings 
that underpin the RSPWC.   Papers reviewed in this section were selected because they 
reported specific timings for the identified activities.  A summary of the key data identified 
is presented in Table 2.1 (Page 55) but the papers are discussed individually here.   
Direct comparison of tasks and times in the RSPWC is most comprehensively done using 
timings identified by Stuchberry et al(41).  This was discussed in detail in the previous 
section.  In their paper they included many of the elements of the RSPWC in their results, 
but all supply elements of the process are excluded. Reported timings, relating to the 
delivery of a clinical service, are largely similar in their paper to those in the RSPWC.  Other 
papers deal with more specific elements of pharmacy service.  
Medicines reconciliation (MR) is the first task in the RSPWC.   The NPSA/NICE alert from 
2009(55) identified the need for hospitals to implement a medicines reconciliation service. 
Based on the evidence from the work of Bond and Raehl(9,10). As with other NICE guidance, 
a costing template for service delivery was included this identified a time for completion of 
MR of 15 minutes per patient, longer than that identified by Stuchberry et al.(41). 
This time is increased further when data from Murphy et al.(56) is reviewed. This American 
team reports on the implementation of a comprehensive MR system, introduced at their 
450 bed teaching hospital. The process evaluated is equivalent to that described in the NICE 
guidance(55) i.e. ideal timeframe within 24 hours, use of more than one source of 
information, documentation of home used medicines (drug history) in the medical notes, 
consideration of appropriateness in the current clinical context and comparison with the 
prescribed in-patient chart and identification and resolution of discrepancies.  The 
outcomes focus on the benefit to patients and improved prescribing as a result of this 
initiative.  Included in the data presented is the time they considered it took to complete 
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MR (including documentation of a drug history) for each patient (31.7 minutes) and this was 
used to calculate the staff resource needed to deliver this service.  
Urban et al.(57) report on a study exploring whether MR best practice (as per NICE(55) and 
WHO(58) guidance) is being adhered to in actual practice.  They reviewed MR in four UK 
hospitals with the aims of identifying how long it took to complete, the number and types of 
sources used to confirm a drug history and the number, type and significance of identified 
discrepancies.  Their results showed that none of the four sites studied fully complied with 
national best practice standards with an over-reliance on GP information and little use of 
patient sources.  The mean time to complete MR for a patient was recorded as 35.4 minutes 
from start to finish but this is reduced to 14.8 minutes if time waiting for other professionals 
was removed. 
A recent American study considered the effectiveness of pharmacist involvement in MR in 
an inpatient behavioural health unit(59).  All patients admitted for a one-month period were 
included in the study.  The existing practice of nurse MR continued, followed by a pharmacy 
technician completing an information gathering exercise (equivalent to the drug history 
component of NICE guidance described previously) which was then passed to a pharmacist 
for review (full MR as per NICE(55).  Data was reported on 57 of 68% of eligible patients 
admitted during the study period (11 patients were not reviewed due to a lack of staff to 
carry out the task).  91% patients were seen within 18 hours of admission.  The mean 
number of medicines identified by the nurses was 4.0 +/- 3.2 compared to 5.3 +/- 3.7 by the 
pharmacist. A mean of 2.9 discrepancies per patient were identified between nurse and 
pharmacist MR and almost half (48%) related to omitted medicines and a third to incorrect 
doses.  This required a mean of 13.9 minutes of pharmacy time to complete.   
53 
 
Nester and Hale(60) found similar outcomes in their earlier study both in terms of improved 
accuracy in MR when completed by pharmacists instead of nurses and also in the time it 
took to complete the task.  They assigned 100 patients alternately to standard nurse-led MR 
(control) or pharmacist-led MR (intervention) and the quality and efficiency of this was 
assessed by the time is subsequently took the dispensing pharmacist to issue the medicines, 
which included solving identified discrepancies.  The intervention group were reported to 
have had MR completed earlier in admission, in less time and with greater accuracy than 
those in the control group.  Time to complete MR was reported as a mean of 13.4 minutes.  
The MR process described was equivalent to those in other studies. 
A European perspective is given by Leguelinel-Balche et al. who report on the impact of 
pharmacist MR on medication safety in a French teaching hospital(61). Their study was 
divided into two phases the observation phase where pharmacist MR was completed after 
the initial writing of the drug chart (as reflects common practice) and the intervention phase 
when pharmacist MR was completed prior to the initial writing of the prescription.  MR took 
a median time of 35 minutes in the observation phase – with the standard for completion of 
MR as reference to three sources of information which is more than the two reported in 
most cases, and 30 minutes in the intervention phase. The authors conclude that MR 
completed in a prospective (intervention) manner is associated with increased safety, but 
the deployment of these staff is resource heavy and a mixed method approach (proactive 
and reactive) should be employed. 
A Canadian team reported their time and motion study on medicines reconciliation at 
admission and discharge(62). They studied two discreet populations - general medicine and 
elderly care - in two academic centres.  On the surface their findings are significantly longer 
for MR on admission than any other study – a mean of 92.2 minutes for elderly care and 
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46.2 minutes for general medicine.  However, when the details of their data are reviewed, 
this time includes activities that are not considered part of the MR process in other studies 
or the RSPWC e.g. reviewing lab results, calculating creatinine clearance. They include the 
waiting time for receiving a fax, though acknowledge other duties would be undertaken 
during this time and the breakdown of time for this is not included in the data. Finally the 
time taken for elements that are part of process in other studies and the RSPWC took 
substantially longer. In the elderly patient these include 29 minutes for reading the medical 
notes, 32.3 minutes for documenting the medication list and 12.3 for documenting 
recommendations for a prescriber. In their conclusions they suggested that multiple health 
professionals are involved in the process and like Urban et al.(57) suggested that process 
differs between different hospitals and that there are inefficiencies in the process that 
might be resolved by better use of informatics. Their data has not been shown in the 
comparative Table 2.1 as the timings are confounded by having different components and 
because not all activities were done for all patients it was not possible to lift out the 
individual elements with any certainty.  For this reason this study was excluded from the 
comparison as it would skew the data.  
When considering the time for clinical interventions, in the few papers that report this data 
the results are quite homogenous. Oh et al.(63) described a time and motion study entitled 
‘Pharmacist time requirements for counselling in an out-patient pharmacy’, the results from 
which were used to form a payment framework for community pharmacists to undertake 
extended duties.   However on closer analysis the data actually captured what would be 
defined in a UK hospital setting as ‘clinical interventions’ and that is how it has been 
recorded for the purposes of this review. They reported a range of times dependent on the 
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nature of the intervention.  This range sits across those times identified by Stuchberry et al. 
(41) and the RSPWC (see Table 2.1). 
If the dispensary elements of the RSPWC are considered, a number of relevant papers can 
be found in the US literature. Jenkins and Eckel(64)  focus on improving workflow by 
changing the skill mix of pharmacy staff, utilising pharmacist time only for activities 
requiring a registered pharmacist completion i.e. they report times for clinical checking, 
counselling and dispensing of out-patient medicines.  Times for the first two categories are 
similar to the RSPWC.  Dispensing is reported as being significantly quicker, but it is not clear 
as to the units of measure.  Their paper refers to ‘prescriptions’ and if this was to be a single 
item rather than complete list of medicines.  Extrapolation of this data to UK hospital in-
patients (median six items per patient(65)) would yield similar values to those in the RSPWC. 
This is likely as out-patient prescriptions are rarely for a patient’s full list of medicines, unlike 
discharge prescriptions, although the process of preparation usually will be identical.  
 The difficulties relating to comparability of data applies with the work by Calabrese and 
Williams(66).  They reported the implementation of a web-based medicines tracking system 
which allowed more accurate prediction and measurement of work flow.  Their data 
included times for clinical checking, dispensing and accuracy checking of final products (see 
Table 2.1) 
The UK perspective is brought by two papers from Welsh research teams who report on task 
times for dispensing of medicines in Welsh hospital dispensaries. James et al.(67) compared 
two techniques for capturing this data to demonstrate that both produced similar data and 
so the less complex method could be used with confidence as a data collection technique in 
practice.  They measured times in two Welsh hospitals, hospital A has an automated 
56 
 
dispensary and hospital B is manual.  They report on items/person/hour and so their data 
has been extrapolated for the purposes of this review using six items per patient(65).   
In the second paper, Hiom et al.(68) bench-marked dispensing rates across a number of 
Welsh hospitals and identified an average dispensing rate of 9.9 items/person/hour – once 
more extrapolated for purposes of comparison. 
Finally, a team from London reported dispensary timings in their report of using ‘discrete 
event simulation’ to design efficient hospital out-patient pharmacies(69).  This involved the 
description of the dispensing process in detail and the generation of a process map.  They 
then conducted a number of time and motion studies in two hospital sites, Charing Cross 
Hospital (CX) and Hammersmith Hospital (HH) which recorded the times taken for a number 
of the tasks.  These times were then used to build a simulation model and then a number of 
scenarios run through the simulation varying either workload or skill mix.  The out-put from 
this study resulted in changes to staffing levels to match peaks and troughs of work both in 
terms of numbers and skill mix. Their times, reported for a six item prescription, are shown 
in Table 2.1.  (It should be noted that *data has been extrapolated for a six item 
prescription). 
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Table 2.1 Comparison of reported times (minutes) for activities from the pharmacy literature  
(NB First-named authors only cited for tabulation purposes) 
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Medicines reconciliation 10 10.2 15 32 15 14 13 39         
Clinical review of notes 5 6               
Interventions 5 6       4.3-6.3        
Ordering of non-stocks 2 3.6               
Clinical check of TTO 5         5.1 6      
Counselling 5 3.8        2.4     3.5 2.6 
Booking in 2.5              0.8 0.87 
Dispensing 20         7 9 60 30 36 16 13.3 
Accuracy check 8          3    2.6 2.75 
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2.7 Implications of the literature review for the RSPWC validation  
This review of the literature identified implications for the proposed validation project in a 
number of different areas. 
Throughout the literature a consistent approach to workforce resource identification is 
demonstrated, regardless of the discipline involved(14,16,17,19,20,23,27,30,40).. Namely 
the identification of a staff group, the tasks they have to complete and the time they take.   
For some professions this has been completed i.e. a calculation tool exists, that can be 
applied simply by other managers applying available local metrics to a developed 
tool(19,20,40).  It is noted however that in these cases there has been limited external 
validation(19,40).  In other cases(14,16-18), all that is described is the process, leaving 
individual sites having to complete substantial local research to populate.  No calculator for 
clinical pharmacy has previously been published.   
An inherent trait of the pharmacy profession is accuracy and this may have inhibited the 
development of any such tool.  The processes of ward-based clinical pharmacy are not 
formally established in any national guidelines and the permutations are complex and the 
search for the ‘perfect’ solution, accurately capturing the requirements for staffing may be 
put into the ‘too hard’ category.  The profession has therefore focused on how to deliver 
services within existing resources(34,43-45,47) and comparing their efforts through 
benchmarking processes(22,49,50).  Outliers in the data sets are almost always explained by 
staffing levels, with the performance of a department being judged against this benchmark. 
A better position to judge the performance of individual sites would be in understanding 
how many staff should be needed to deliver a service and then being able to recognise the 
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efficiencies made and productivity improved, by demonstrating clinical and economic 
outcomes.   
This review has demonstrated that the approach taken in the construction of the RSPWC is 
supported by the literature from various disciplines and follows the principles of WISN(23) 
which is an internationally recognised method of identifying healthcare workforce resource.  
At this stage the ‘experts’ involved in the identification of the tasks have been local to Stoke-
on-Trent and the timings used to drive the calculator are also sourced from one site.  
Validation requires confirmation of the former through development of consensus and the 
latter by collection of timing data from a variety of settings, addressing the weaknesses 
identified by Skills for Health(19), Stuchberry et al.(41) and Hurst et al.(20) in their work.   
The review also identified shortfalls in the initial version of the calculator.  A key step 
missing is the omission from the calculation of the ‘unavailable time’, inherent in employing 
a staff member e.g. study, sick and annual leave, mandatory training, travel time.  This 
needs to be addressed to ensure that the staffing levels calculated can deliver sustainable 
service delivery that should be resilient to predictable absences.  Another issue with the 
initial version of the RSPWC is that it currently does not address the issue of patient acuity; 
it is a one-size fits all approach. This is recognised by the developers, as the frequencies of 
the tasks are based on agreed minimum standards of care and may therefore be an 
underestimate.  Following this review modifications have been made to improve the 
sensitivity of the tool to different patient groups by calculations being driven by numbers of 
prescribed items rather than just by simply admission numbers.  It is accepted that this still 
falls short of perfection but as per Ghosh and Cruz(27) – it is a starting point. 
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Finally the value of a ‘ready-to-use’ tool has also been identified(20,27). Local managers 
need to be able to simply apply population data to generate a resource calculation and this 
is a solution that is offered by the RSPWC for the pharmacy workforce. 
Support and guidance for the project methods can also be found in the literature.  WISN(23) 
requires the ‘gathering of experts’ to determine tasks to be completed.  This requires a 
method of developing consensus.  This is also reflected in the pathology tool(18) where the 
‘PAT’ categories were established from ‘people working in the service’, though the 
participants in this process are not identified.  The Hurst et al. paper(20) identifies that a 
weakness of previous models for staffing were because they were based only on 
‘professional judgment’ and so their validity was questioned.  With no agreed standard 
operating procedures on the delivery of the clinical pharmacy service, ‘professional 
judgment’ has to be used to shape what it should look like.  It was important therefore to 
ensure that consensus on the tasks is achieved from a ‘broad church’ and includes key 
stakeholders as well as being from a large enough representation of the pharmacy manager 
population.  The approach of collecting data relating to task timings using senior 
pharmacists from differing sites is supported used by Hurst et al.(20) for their nursing 
calculator.  This approach may improve acceptance of the tool if local data from wide 
ranging participants is seen to be utilized in its development. 
The literature review has demonstrated that apart from the issue of MR there is very little 
published time and motion data for pharmacy practice activities.  On the subject of how 
long it takes to complete MR there are differences in definition, although those with 
outlying opinions can be easily identified(62).  When the data is reviewed overall a mean 
time for MR calculated from those reported in the literature is 19.74 minutes.  This value is 
greater than that in the current version of the RSPWC.    
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What little data is available around interventions and clinical checking of prescriptions is 
reasonably homogenous and reflects that in the RSPWC, though the small data set is 
acknowledged.  This too requires confirmation from current working environments. 
Finally when dispensing time and motion is considered a problem of standardisation is 
encountered.  All papers that report timings for the different elements of dispensing use 
different denominators and it is not possible to accurately extrapolate the data to a 
common value for comparison purposes.  This difficulty informed the study methods and 
‘time per item’ was used as the unit for comparison dispensing/checking activities. 
Finally, the use of evidence from literature, combined with data collection to validate a 
workforce tool was described by Hurst et al.(20)  and supports the approach to the 
validation of the RSPWC. 
2.8 Literature review summary 
In summary, completion of this review has confirmed that there is no published, validated 
calculation tool for identifying staff resource for the delivery of pharmaceutical care.  As 
such the RSPWC is novel, but requires validation for acceptance into practice.  The approach 
taken in the early development of the RSPWC is supported by evidence from a number of 
disciplines and the proposed study methodology can be justified by the literature.  Some 
evidence for the timings that drive the RSPWC can be found in the literature, though 
robustness of this is limited by inconsistencies in data presentation.  The omission of 
‘unavailable time’ in the initial version of the RSPWC was identified through the literature 
review and steps were taken to address this in the study version of the tool, which included 
this adjustment in its calculation. 
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3. Aims and Objectives 
The aim of this research was to explore whether a tool, developed to calculate the staff 
resource required for delivery of pharmaceutical care to hospital in-patients at a RSUH, 
could be applied to equivalent services delivered at other hospital sites.  Research questions 
considered in the scope of this project included: 
i. Does the delivery of pharmaceutical care at other sites require the completion of 
the same task list as at RSUH? 
ii. Do pharmaceutical care activities take the same time at other sites and does 
automation have an impact on these processes? 
iii. Do other sites use the same staff groups as RSUH for delivery of various tasks? 
iv. How often are the activities completed for individual patients? 
v. If there are differences in the tasks, times, staff groups or frequencies of different 
activities between, can a consensus be reached to allow the development of a more 
widely applicable staff resource calculator for clinical pharmacy staffing? 
 
 
From the literature review it was identified that the WISN(23) approach to identifying 
staffing levels for healthcare delivery would be an appropriate overarching methodology for 
this study.  This required the completion of a series of objectives 
 Objective 1: To develop an ‘activity standard’(23) for clinical pharmacy i.e. establish 
consensus on the form and nature of the job, how long it takes, how often it should 
be done and the staff group required for its delivery. 
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 Objective 2:  To identify ‘unavailable time’ inherent in the employment of pharmacy 
workforce to ensure the sustainability of the service across the full year irrespective 
of annual leave, sick leave etc. 
These first two objectives were required to compare the prototype RSPWC with practice in 
other settings and identify consensus where differences were identified. 
The validity of the RSPWC in different settings and its reliability in the hands of different 
operators was explored by the completion of further objectives, namely: 
 Objective 3: To explore the current staffing resource requirements as perceived by 
hospital pharmacy managers and  the comparison of these to the resource 
generated by the RSPWC 
 Objective 4: To demonstrate the transferability of the tool to different operators, by 
comparison of out-put values from its application in a number of scenarios by 
different pharmacy managers 
 Objective 5: To explore the applicability of the tool in different settings through 
qualitative interviews 
 Objective 6: To explore the reasons for any outlying data  through qualitative 
interviews 
The final objective of the study (Objective 7) was to produce a consensus-based workforce 
calculator for clinical pharmacy services that could be utilised by pharmacy managers in 
different settings to identify required staff resource for delivery of pharmaceutical care. 
To meet the identified aims and objectives of this study, methodological consideration was 
required on the approach to development of consensus, the establishment of validity, the 
design and delivery of questionnaires and approaches to qualitative research in the form of 
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semi-structured interviews.  The iterative nature of practice-based research also requires 
consideration of reflexivity (i.e. how process are continuously remodelled on the basis of 
new knowledge and social context) and its influence on the methods employed and the 
results achieved.  
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4. Methodology 
The RSPWC has been developed to identify the resource required to deliver pharmaceutical 
care to in-patients at the Royal Stoke University Hospital.  For other centres to use this tool, 
confirmation is required that it accurately reflects ‘pharmaceutical care’ in those settings i.e. 
that it is valid and reliable in the data it produces when applied to different services. 
From the literature review it was identified that the methodology which underpins the 
WISN(23) approach to calculation of staffing levels is appropriate for application in this 
research and the theories behind the algorithms which drive WISN will be explored in this 
chapter. 
Using the WISN model first requires the agreement of experts about the details of the work 
to be completed by the staff – consensus will have to be identified. In this chapter 
consensus methodologies are discussed alongside those of questionnaire and interview 
design as tools to capture consensus data.  Also within this chapter the concepts of validity 
and reliability are explored and applied to the context of this study.   Finally, the place of 
‘mixed-methods research’, using quantitative and qualitative approaches to explore this 
subject are considered 
4.1  Research question 
Pharmaceutical care has been clearly defined as  
“the responsible provision of drug therapy for the purpose of achieving definite 
outcomes that improve a patient’s quality of life” (2).  
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However, this clarity of definition on the delivery of this care has not been established. 
There is evidence that providing this care is of benefit to both patients (reduced morbidity 
and mortality)(5,8,9,9) and organisations (financial and governance)(5,6) but what tasks 
have to be completed in order to ensure that all the medicines related problems described 
by Strand et al.(3) are identified and addressed has not been established.  The provision of 
pharmaceutical care has developed centre by centre.  Key statements on purpose(2) and 
national drivers(70),(55) have resulted in commonalities developing but there is no standard 
procedure for the delivery.  Views on how to deliver pharmaceutical care differs between 
settings and therefore calculation of how many staff are required will be dependent on the 
individual understanding of what that service should consist.  If one considers the ontology 
(the nature of existence of this phenomenon) there is not a single, objective reality, to be 
identified, measured and described.  However, in the current political and financial context, 
there is a desire to strive for consistency in healthcare; that regardless of location a patient 
should experience the same quality and content of a service.  The removal of ‘unwarranted 
variation’ is desired(21).   This requires an epistemological approach to explore and refine 
these multiple realities on the delivery of pharmaceutical care, which acknowledges the 
socially contingent nature of the data, whilst gathering and ‘converting’ them into a single 
agreed reality. 
For a single calculator tool to be applicable to a variety of settings, agreement on this 
‘converted’ reality needs first to be established; some sort of consensus needs to be 
achieved. The tool then needs to be demonstrated to be valid for different settings and 
reliably generate data on required resource.  
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4.2 Workforce calculation using WISN 
The theory of workforce modelling techniques lies in the domain of mathematics and 
business management.  This section gives an overview of this field to place the use of the 
WISN approach in context of workforce planning theory and to understand its relevance to 
the RSPWC 
WISN(23,71) as described previously, is the WHO model for calculation of staffing 
requirements for the provision of healthcare.  It is published as a practical manual, outlining 
a step by step process for calculating staffing need, giving instructions in simple to follow 
language. However, the theoretical basis underpinning these calculations needs to be 
understood. 
In his paper ‘A study of Factors Affecting Effective Production and Workforce Planning’(72) 
Dr Hallim Kazan identifies that whilst many of the issues related to workforce planning have 
already been investigated through various studies an additional feature of the field of 
workforce modelling research is the need to manage the ‘stochastic’ demand for staff.  
Stochastic demand, being defined as ‘a randomly determined probability distribution or 
pattern that may be analysed statistically but not predicted precisely’(73).  This is of direct 
relevance to healthcare workforce planning, as at healthcare facilities patient attendance is 
difficult to predict (other than seasonal variation) and therefore there is a significant 
challenge to match staff resource to the patient need.  Prestwich, Tarim and Hnich(74) 
suggest that stochastic techniques such as ‘evolutionary search’ are not guaranteed to 
generate optimal solutions but do offer a quick, pragmatic solution.  A review of the 
literature in this area reveals that there are many complex mathematical algorithms 
developed to calculate manpower requirements.  The application of these to real-life 
settings is limited by the ability of non-mathematicians to these algorithms to generate valid 
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calculations specific to their situation. However, these algorithms can be demonstrated to 
directly relate to the basis of WISN see Table 4.1. 
Table 4.1 Comparison of the mathematical algorithms of Kazan(72) to WISN (1998)(71) 
Establishment of Need of Real 
Personnel. Kazan(72) 
WISN(71) 
RPR =  TT 
          AWT 
 
TT =∑    Ri  *Ti 
Staff resource = Time to perform role for full patient population 
                                                       Available working time 
 
Time to perform role= Activity standard x number of patients 
Where 
 TT: Total time needed to finish 
whole job 
 
Time to perform full role for all 
patients 
 
 
  
Ri: the number of repeats Frequency with which task done 
    
    Activity standard 
Ti: The required time to perform a 
job at least once 
How long it takes to do a task 
i: the individual task Each task identified 
n: total operation Total number of tasks required 
to perform role 
 
 
RPR: real personnel requirement Staff resource 
 
 
AWT: average workforce time Available working time 
= 
Time available for patient care 
 
 
 
Therefore, as this comparative table shows, WISN can be demonstrated as equivalent to an 
accepted mathematical algorithm for workforce planning so, therefore, using its approach 
to resource calculation can be considered theoretically sound for the development of 
staffing models.  
Once a staff resource is identified it is followed by the need to improve the productivity of a 
service.  Developing service standards (i.e. for one patient what tasks should be completed, 
how long they should take and how often they should be done) for different staff groups 
should allow the establishment of productivity measures for different professions.  It should 
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therefore follow that improved efficiency of this group results in delivering either the same 
service standard with fewer staff or caring for more patients with no additional resource.  
However, the challenge of measuring productivity in healthcare as described by Scott(75) 
recognises that this is confounded by the issue that patients seen by the same doctor for 
the same condition may respond differently to the same treatment and that patients with 
the same condition may be treated differently by different doctors due to the difference in 
their knowledge and experience. Therefore outcomes and resource requirements are not 
always predictable. In addition the usual market forces do not apply, as the recipient of the 
service rarely pays the full cost of the service they receive which results in market forces 
being skewed. However, with productivity becoming increasingly important in a modern 
healthcare system it is essential that baseline resource is first identified and standardised, in 
order that productivity can be demonstrated. 
The calculations that drive the RSPWC are based on the same mathematical principles 
suggested in WISN and therefore as such can be considered an appropriate approach to 
workforce calculation.  For WISN to be applied, the activity standards must be established 
for individual staff cadre in a particular setting.  The RSPWC has achieved this for pharmacy 
staff in Stoke-on-Trent(13).  This validation study explored whether this activity standard 
was valid for other pharmacy settings i.e. the staff cadre was the same but the setting is 
different. Within NHS Trusts the available working time of staff is largely fixed by the 
‘Agenda for Change’ terms and conditions with respect to annual leave and sickness 
absence(76).  However, unavailable time’ for other reasons (such as travel between 
locations and training etc.) required confirmation.  The WISN approach relied on the 
development of ‘activity standards’ by the establishment of consensus on the tasks required 
and the confirmation of how long these tasks should take and how often they should be 
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completed should focus on the use of existing local data,  rather that the collection of new 
time and motion data.  This is also supported by the work of Hurst et al.(20).  How to 
identify this consensus will be considered in the following section. 
4.3 Consensus 
The considerations above suggest that validity of the RSPWC is dependent on the 
establishment of ‘consensus’ – both to demonstrate elements of validity (see later section 
4.4) and that appropriate approaches to workforce planning have been applied(20,71).   
Consensus is defined as a ‘general or widespread agreement’(77) that is achieved from 
listening to the views and opinions of a population.  It differs from ‘voting’ in that there are 
no ‘winners’ or ‘losers’ but the solution or plan agreed on is one which has the support of 
the whole group(78); it is deemed acceptable to all(79).  Moreover a decision can be 
developed through consensus, rather than being a simple choice between conflicting 
option(80,81).   When consensus is sought in an ideal process, it requires active 
participation of all parties who should be considered as ‘equals’(78).  There should be no 
weight given to those in hierarchical positions(78).   The process will be more successful if 
certain prerequisites are achieved. These include a commitment to reach a consensus - 
everyone involved should be seeking a common goal, no one should approach this process 
with a fixed view or a hidden agenda. There needs to be trust and openness – one needs to 
be able to voice opinion without fear of retribution and the process should be clear and all 
play their part(78).   
Consensus is used in different groups and communities as a way of decision making(78) and 
is increasingly used in healthcare, particularly in the area of policy decision making where 
the need to move away from the authority of a single practitioner has resulted from a 
71 
 
number of legal and technological developments, which have challenged the 
appropriateness of such practice(79).  As a consequence consensus has become a necessary 
philosophical consideration particularly with respect to epistemology i.e. the nature of how 
this process is achieved(79).  When approaching the subject of developing consensus one 
must consider both the approach used to gather opinions that will form the consensus and 
the level of agreement that is required for consensus to be considered to have been 
reached. 
A number of techniques of gaining or identifying consensus exist and a number of studies 
have reviewed the relative merits of each(81-85).  For example the ‘Nominal Group’ 
technique has been employed in healthcare where individuals initially write down their own 
thoughts without discussion and then in turn share ideas with the group, which then ranks 
and votes on the collected list(81,82); the Quaker technique, whereby each individual is only 
allowed to speak once, until all have spoken, ensuring the consideration of all views and 
opinions(78).  Brainstorming and focus group activities(82) could also be applied although 
these are known better for idea generation than problem resolution.   The ‘World Cafe’ is 
another approach, where smaller groups of individuals gather to discuss specific issues 
around tables(80). Key points of agreement are captured and added to as conversations 
progress.  Members of the ‘cafe’ switch tables periodically, to ensure that they contribute to 
all discussions and that the final out-put includes everyone’s opinions and is enriched by the 
diversity of the discussions held.  These face to face techniques risk the discussions being 
dominated by strong individual opinions which may skew the outcome and reduce the 
strength of the consensus, as less vocal individuals may consider the validity of the 
consensus tainted by a domineering view.  In addition the physical presence of the 
stakeholders in the same venue is imperative and attracting the presence of the relevant 
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experts requires an acknowledgement of the credibility and importance of the task in hand. 
For the validation of the RSPWC, these techniques would prove challenging on both areas 
described above.  Any ‘expert group’ gathered to develop consensus would require the 
presence of representatives from the Shelford Group of Trusts, as significant service 
influencers(86).  For greater richness in the consensus, the presence of smaller regional 
units is needed.  In face-to-face techniques discussions may be dominated by the experience 
and ‘expertise’ of the large teaching hospitals, with quieter voices failing to be heard.  In 
addition the gathering of such a group would be challenging in terms of logistics and cost.  
As a consequence these techniques were discounted for the generation of consensus on the 
tasks and times that drive the RSPWC as a more pragmatic approach was required. 
An alternative approach is the application of the Delphi technique(80,81,87), where the 
general principles are that a group of stakeholders or experts are asked to anonymously 
state their views on a number of issues.  These views are then summarised and fed back to 
the group who are then asked to identify their level of agreement or disagreement with the 
list of issues and articulate their reasons for this opinion.  This data is then gathered and 
summarised by an independent facilitator and fed back to the group who are asked to 
review their original response in the light of the knowledge of the responses of their peers. 
The process is iterative until an acceptable level of agreement or, consensus, is reached.  
However, consensus is not the only end point that should be sought in Delphi research.  Von 
der Gracht(88) also argued that stability of data needs to be achieved, i.e. that opinions 
have settled and stopped changing over the course of repeated rounds.   
Delphi can be administered in a questionnaire format which has the advantage of being able 
to be delivered electronically and therefore wide-spread geographical distribution of 
participants is not a barrier to its success.  Its use is particularly appropriate if the research 
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subject cannot be investigated by analytical techniques, but would benefit from “subjective 
judgements on a collective basis”(89).  This method is increasingly gaining credibility in the 
field of healthcare research generally and in pharmacy specifically.  It has been used to 
establish the European Standards for Hospital pharmacy(80) and policy solutions for 
medicines adherence(87) .  However, it is not without its criticisms.  For example it has been 
suggested that the data summary stage risks feeding back the ‘right’ answer as perceived by 
the researcher and therefore the consensus process has the potential to be 
manipulated(79).  Modifications of the original technique have evolved e.g. ‘reactive Delphi’ 
where respondents are asked to give their opinions on a previously established set of 
information.  Whilst it is recognised that such evolution is an expected phenomenon when 
considering human activity there is a risk that in modifying the process the fundamental 
validity of the approach may be lost(89,90). The scientific credibility of the approach has 
also been questioned(90). These challenges include reliability (would the same result be 
achieved by giving the same information to more than one group), the potential bias in the 
selection of ‘experts’ and validity of the out-put (consensus does not necessarily equate to 
absolute fact).  These are, however, criticisms raised against other qualitative methods and 
the Delphi technique is recognised as having application in subjects which require broad 
consensus or direction of group decision making(90).  Powell(91) suggests that researchers 
using this technique identify the ‘goodness criteria’ of their results, by triangulation with 
literature and other data sources, using follow up research to explore outlying data sets and 
establishing credibility in the transparency of the decision process used in their study design 
and implementation.  These triangulation methods are built into the approach taken in this 
validation study. 
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The strengths identified above are particularly relevant to this study, because the ability to 
deliver the questionnaire electronically allows for a wide geographical distribution of 
participants, preventing a regional bias and the anonymity of the process removes any 
hierarchical effect.  However, acknowledgement of participant lists will enable individuals to 
respect the outcome on the basis of knowing that key stakeholders have been involved.  
Caws(79) identifies that having respect for the participants in a consensus process is critical 
to the acceptability of that consensus in practice.  This leads to consideration, when using 
the Delphi technique, of the definition of ‘experts’.   The use of this title might preclude the 
contribution of knowledgeable individuals not classed as experts e.g. a clinical pharmacist in 
a district general hospital many not be considered (by themselves, the researcher or their 
peers) an ‘expert’ compared to a clinical lead pharmacist at a London teaching Trust.  
However, their views and opinions are valid for the delivery of service in their setting.  
Powell(91) suggested that knowledge of a topic and willingness to participate in the 
discussion is of more value than a remote non-participant ‘expert’.   
Finally when considering the establishment of consensus it is essential to recognise when 
this has been reached. There is little agreement in the literature as to what level of 
agreement is required to demonstrate that consensus has been achieved(88).  Various 
approaches to the identification of the establishment of ‘consensus’ have been 
reported(88).  These range from subjective analysis(92), stipulated numbers of rounds(93), 
specified levels of agreement – which in turn range from as little as 51% agreement(94) 
though other authors suggest figures as high as 95% are needed(95) – to the calculation of  
a variety of inferential statistics(88).  However, what is recommended for the robustness of 
the outcome is that the level of agreement required to prove consensus is specified prior to 
data collection and not simply interpreted during the analysis phase(88,96)  Where 
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inferential statistics are used to demonstrate consensus it is important to select appropriate 
measures as ‘violations in basic assumptions’ (von der Gracht 2012 p 1533) have been 
identified in published studies. For the purposes of this study consensus was predefined 
using specified levels of agreement between participants (see section 6.3.3) as participant 
numbers were unlikely to be sufficient to allow meaningful inferential statistical analysis to 
be applied. 
There is also a need to ensure that the sample size is credible. Hsu and Sandford(96) 
recommend that a Delphi study should utilise the smallest acceptable sample size.  Delphi 
studies with participants from homogenous backgrounds tend to have 10-15 members.  
However, even with greater heterogenicity of participants and more complex issues, Delphi 
studies have rarely included more than 50 participants(97).  The participants in this study 
were all pharmacists, practising in different settings.  The subject is complex and so it would 
therefore seem reasonable to aim for a minimum of ten participants from each setting e.g. 
teaching hospitals, district generals, community hospitals.  Therefore the total study sample 
size was anticipated to be in the region of 30-50 participants depending on the range of 
participants that accepted the invitation (see section 6.2.2) 
The establishment of consensus, as discussed in this chapter, is required in this study both 
as part of the WISN methodology for calculating staffing resource and in contributing to the 
establishment of the validity of the tool.  This is discussed in detail in the next section. 
4.4  Validation of the RSPWC – validity & reliability 
For a tool to be valid it needs to be shown to accurately represent what it claims to 
represent, within acceptable limits.  Its reliability is demonstrated in the reproducibility and 
consistency of its output.  Both are considered and applied to the RSPWC.   
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Determination of validity first requires an independent knowledge of the nature of the 
phenomenon.  As discussed in the literature review there is no agreed standard for delivery 
of pharmaceutical care and therefore validity of any tool measuring this phenomenon has to 
be demonstrated from a number of different perspectives.  Validity and reliability of ‘tools’ 
often relates to educational assessment e.g. written exams, Objective Structured Clinical 
Examinations (OSCEs) or to those capturing data for studies e.g. questionnaires, assays, 
observations.  The RSPWC falls into neither category but the principles applied can be 
transferred to this work.   
In educational arenas, issues around validity theory are widely debated - which form of 
validity is most valid?(98)  It appears that even the experts do not agree.  Some clarity is 
brought by Gorin’s article(98) responding to a new framework proposed by Lissitz and 
Samuelson(99) where she concludes that 
 “Validity is a judgement, and like all judgements is relative and ever evolving.  
It can be, and should be evaluated in the light of new evidence and desired 
interpretations, making validity and validation an ongoing process” [Gorin 
2007, pg 461)](98).  
This suggests that finality and precision will not be achieved in any validation and ongoing 
re-validation will always be required, it will never be ‘job done’.  There is a large body of 
literature on the subject of validity of research tools, which is summarised in Chapter 9 of 
Sim and Wright’s ‘Research in Healthcare’ (2002)(100).   They identify several different 
forms of validity and each will be discussed in turn.   
Face validity is the extent to which the tool ‘appears’ to be valid when assessed by impartial 
‘experts’.  This is important for the credibility of the data generated – if it does not ‘look 
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right’ then its output will not be believed.  Face validity for the RSPWC has already been 
achieved through presentation at conference.  This peer review suggested that at ‘face 
value’ the tool was worth developing.  This will continue to be developed throughout the 
course of the study. 
Content validity measures the extent to which any tool addresses the full scope of the 
phenomenon being measured.  The RSPWC is calculating resource for the delivery of ward 
based pharmaceutical care and to demonstrate content validity it therefore needs to 
measure all, or certain, clearly defined elements, of ward based pharmacy services.  There is 
no standard for such services and as a consequence the tool in its current version measures 
the elements that the developers believe to be necessary.  What needs to be established is 
whether this is considered to be the full extent of the service or whether there are other 
aspects that need to be added to or removed from the tool to improve its validity. 
Criterion validity consists of three associated types of validity; ‘concurrent’, ‘predictive’ and 
diagnostic’ validity.  The first, ‘concurrent validity’, is concerned with comparison of a tool to 
a ‘gold standard’.  For the delivery of pharmaceutical care there is not  a ‘gold standard’ yet 
established, though the ‘Hospital Medicines Optimisation’ group (HopMop)(21) are working 
to identify a ‘model hospital’ based on what ‘good looks like’, though this model stops short 
of specifying staffing levels.  The WISN(23) tool for workforce calculation, howev, is 
considered a ‘gold standard’ method for determining healthcare staffing.  Whilst this has 
not previously been applied to pharmacy, the development of the RSPWC follows the key 
steps in their recommended process and therefore its output can be justified by its 
approach.  The ‘gold standard’ does not exist but the method used to calculate the value is 
structured on a ‘gold standard’ method of staffing calculation. 
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Predictive validity relates to how the prediction is borne out in reality.  For the RSPWC the 
resource calculated needs to work in practice.  With the resource calculated can the service 
actually be delivered in a consistent manner – does it still under-estimate the requirement 
leaving services stretched or does it overestimate the resource required and so lose 
credibility in the eyes of the financiers and management? From a local perspective it has 
already been recognised that the resource falls short, as the initial version of the tool does 
not include the WISN requirement for the identification of ‘unavailable’ time. This needed 
to be identified and incorporated into a ‘validated’ version of the calculator.   
Diagnostic validity considers whether a tool identifies true or false positives/negatives.  This 
is not applicable to the RSPWC as that is not the nature of its out-put. 
Finally, construct validity requires correlation of out-puts of some elements of the tool with 
values calculated by a different method.  This is particularly important if the tool being 
validated is theoretically novel.  This is directly relevant to the validation of the RSPWC.  
Some construct validity can be demonstrated by reference to the literature – certain 
elements of the tool e.g. medicines reconciliation (MR) are well reported and published data 
reflects that in the RSPWC(41,55-57,59-61)  Moreover, confirmation of tasks, times and 
frequencies which drive the tool can be collected from other hospital sites to identify the 
consensus of the profession on the subject. 
The validity of health care models was considered by a US task force(101). They identified 
five optimal elements of validity that model developers need to strive to achieve if they are 
to demonstrate best practice.  Of these five forms, three (face, cross or construct and 
predictive) are covered in the descriptions above.  In addition they identify internal and 
external. Internal validity requires the computational elements of the model to be proven 
i.e. are the calculations correct.  The methods for this depend on the complexity of the tool 
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in question.  In the case of the RSPWC this would need to be done manually by a second 
programmer and the calculations made available to users for their own verification.  The 
former has been done, but needs to be described, and the latter is achieved by the issue of 
the tool as the calculations are accessible through the spreadsheet, though protected by 
password to prevent inadvertent modification. External validity requires the forecasts of a 
model to be proved in reality so that its output can be seen to generate realistic figures.  
This is difficult to achieve in the case of the RSPWC as the pharmacy workforce has not been 
thoroughly described and agreed upon.  With no agreed formula to quantify staffing need, 
the tool cannot be checked against reality.  It may not generate the same level of staffing 
that currently exists in hospital pharmacies, but that will not necessarily make it invalid.  
This is accepted by Eddy et al(101) as they acknowledge that not all models will achieve all 
measures of validity, but this should be the aim of the researcher. 
Eddy et al.(101) also require a further element of ‘transparency’ which requires the 
developer to provide users with technical details of how to utilise the tool so they 
understand the way in which the calculation works, and provide sufficient detail so that the 
computational basis can be checked or developed. This needs to be done in the context of 
confidentiality and intellectual property rights.  When the RSPWC is issued to users it will be 
accompanied by a ‘user guide’ to aid its application and the calculations will be visible 
though password protected as described above.  In their conclusion, having extolled the 
virtues of robust validation Eddy et al.(101)  remind the reader that a model is only ever a 
model and not reality and that, effectively, validity is in the eye of the user, who needs to 
determine whether it is ‘fit for purpose’.  
Reliability of a tool i.e. the consistency and reproducibility of the data it produces also 
needs to be established.   Sim and Wright(100) consider there to be three types of 
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reliability: equivalence, stability and internal.  This latter is not relevant as it considers how 
a tool cross references answers and is generally applied to questionnaires.  Equivalence 
requires the tool to produce consistent measurements in the hands of two or more 
investigators – can other pharmacy managers generate the same data with the RSPWC using 
the same criterion? This inter-rater reliability is vulnerable to the active participation of the 
user.  Equivalence reliability is increased when the variables that are under the control of 
the operator are limited to a minimum.  The validated tool will require protected cells to 
limit the editing ability of third parties, to assure the reliability of output. This may prove 
challenging as the desire to ‘bespoke’ the tool to different settings may result in increased 
numbers of variables made available for individual operators to manipulate, which in turn 
may diminish the validity of the tool.  Consideration of this will have to be made at the time 
the tool is issued.  This study will need to demonstrate equivalence reliability by assessing 
the use of the tool in the hands of other operators. The matter of stability (that a tool 
consistently produces the same data in the hands of a single operator) has already been 
established(13).  Importantly reliability relies on the assumption that the phenomenon 
being measured remains the same between measurements.  For the RSPWC this has the 
implication that as technology progresses and pharmacy practice changes the tool will need 
to be recalibrated – it will not be a one-time process. This reflects the opinion expressed by 
Gorin(98) on the need for ongoing re-validation. 
In summary the validation of the RSPWC needed to be multifaceted.  Some elements have 
already been partly achieved i.e. face and concurrent validity, others needed to be 
confirmed during the progress of the study.  Predictive validity was enhanced by identifying 
the ‘unavailable’ time inherent in the employment of staff.  Content and construct validity 
was confirmed through the generation of consensus on the tasks, times and frequency that 
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drive the tool.  Internal reliability was documented and reliability was achieved by assessing 
the utilisation of the tool by study participants.  External reliability requires longer term 
evaluation and was not addressed in this study. 
4.5 Questionnaires and interviews 
It has already been identified that, to achieve validation of the RSPWC, consensus will need 
to be developed on the form of the phenomenon of delivering pharmaceutical care.  We 
have established that this phenomenon does not exist as one finite reality, but is dependent 
on the opinions, experience and setting of individual practitioners.  The epistemology of this 
suggests that data on this subject can only be collected from these individual practitioners 
i.e. you have to ask them.  The Delphi technique has been identified as an appropriate 
approach for establishing consensus in this field of research and its use requires the 
construction and delivery of an effective questionnaire.  Consideration must be given to the 
various theoretical elements which lead to the development of a robust data collection tool.   
Finally, it is recognised(21,22) that there is substantial variation in practice and therefore 
opinion on this subject and a qualitative approach to capturing this breadth of data needs to 
be included in the study plan. This section explores the methodology behind the 
development of quantitative questionnaires and the exploratory approach of qualitative 
interviews. 
4.5.1. Questionnaire design 
For the Delphi approach a self-completed questionnaire is required, as opposed to a 
researcher-administered tool.  The construction of an effective questionnaire is crucial to 
the successful delivery of research using this technique.  It is acknowledged that three types 
of problems may be experienced in the completion of questionnaires(102): 
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 That respondents do not understand the question being asked of them 
 That respondents interpret and therefore answer the question from their own 
perspective  
 That the respondents experience difficulty in remembering the answers to 
questions if drawing on factual knowledge 
It is therefore the researcher’s responsibility and challenge to manage these problems and 
this can be achieved if a number of fundamental rules are obeyed(103)  
 The language used should be non-technical 
 Individual questions should be unambiguous 
 Answers need to be unambiguous and so the researcher needs to consider the 
possible responses that will be made 
 Answers to questions should not be mixed – factual response and opinions need to 
be separated for data analysis purposes 
 It should be clear what requires answers from a participant and how they should 
respond 
 A participant should be able to respond to all elements of the questionnaire 
When conducting data collection using questionnaires the researcher needs to be aware of 
various forms of bias which might limit the quality or reliability of the data.  Individual 
responses are personal and as such will be affected by the social context in which they are 
being given.  Respondents may answer in a certain way to achieve their own personal 
outcome.  Examples include the desire to be socially accepted, to appear to conform, to 
avoid being seen as extreme and take the middle ground(104).   
Researchers may generate bias by asking leading or presumptive questions.  Finally the 
process of research might generate its own bias.  Respondents may rate items according to 
83 
 
their general rather than specific perceptions, they may fall into a pattern of answers e.g. 
always tick ‘C’ or demonstrate ‘yea-saying’ or always agreeing with a statement.  Steps must 
be taken to limit bias in questionnaire design or identify and acknowledge its impact when it 
does occur(105).   
When conducting a study using a questionnaire effort must be made to maximize the 
response rate and a number of considerations should be made.  The method of initial 
approach, receipt of the form, length and layout of the questionnaire, use of open and 
closed questions and clear instruction for completion should all be considered.  The 
questionnaire should flow and similar questions, both in style and content, should be 
grouped together, with transitions statements between sections(106).  The length of 
questionnaire is dependent on the nature of the subject being explored and the intended 
recipients.  Commentators within Sim and Wright(107) suggested that if the topic is of direct 
relevance to well informed participants 12-16 pages is not unreasonable, but more general 
topics to a general population should be limited to  4-6 pages.  Consideration should be 
given to font size and type and pagination.  All of these elements will improve the aesthetics 
of the document and the impression that it generates, and increase the likelihood of 
completion.  However, there is also the need to plan for the follow up of non-responders.  It 
has been suggested(107) that reminders should be accompanied by another copy of the 
questionnaire to aid response. There is an acknowledgement that response rates are 
unlikely to be 100% and a response of 60% or more is considered acceptable(107).  
The issue of anonymity brings further challenges. Fully anonymous data might result in 
more honest and complete responses, though this does not allow for contextual analysis of 
the data and follow up is more difficult as it is not known who has not responded(107).  
Identifiable data might preclude participation in some settings or generate preconceptions 
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in the analysis. A balance needs to be struck, dependent on the nature of the study and in 
topic under investigation. When anonymity from the researcher cannot be assured then 
confidentiality of any data collected must be. 
Consideration should also be given to the analysis of the data that the tool will generate.  In 
some cases questionnaires are pre-coded so that data entry is clear, but this can add to the 
complexity of the appearance of the tool which might be off-putting to respondents(108). 
Finally piloting the questionnaire in a small group is essential to identify potential 
ambiguities or data retrieval challenges that might present in a larger scale delivery(109). 
4.5.2. Mixed methods research 
Up to this point the approaches to identifying and collecting data on the phenomenon of 
delivering pharmaceutical care has focused on quantitative measures i.e. counting and 
measuring.  Quantitative research is perhaps still the most common approach in health care 
research, often driven by the need to prove outcomes i.e. blood pressure reduced by 20% 
by the use of drug A.  However, it is increasingly recognised that qualitative research, which 
explores social context, motivations and opinions(110) has a valuable place in healthcare 
research.  For example, patients’ use of medicines and understanding how their social 
context might alter the use of the medicine is essential to understanding how that medicine 
will work in reality rather than laboratory.  Moreover it is being increasingly recognised that 
using ‘mixed methods’ where both quantitative and qualitative approaches are used within 
one study is of value.  This  is a useful technique as it benefits from the strengths of both 
approaches and can achieve a number of outcomes, including triangulation of data, added 
depth of knowledge and exploration of deviant or outlying data sets(111,112).    
Understanding the utility of the RSPWC in different settings will require qualitative 
exploration, this is not something that can be measured and, given the ‘unwarranted 
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variation’(21) that is known to exist within health care delivery, there is likely to be outlying 
data to explore in the course of this study.  To that end there is a need to consider the 
methodological approaches to qualitative research in the context of this work. 
4.5.3. Qualitative data collection and analysis 
As described above qualitative research explores the ‘uncountable’ – beliefs, opinions, 
influences and motivations(110). This can be explorative, reviewing previously uncharted 
knowledge and this type of research cannot follow a predetermined structure and its design 
is described as emergent. The alternate type of qualitative research is descriptive, where a 
framework of knowledge exists and the investigation is adding further detail.  Descriptive 
research in this field is largely structured, sequential and predetermined.  It can be 
conducted quantitatively but benefits from a mixed methods approach because of the 
ability to triangulated data from different sources, gain depth of knowledge and explore 
outlying data more fully. Data collection in this particular type of qualitative work is often in 
the form of ‘semi-structured’ interviews. An interview ‘guide’ is prepared in advance and 
outlines key topics for discussion, but allows the conversation to develop between 
interviewer and interviewee.  This process is, as Sim and Wright quote(113): 
“not a transfer of information from one person to another but a creation of 
knowledge and understanding through interaction of researcher and 
informant” [Holstein and Gubrum in Sim and Wright 2002, pg 55] 
The effective conduct of these interviews, which are perhaps better thought of as 
conversations with a purpose, requires a skilful researcher.  There is a need to balance the 
active participation of the interviewer with leading the interviewee or dominating the 
conversation.  However, neutrality or indifference are not helpful demeanours, as the key 
skill is developing a rapport, so participants are comfortable talking.  What should be aimed 
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for is “conscious partiality”(114) i.e. partial identification with the study participants.  
Specific skills or techniques that need to be employed include(115): 
 Active listening 
 The use of open-ended questions 
 Use of examples to give the participant something tangible to discuss 
 Probes to further explore initial answers 
 Paraphrasing responses, sometimes incorrectly, to elicit a more robust and detailed 
confirmation 
 Managing of the silences – not necessarily filling them 
If the research activity for qualitative studies is usually conversation (though observation is a 
technique sometime employed), the data which is produced is textual.  This can be in the 
form of verbatim transcripts of recordings of the conversation, hand written field notes or 
post activity reflections.  These however require management and analysis if they are to be 
distilled into new understanding, knowledge or theories – they require content analysis. 
This content analysis can be ‘inductive’ – the categories and themes that are generated 
come from the data – ‘constant comparison’(116) or ‘thematic content analysis’ are 
techniques employed to achieve this.  Alternatively the analysis can be ‘deductive’, whereby 
some categories are pre-determined before data collection and then applied to the data set.  
The latter is more readily applied to descriptive studies and one technique which is growing 
in its popularity, particularly in the field of applied healthcare and policy research is that of 
‘framework analysis’(117).  It is useful when objectives have been set in advance and are 
being shaped by the information requirements. It has applications when timescales are 
short and can be used to link to quantitative data. Gale et al.(117) identify its value in mixed 
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method studies and it’s accessibility as a technique for non-specialist qualitative 
researchers. 
 Pope, Ziebland and Mays(118) describe five stages of analysis using the framework 
approach. 
- Familiarisation – this requires the researcher to immerse themselves in the data, by 
reading and re-reading transcripts and listening to recordings, adding reflections 
and comments to the data in the process 
- Identification of the thematic framework – this is based on the aims and objectives 
which are pre-determined and added to by the familiarization with the data which 
may generate additional, unconsidered  issues 
- Indexing – the data is coded against the identified framework 
- Charting – the data is rearranged into a  structured grid or ‘framework’ so that it can 
be seen in one place and in relative context 
- Mapping and interpretation – the data in the framework is analysed to define 
concepts and map the range of the issues that have emerged. 
This analysis often runs concurrently with data collection (unlike quantitative research when 
analysis is more often held until all data has been collected).  This results in findings in the 
early part of the study informing future data collection, directing enquiry to develop themes 
and ideas that have begun to emerge that might not have been predicted.  It is therefore a 
reflexive process, which is discussed in more detail in the next section. 
How much data to collect is a question that is more difficult to answer in the field of 
qualitative research than in quantitative work, as in the latter sample sizes are often 
determined by the need to adequately ‘power’ the research for effective use of inferential 
statistics and probabilities.  It is usual to continue data collection until ‘data saturation’ is 
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reached i.e. that no new themes or ideas are being generated in the conversations.  
Sometimes the availability of the population being studied will define the sample size.  The 
analysis then has to convey the population context of the findings – the ‘generalisabilty’ of 
qualitative data is not a key consideration of the technique, of greater value is the deeper 
understanding of specific perspectives. 
Qualitative research has a number of limitations that need to be acknowledged.  Even more 
so than with questionnaires, the data produced is socially contingent.  What the participant 
says will be influenced by environment, prior experience, opinions of the researcher, 
perspectives or understanding on what it will be used for as well as culture and background.  
It is possible that different data would be collected from the same individual, on the same 
subject, on different days.  This lack of consistent reproducibility is cited as limitation of this 
type of research, along with the potential for bias to be added by the researcher’s own 
social contingencies, as the output is their ‘interpretation’ of what someone has said.  Mixed 
methods can help to address this if data can be triangulated by another source or type of 
data. Studies of this nature are best supervised by an experienced researcher(117,119). The 
influence of the researcher and their experience and perspective is an important 
consideration in qualitative research and is discussed further in the next section. 
4.6 Reflexivity in service development research  
It could be argued that the personal, social, educational background and experience of a 
researcher are factors that may influence the manner in which they approach a research 
question and their chosen methodologies may impact on the outcomes they measure, even 
if the subject matter and methods employed are purely science-based, objective 
measurements of a phenomenon.  All researchers should be aware of this social 
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contingency in their work and either embrace it for the richness that it will bring to the data, 
or mitigate against it confounding their objective results.  This is reflexivity i.e 
 “..taking account of itself or of the effect of the personality or presence of the 
researcher on what is being investigated..”  [Oxford Dictionaries 2017](120) 
The recognition of the need for researchers to become reflexive in their practice is a 
relatively recent development.  Rather than ignoring or denying the social contingency of 
research, the reflexive researcher embraces it and explores its impact to gain greater 
breadth and insight in to the phenomena they are considering.  As Sim and Wright quote 
Tindall in their explanation of reflexivity(121), that it: 
‘centralises, rather than marginalise or denies, the influence of the researcher’s 
life on the research and construction of knowledge’ [Tindall in Sim and Wright;  
2002 pg147] 
Reflexivity recognises the value of applying knowledge and experience gained in one 
element of the research in shaping its future progress and that in doing so greater richness 
of knowledge is achieved.  Actively employing reflexivity within a study requires a number of 
considerations which are outlined below. 
Greenaway suggests that reflexivity allows different ‘voices’ within a study to be heard(122).  
The researcher needs to consider what ‘voices’ are participating in a study and the 
implications of ensuring they are all ‘heard’.  For example these ‘voices’ will include the 
participants, the practitioners, the organisations which are being studied or who are funding 
the work in addition to that of the researcher.  Capturing this ‘speech’ within the text of a 
report is important, though Wilkie(123) cautions that in writing reflexively about their place 
within the study a researcher risks only their ‘voice’ being heard. 
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Reflexivity is particularly relevant to research related to service development.  In contrast to 
pure scientific research, where external influences have to be excluded or controlled, 
service development is often an iterative process which aligns strongly with the concept of 
reflexivity.   The development of the RSPWC has itself been an iterative process, grown 
through trial, evaluation and modification.  Its validation requires the generation of 
consensus amongst peers and the use of Delphi as a technique for achieving this is again 
iterative and so reflexive in nature.  The inclusion of a qualitative element at the end of this 
study was therefore the natural part of this approach and which allowed examination of the 
social and political context of healthcare delivery and workforce requirements.  The 
reflexive approach taken in this study is discussed in Chapter 9. 
4.7 Summary of methodology 
There are accepted approaches to workforce calculations.  One of these is the WISN 
approach and the construction of the RSPWC follows these principles.  The tasks, times and 
frequencies (service standard) need to be agreed and consensus amongst experts is 
required to achieve this. 
A reactive Delphi approach has been demonstrated as appropriate to develop the 
consensus in this field and the tool will be adapted in the light of that consensus. 
The applicability of the RSPWC to other settings needs to be confirmed. The tool needs to 
be validated.  The study has to demonstrate as many forms of validity as possible and these 
will be identified using the approaches identified in Table 4.2. 
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Table 4.2 Validation activities for the RSPWC 
Type of validity How this will be demonstrated 
Face  Already achieved through peer review at conference 
Content  Consensus from profession on what constitutes delivery of 
pharmaceutical care 
Criterion (concurrent) Comparison with NHS Benchmarking 
Construct Comparison with evidence in literature. Consensus on tasks, times and 
frequencies 
Internal Detailed explanation of the construction of the tool and confirmation of 
the accuracy of its mathematical calculations 
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5. Feasibility Study 
Through the previous chapters it has been identified that an appropriate approach to the 
validation of the RSPWC requires the establishment of consensus amongst pharmacy 
managers on the tasks required to deliver pharmaceutical care, how long these take and the 
frequency with which they are done.  The data on these issues, which initially drove the 
RSPWC were collected as part of a local time and motion study at the Royal Stoke University 
Hospital in 2009(12).  What was unknown was whether pharmacy managers at other 
hospitals would be able to provide either local data or experienced ‘best guess’ estimates on 
this subject to facilitate the generation of a consensus on the subject.  In addition, it was 
necessary to explore the ‘unavailable time’ inherent in the employment of different grades 
of staff and to understand what resources managers would request for different scenarios.  
Collecting data for these different elements required the administration of a detailed 
questionnaire and it was considered necessary to establish the feasibility of this approach 
prior to commencing the full research project (see 4.5.1).  
5.1 Feasibility Study Aim and Objectives 
The aim of this initial or ‘feasibility’ study was to establish whether it was possible to collect 
appropriate data to validate the tasks and timings of the RSPWC by the use of a 
questionnaire based survey.  Specific objectives were as follows: 
1. To design a questionnaire to capture data relating to tasks, timings, resource 
requirements and ‘unavailable’ time in the delivery of pharmaceutical care 
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2. To distribute the questionnaire to a small number of participants to establish if the 
data is available for this to be adequately completed and to understand the 
operational and governance challenges that may present in completing it. 
3. To identify additional tasks that are not routinely completed at RSUH and therefore 
not captured by the RSPWC. 
4. To identify ‘unavailable’ time that exists in the employment of different grades of 
pharmacy staff.   
5.2 Feasibility Study Methods 
5.2.1. Ethics and research approval 
This was sought and received from the Keele School of Pharmacy Research Ethics and 
Governance Committee and UHNM Trust Research and Development (R&D) department. 
The project was registered with UHNM audit department as per R&D advice and 
subsequently with the audit departments of participating Trusts, again as per R&D advice.  
NHS ethics approval was not required. 
5.2.2. Questionnaire design  
The questionnaire design followed the guidance identified in the methodology (see section 
4.5.1).  The questionnaire was limited to 6 pages(107,124), with clear instruction for 
completion(124). Transition statements were included between sections to guide the 
respondent through the process(124). Each section was contained on a single page and all 
technical language that was essential was clearly defined.  The content of the questionnaire 
was divided into four sections (see Appendix 3). 
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Section 1 – Identification of tasks and times 
This related to the tasks performed for the delivery of pharmaceutical care.  The tasks 
identified in the RSPWC were converted into a questionnaire with participants requested to 
identify if their staff routinely complete the tasks identified.  If so, how long it takes for 
these to be completed, by which staff group and the frequency with which they did so in 
normal practice.  It was also explored if this was guided by local standard operating 
procedure (SOP) or personal practice. To establish if this was the full extent of the 
phenomenon, participants were given the opportunity to identify additional tasks routinely 
completed by their staff along with the same details relating to staff group, time and 
frequency.  
Section 2 – Scenario based resource requirements 
This asked the participant to identify the resource they would request for the delivery of 
pharmaceutical care in a number of scenarios and the issues they would take into 
consideration.  These scenarios are shown in Figure 5.1 and are representative of real-life 
situations in which the RSPWC has previously been applied. 
Figure 5.1 Staffing scenarios presented in feasibility study questionnaire  
 
Scenario 1: 
 
A new medical ward is planned to open. This will have 28 beds and an average 
length of stay of 5 days.  You have to identify the pharmacy staff (WTE) required 
to deliver your standard ward based service. 
 
 
Scenario 2: An existing 28 bed medical ward with average length of stay of 4 days is being 
converted to a short stay (48 hour) unit.  What impact will this have on your 
pharmacy service and what if any additional staff would you request? 
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Section 3 – Identification of ‘unavailable time’ 
Here the participant was asked to identify the ‘unavailable time’ associated with employing 
various grades of pharmacy staff.  Examples of this were given; including travel time 
between departments, mandatory training, professional training, meetings, rest time and 
other participants had opportunity to add other issues they wished to identify. Unavailable 
time for annual leave and sickness absence were not included as these are already identified 
in Agenda for Change(76) This was a key element included in both WISN(23) and the 
Australian study(40) (see section 2.3 and 2.5) but had not been considered in the RSPWC in 
its initial development.  This needs to be addressed for the tool to generate a resource 
which is sufficient across a full year, allowing for expected absences. 
Section 4 – Demographics 
Finally participants were asked to identify the nature and size of their organisation and any 
speciality services it provides.  This was included to allow analysis of the influence that 
organisational differences may generate.  No site identifiable data was collected in this 
document. 
5.2.3. Participant identification and project registration 
For the purposes of the feasibility study an invitation to participate in the evaluation of the 
RSPWC was issued through a United Kingdom Clinical Pharmacy Association (UKCPA) online 
forum.  When pharmacy managers responded and volunteered to participate, the relevant 
Trust Audit Department was contacted to register the project at the individual Trust and 
gain permission for participation in the study. 
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5.2.4. Questionnaire distribution 
Once authorisation from the individual trust was received, the pharmacy manager was sent, 
by email, a participant information sheet (Appendix 4), consent form (Appendix 5) and 
questionnaire (Appendix 3) and asked to complete the information and return the data by 
email in a 2-week timeframe.  Those not returned in this timeframe were sent a polite 
reminder with a second copy of the paperwork attached.  A third and final reminder was 
sent if necessary. 
5.2.5. Data analysis 
Returned data was entered into a bespoke Microsoft Excel® spreadsheet which allowed 
data to be filtered by category for ease of analysis. A study register was established which 
identified to the researcher the site name and key contact details.  However, each 
participant site was allocated a consecutive number and the data recorded was anonymised 
to all but the researcher, by the use of this number in all further documentation. Data was 
analysed using descriptive statistics. 
5.3 Feasibility study results 
5.3.1. Data return and quality 
From the original invitation to participate in the study, responses were received from ten 
pharmacy departments. Two of these expressed interest in the project but were unable to 
participate in the feasibility study due to current work commitments that precluded data 
return within the required timeframe for the study completion.   Authorisation from the 
relevant Trust audit departments was requested for the eight remaining departments.  This 
was received in a timely manner from six sites and study documentation issued to the 
pharmacy personnel. Of these authorised sites, data from five sites was returned, analysed 
and is presented below. From the remaining site no data was returned for analysis at this 
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stage, despite several reminder emails.  Finally, Trust authorisation was not received from 
the last two sites who had agreed to participate and so they were excluded. The pharmacy 
managers involved were informed of progress difficulties. 
From the sites who returned data, fully-completed questionnaires were received from four 
sites and the fifth only completed data relating to clinical service activity and some 
demographic details, they omitted data relating to unavailable time and resource requests 
for the scenarios. 
5.3.2. Demographics 
All respondent sites were teaching hospitals, one was in New Zealand (this is discussed in 
detail in the limitations of the study, see section 9.4.1) and the other four were from 
England. Size of Trust ranged from 246 to 2600 beds.  Staffing levels ranged from 9 to 160 
pharmacists and 7 to 150 technicians.  The specialities provided by the participant sites 
were largely similar, including the full range identified in the questionnaire. Not all sites 
provided neurology/neurosurgery, long stay elderly or cardiac surgery. The expression 
‘T&O’, the abbreviation used at RSUH for ‘Trauma and Orthopaedics’, was not recognised by 
one participant and so the full term will be used in future versions of the questionnaire.  As 
such, this data demonstrates that different-sized and resourced sites participated in the 
project but that this small feasibility study did not included specialist units such as mental 
health trusts or community health care units. 
5.3.3. Pharmaceutical care tasks 
Data relating to the routine completion of the pharmaceutical care tasks demonstrated that 
the clinical tasks included in the RSPWC were common to all sites. Dispensary task data was 
available from four sites and this was largely similar, with the exception of the ‘tracking in’ 
task which was not routinely completed in all sites.   
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5.3.4. Time required to complete tasks and frequency with which performed 
A range of timings existed for many of the reported tasks and are displayed in Table 5.1. 
Some of these were based on existing local data, some collected for the purposes of the 
study and the rest were the ‘best guess’ of the pharmacy manager.  For MR the reported 
range of 10-20 minutes reflects that found in the literature but a larger sample is needed to 
understand whether the extremes fall within an acceptable range. Dispensary tasks timings 
were variable and the values in the RSPWC were at odds with those reported by other sites 
(see highlighted rows in Table 5.1).  This largely related to non-comparable data sets 
generated by the questionnaire.  This was addressed in the main study.  For other tasks, 
timings and frequency of completion by staff groups were similar to the RSPWC.  
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Table 5.1 Feasibility study task timing results 
 
Key:  NR= not reported NK=not known 
 
Table 5.2 shows the frequency with which each of the tasks was reported to be completed 
and whether this was determined by local SOP or personal practice; for some tasks this was 
not reported. It can be seen that for many of the tasks the frequencies are broadly similar 
across the sites and on the whole was guided by local SOPs. Where ‘variable’ or ‘daily’ 
frequency timings were reported conversion to a numerical value is needed for application 
of the calculator to the service data.   
 
Participant Sites 
Pharmacy tasks included in RSPWC RSPWC A B C D E 
  TIME TAKEN (minutes) 
Medicines Reconciliation (pharmacist 
confirmed and signed off) 
10 10 15 20 10 10 
Check of PODs 5 7 7 10 5 5 
Clinical Review of Notes 5 5 5 3.5 NK 5 
Review of Blood results 1 3 3 3.5 NK 1 
Initial review of Drug Chart 5 3 3 2.5 5 5 
Initial endorsing of Drug Chart 2 5 4 1 5 2 
Subsequent review of Drug Chart 2 1 2 3 5 2 
Subsequent endorsing of Drug Chart 0.5 1 2 2 3 1 
Completion of Paperwork 2 1 NK 0 NK 3 
Ordering of Non Stocks 2 0 5 2 NK 2 
Clinical Check of TTO 5 5 5 3 17 5 
Talking to patient about their medicines 5 5 10 1 NK 5 
Making interventions on patient care 5 10 5 2 10 5 
  
      
Booking on to tracker system 2.5 0.5 NR NR 1 N/A 
Dispensing 20 3 4 NR NK 5 
Checking 8 2 3 NR NK 5 
  
      
Booking onto tracker system 2.5 0 NR NR 1 1 
Triage (Clinical Check) 5 0 5 NR 17 5 
Dispensing 20 10 - 15 7 NR NK 5-10 
Checking 8 3 5 NR NK 5-10 
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Table 5.2 Feasibility study task frequency results 
 
Key: NR=not reported  SOP=standard operating procedure PP=personal practice 
 
5.3.5. Additional tasks identified 
Data was provided by two sites for additional tasks routinely performed by their staff when 
delivering pharmaceutical care.  This demonstrated an average additional 33 minutes of 
care that was not incorporated into the RSPWC.  Moreover there was one activity identified 
in both responses (the writing of the discharge prescription, either electronically or 
manually) which may need to be incorporated into the tool. This requires further 
investigation in a larger sample size to determine whether this is an activity which is 
commonly conducted across many sites or maybe limited to a small number of sites with 
pharmacist prescribers and therefore not generalisable to the whole country. 
  
Pharmacy tasks included in RSPWC RSPWC A B C D E RSPWC A B C D E
Medicines Reconciliation (pharmacy 
confirmed and signed off)
1 1 1 1 1 1 SOP NR SOP SOP SOP SOP
Check of PODs 2 1 1 2 1 1 SOP NR SOP  SOP  SOP SOP
Clinical Review of Notes 2 3 to 5 3 variable 3 1 SOP NR SOP PP PP SOP
Review of Blood results 2 3 to 5 daily variable 3 2 SOP NR SOP PP PP SOP
Initial review of Drug Chart 1 1 1 1 1 1 SOP NR SOP SOP SOP SOP
Initial endorsing of Drug Chart 1 1 1 1 1 1 SOP NR SOP SOP SOP SOP
Subsequent review of Drug Chart 2 3 to 5 daily daily 2 1 SOP NR SOP SOP SOP SOP
Subsequent endorsing of Drug Chart 2 3 to 5 daily daily 2 1 SOP NR SOP SOP SOP SOP
Completion of Paperwork 2 3 to 5 2 NK 1 SOP NR PP SOP NK SOP
Ordering of Non Stocks 2 3 to 5 3 1 2 1 SOP NR SOP SOP SOP SOP
Clinical Check of TTO 1 1 1 1 1 1 SOP NR SOP SOP SOP SOP
Talking to patient about their 
medicines
1 3 to 5 variable 2 1 3 TO 5 SOP NR PP SOP PP SOP
Making interventions on patient care 1 3 variable variable 2 1 SOP NR SOP SOP PP SOP
Booking on to tracker system 1 1 NR 2 N/A SOP NR NR NR SOP  SOP
Dispensing 1 1 2 to 3 NR 2 1 SOP NR SOP NR SOP  SOP
Checking 1 1 2 to 3 NR 2 1 SOP NR SOP NR SOP  SOP
Booking onto tracker system 1 0 NA NR 1 1 SOP NR NR NR SOP SOP
Triage (Clinical Check) 1 0 1 to 2 NR 1 1 SOP NR SOP NR SOP SOP
Dispensing 1 3 1 to 2 NR 1 1 SOP NR SOP NR SOP SOP
Checking 1 2 1 to 2 NR 1 1 SOP NR SOP NR SOP SOP
Frequency determined by?Frequency task completed/admission
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5.3.6. Resource scenarios 
Table 5.3 shows the resource requested for Scenario 1 ranged from £25.5k to £150k and for 
Scenario 2 the range requested was £0 to £85.5k (see Table 5.3).  This represents a 
substantial variation in staffing requested across the study population, given that the roles 
these staff will be expected to carry out were described very similarly in the first part of the 
results.  
Table 5.3 Feasibility study resource requested for staffing scenarios 
Staffing 
scenarios 
Participant Sites 
RSPWC 
A  
(£/annum) 
B  
(£/annum) 
C 
D 
(£/annum) 
E 
(£/annum) 
Scenario 
1 
£68,359.00 £150,000 £0 
No data 
supplied 
£34,057 £25,431 
Scenario 
2 
£85,449 £0 £0 £0 £3,547 
      
 
5.3.7. ‘Unavailable’ time 
Participants were asked to identify ‘unavailable’ time that is inherent in the employment of 
staff.  Pre-identified examples listed in the questionnaire included travelling time from 
department to ward, mandatory training, professional training, meetings.  Sites were asked 
to identify time taken by different grades of staff to fulfil these duties and identify any 
others that applied.  Data was returned from three sites (A, B & D) and compared to that for 
RSUH.  Table 5.4 shows that on average 0.25 WTE pharmacists and 0.2WTE technical staff is 
absorbed through annual leave and non-operational activities. 
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Table 5.4 Feasibility study ‘unavailable time’ results 
 
Key:  RSUHNL=Royal Stoke University Hospital  WTE=whole time equivalent
AfC 
grade
Site
Travel 
(mins/
week)
Mandatory 
training
(mins/
week)
Professional 
training(mins
/week)
Meeting
s(mins/
week)
Rest Time Other
Total 
Additional 
time(mins)/
week
Total 
Additional 
time(hrs)/
week
Non-
operational 
employmen
t time 
(WTE)
Annual 
leave 
(WTE)
Total Average
A 100 7.5 100 90 0 17.3 314.8 5.2 0.14 0.1 0.24
B 150 1.25 30 300 0 0 481.3 8.0 0.21 0.1 0.31
D 100 14 30 400 0 0 544.0 9.1 0.24 0.1 0.34
RSUH 100 7.3 17 120 0 0 244.3 4.1 0.11 0.1 0.21
A 150 7.5 50 60 0 17.3 284.8 4.7 0.13 0.1 0.23
B 150 1.25 60 200 0 0 411.3 6.9 0.18 0.1 0.28
D 50 14 90 120 0 0 274.0 4.6 0.12 0.1 0.22
RSUH 150 8.4 17 60 0 0 235.4 3.9 0.10 0.1 0.20
A 150 7.5 100 60 7.5 2 327.0 5.5 0.15 0.1 0.25
B 150 1.25 120 160 0 0 431.3 7.2 0.19 0.1 0.29
D 50 14 90 120 0 0 274.0 4.6 0.12 0.1 0.22
RSUH 150 8.4 150 60 0 0 368.4 6.1 0.16 0.1 0.26
A 75 7.5 50 60 0 4 196.5 3.3 0.09 0.1 0.19
B 300 1.25 0 30 0 0 331.3 5.5 0.15 0.1 0.25
D 100 14 30 60 0 0 204.0 3.4 0.09 0.1 0.19
RSUH 150 7.3 0 45 0 0 202.3 3.4 0.09 0.1 0.19
A 75 7.5 50 60 0 4 196.5 3.3 0.09 0.1 0.19
B 300 1.25 0 30 0 0 331.3 5.5 0.15 0.1 0.25
D 100 30 30 0 0 160.0 2.7 0.07 0.1 0.17
RSUH 150 7.3 0 30 0 0 187.3 3.1 0.08 0.1 0.18
A 75 7.5 30 60 0 4 176.5 2.9 0.08 0.1 0.18
B
D 50 0 30 30 0 0 110 1.8 0.05 0.1 0.15
RSUH 150 7.3 0 30 0 187.3 3.1 0.08 0.1 0.18
Non-operational activities 'unavailable time' (minutes)
0.28
0.23
0.26
0.20
0.20
0.13
No data for this staff group
8a
7
6
5
4
2&3
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5.4 Discussion of feasibility study results 
Analysis of the data returned by participant sites suggests that regardless of size of hospital 
or staffing resource available and the lack of formal guidance as to the delivery of 
pharmaceutical care, the tasks performed by pharmacy staff to ensure the safe and 
effective use of medicines maybe consistent and reproducible.  Also data is available around 
how much time each task takes at different hospital sites and for several of the tasks a wide 
range of times was reported which is reflective of the literature(41,55-57,59,59-61,63,64,66-
69).  
Additional duties not captured by the RSPWC were identified in this feasibility study.  These 
amounted to around half an hour of extra time required for each patient, which is 
substantial and so this element needs to be fully understood.  Transcribing of discharge 
medicines on the discharge letter is a task reported by both respondents in this section of 
the study and one which may need incorporating into the calculator should it generate the 
same level of consensus as other tasks which are included in the RSPWC.  The full range and 
significance on staff time of duties not included in the RSPWC will be better understood 
with the larger sample size of the main study.  Finally the issue of ‘unavailable’ time was 
identified as one that needed to be better understood for the RSPWC to more accurately 
calculate the resource required to deliver pharmaceutical care.   
The results from this study were not intended to demonstrate conclusive findings or 
establish consensus as participant numbers were too small.  The intended outcome was to 
determine the feasibility of this approach to data collection and this too is relatively limited 
by the small data set and predominance of teaching hospitals (i.e. it is not possible to 
identify whether smaller, specialist units are able to complete the questionnaire adequately 
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enough to establish consensus for their areas of practice). Limitations also result from 
incomplete data sets, as full comparison of all elements of the service could not be made.   
5.5 Implications of this research for the main study 
The numbers of participants in this feasibility study were limited, not by the enthusiasm of 
the pharmacy departments, but by the process of registering the study with the relevant 
body in each Trust.  The nature of the project meant that it does not sit comfortably within 
‘audit’ and therefore some audit departments were not happy to approve as it was not in 
their remit, so passed responsibility on to someone else, until eventually someone was 
prepared to give approval.  This generated an inherent delay in the study timeframe and 
was discussed at length with the R&D team at RSUH prior to the main study, to explore the 
level of registration required to meet R&D governance standards, whilst not creating 
unnecessary barriers for participation. The decision reached by the R&D manager was that 
the project should be considered ‘service development’ and not audit, thereby removing 
the need for the involvement of audit and research departments at other sites. 
Another issue was that return of the questionnaires from the participants was slow and did 
not meet the initial 2-week deadline in most cases.   Questionnaire return is an inherent 
problem in this type of research(107) and this might limit data collection in the main study.  
A robust reminder process was  therefore incorporated in to the main study design. 
For both clinical and dispensary tasks further clarity on units and denominators was 
required in the main study to allow reliable comparison between sites.   In relation to 
clinical activity some sites did not put a figure to the frequency, but simply said ‘daily’ or 
‘variable’.  ‘Daily’ can be translated into figures by multiplying by average length of stay 
(LOS) of patients, but ‘variable’ requires interpretation, which may be incorrect. 
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Consideration needed to be given as to whether the questionnaire needed to be more 
explicit, whether further comment would be  requested if a figure is not reported or 
whether this would be done informally through follow up with the participant or in the 
qualitative stage of the study.  A balance needed to be struck between data clarity and 
questionnaire complexity, to avoid a detrimental effect on the volume of data returned. 
For dispensing activities in the RSPWC these figures were constructed from an average time 
to complete the dispensing tasks for each patient at RSUH.  This is driven by the number of 
factors within the medicines supply process, which may differ between sites and therefore 
result in non-comparable data sets.  To address this in the main study, data at a more 
granular level were requested, which included dispensing and checking times per item, the 
average number of items on an inpatient prescription and questions relating to the types of 
medicines dispensed and the level of automation existing in the process. 
This ‘unavailable time’ element is required to bring the RSPWC in line with the WISN 
formula(23) and data from this feasibility study suggested that this is a substantial part of 
any whole time equivalent (WTE) hours.  Identifying consensus on this element was 
important for the main study as without it services will always be under-resourced.  The 
risks associated with inclusion of it in any final version of the tool also needed to be 
considered.  On the basis of this early data it is suggested that for every WTE post funded 
through application of the calculator, the funds requested will have to be increased by 
another 25% to account for the ‘unavailable’ time, substantially increasing the value of 
staffing resource identified.  .   
Finally, consideration was given prior to the main study to the statistical analysis of data 
generated. These are described later in the Main Study Methods section.  
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5.6 Summary of findings from the feasibility study 
The development of a workforce calculator tool required the identification of a consensus 
on what tasks are required, how often they should be done and how long these take. Data 
from this feasibility study, suggested that the tasks that drive the RSPWC were routinely 
completed at other sites and some of the timings were consistent. This reflected the 
published literature(41,55,56,56,57,59-61,63,64,66-69). A larger sample size was required to 
determine more robust timings for all activities.   
The use of a questionnaire appeared to be an effective method of capturing this data and, 
with modifications to address identified limitations, could be applied as a first round in a 
consensus project using Delphi methodology.   
Non-operational time inherent in the employment of pharmacy staff is significant and 
consideration of its incorporation into the RSPWC is essential if the resource the tool 
calculates is to be sufficient to deliver the defined service.  
Changes to the methods used in the main study in light of the findings of the feasibility 
study are shown in Table 5.5. 
Table 5.5 Summary of changes to study methods in response to feasibility study results 
Method section Changes made 
Governance  Removed need for audit department authorisation at each 
participating Trust 
Questionnaire 
design 
 Wording changes for clarity and removal of local abbreviations 
 Change of approach to capturing dispensing activity times from 
‘per admission’ to ‘per item’ for improvement in data 
comparability 
 Inclusion of questions relating to e-prescribing and automation 
Questionnaire 
distribution 
and return 
 Establishment of a dedicated email address for all study 
communication 
 Inclusion of specific follow up process for non-responders 
RSPWC 
development 
 Inclusion of ‘unavailable time’ in algorithm 
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6. Main study methods 
The feasibility study (as described in Chapter 5) informed the methods in the main study. 
Changes made are described in Table 5.5.  For the main study research there were three 
distinct parts (as shown in Figure 6.1) 
 Part 1: A two round Delphi consensus study to generate agreed tasks, times and 
frequencies for activities required for the delivery of pharmaceutical care  
 Part 2: A scenario-based questionnaire evaluation to understand the transferability of 
the tool to  different operators 
 Part 3: a series of semi-structured interviews to further investigate reasons for outlying 
data and the utility of the RSPWC  
 The research methods applied to each of these parts will be discussed separately.  
6.1 Ethics and NHS Research and Development (R&D) approval 
Prior to participant recruitment full applications for approval were submitted to both the 
Keele University Ethics Review Panel and to University Hospitals of North Midlands (UHNM) 
R&D for NHS management approval.  Copies of all study documentation and planned 
communication were submitted.  The study received University Ethic approval in December 
2015 (see Appendix 6) and NHS R&D approval in March 2016.  Participant recruitment 
commenced in April 2016. From the R&D NHS perspective the study was deemed service 
evaluation and as such required no further NHS research registration.
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Figure 6.1 Validation of the RSPWC – project plan 
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6.2 Study population 
6.2.1. Sampling  
The methodological considerations on sample size discussed in section 4.3 guided the 
identification of sample size.  For the purposes of this study a ‘homogenous’ population was 
defined as ‘from the same hospital setting’ e.g. acute hospital trust, with distinctions made 
between district general hospitals (DGH) and teaching hospitals, mental health units and 
community hospitals.  The desired study sample size was identified to be in the region of 10-
15 participants from each contributing sector for consensus from within each sector to be 
achieved. Excessive participant numbers were not anticipated from the responses in the 
feasibility study and so the ‘selection’ of participants to form this population was considered 
unnecessary.  
6.2.2. Recruitment 
Inclusion criteria for study participants were 
 Clinical pharmacy managers currently employed in a hospital setting 
 Authorised to participate by their Chief Pharmacist 
 Able/willing to complete the questionnaire in the required timeframe as indicated 
by their email communication following reminder emails. 
There were no exclusion criteria in this study. 
For the main study, participants were recruited via invitations issued through a number 
professional network forums (United Kingdom Clinical Pharmacy Association management 
on-line forum, Royal Pharmaceutical Society hospital pharmacy on-line forums, Chief 
Pharmacist Regional Network meetings and Clinical Pharmacy Congress) and direct email 
approach to selected individuals, where specific regional contacts were identified from the 
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professional forums.  These invitations explained the background of the study, the expected 
requirement of participants and requested that interested parties contact the study 
investigator by email to register their interest.  A dedicated email account was set up to 
receive and send emails relating to the study. 
Participants were informed of their ability to withdraw from the study and assured of the 
anonymity of their data i.e. no data or direct quotes would be directly attributable to any 
participant.   
6.3 Data collection – Parts 1 and 2 
As outlined in Figure 6.1 there were three parts to the main study.  Parts 1 and 2 required 
the design, delivery and analysis of questionnaires and the details of the approach taken in 
these activities are considered below. Data collection for Part 3 of the study, the qualitative 
semi-structured interviews, is considered in section 6.4.   
6.3.1. Data collection – questionnaire design 
Following the feasibility study some changes were made to the questionnaire for the first 
round Delphi (see Table 5.5).  As discussed in the findings of the feasibility study the timings 
for supply related tasks (dispensing and checking) were very disparate and this was thought 
to be due to non-comparative data being submitted, caused by imprecise language in the 
questionnaire e.g. time to dispense a prescription was interpreted as a single item 
prescription or as multiple items on one prescription.  In addition the existence of electronic 
prescribing and automated dispensing was considered to be a factor in the timings of tasks.  
These issues were addressed by asking more specific questions in the first round Delphi 
questionnaire (Appendix 7) of the main study.   
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The questionnaire complied with core elements of questionnaire design as described in the 
literature (discussed in section 4.5).  The feasibility study acted as a pilot of the 
questionnaire and modifications were subsequently reviewed by the project supervisor and 
independent colleagues.  Data from the feasibility study was included in the main study 
results of round one, though the elements relating specifically to the supply timings were 
not collected from feasibility sites and so data for this section was from a reduced number 
of participants.  
Following receipt and subsequent analysis of the first round data a summary of findings was 
produced and each participant sent a copy of this compared to their own responses and 
asked to review and amend their data as they saw fit in light of the results.  In addition to 
the results of the first round, early information identified through the qualitative interviews 
conducted as Part 3 of the research, identified the need to explore the issue of patient 
pharmaceutical acuity.  This was addressed as part of this second round questionnaire.  This 
process is indicative of the reflexive nature of this work.  Guidance from a participant in Part 
3 helped to shape the structure of the question asked around the management of an 
exemplar patient (see Appendix 8). 
The design of the Part 2 operator evaluation questionnaire (Appendix 9) also followed 
guidance from the literature and built on the results of the feasibility study.  The scenarios 
presented for the participants to use the RSPWC to calculate the required resource were the 
same as in Part 1, questionnaire 1, so as to allow direct comparison of resource requests. 
6.3.2. Data collection - process 
The data collection for the Parts 1 and 2 of the main study ran in parallel (see Figure 6.1) 
and followed the steps outlined below. 
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 On receipt of an expression of interest, each participant was sent a ‘Participant 
Information Sheet’ (Appendix 10), a consent form (Appendix 11) and a copy of the 
Delphi round one questionnaire 1 (Appendix 7) for them to complete and return by 
email within a four week period.   
 Following receipt of all data sets from round one, Questionnaire 2 was issued to all 
participants.  This included a personalised summary of the data, allowing them to 
compare their data with that submitted by their peers (see Appendix 8).  For 
questions where consensus was not achieved in round one, additional questions 
were asked to explore these issues further. This related particularly to frequency of 
completion of tasks, which respondents suggested “depends on the patient”.  In this 
second round, patient characteristics which would generate increased pharmacy 
input were explored and exemplar patient cases were provided for participants to 
indicate ‘typical’ service delivery. Participants were asked to review the data and 
return answers to Questionnaire 2. 
 On return of the first round Delphi data set, each participant was sent a copy of the 
study version of the RSPWC (Appendix 12) and the Operator Evaluation form 
(Appendix 9) to complete and return. 
For each part a reminder email, including a copy of the questionnaire,  was sent if the 
response was not received within the allocated four week time frame, followed by one 
further contact two weeks later.  If no response was received after this point, no further 
contact was made. 
6.3.3. Data collection – administration and analysis 
All data was collected electronically via email. This study was planned as a two-round 
Delphi, with the qualitative stage intended to explore the ongoing outstanding data.  On 
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receipt of completed first round questionnaires, the data was entered into a Microsoft 
Excel® spreadsheet which was copied into an SPSS® database. Both programmes were used, 
as each offered different functionality e.g. SPSS® allows easy plotting of distribution graphs 
which identifies skewed data and outliers more easily, whilst data filters in Microsoft Excel® 
enables simple subgroup analysis.  Data analysis was done using descriptive statistics, as 
consensus studies do not always generate data suitable for inferential statistical analysis.  
Guidance on statistical analysis was provided by statisticians working with the Research and 
Development team at the University Hospitals of North Midlands NHS Trust (UHNM).   
The objective of Part 1 of the study was to gain consensus or agreement on the tasks that 
are required to deliver pharmaceutical care. The establishment of consensus is not well 
defined, with different authors taking different approaches (see section 4.3)(88,92-95). For 
the purposes of this study the measure of ‘agreement’ was determined as the most 
common response i.e. the ‘mode’ and this was taken as the measure of consensus for each 
task, time and frequency.  Prior to data collection it was agreed by the research team that 
consensus should be classified into two levels.  ‘Strong’ consensus was defined by an 
arbitrary, but substantially, ‘greater than 2/3’(88), value of  70% or more of the respondents 
sharing the same opinion.  This data was rated as ‘green’. Where that value represented the 
opinion of 50-69% of respondents, ‘moderate’ consensus was deemed to be achieved and 
data was rated as ‘amber’.  If the mode value represented less than 50% of respondents’ 
views, consensus was deemed to have not been achieved, even if there was plurality in that 
mode and the data was rated ‘red’.  This Red/Amber/Green (RAG) rating of the data allows 
a reviewer to see at a glance the strength of consensus on the details that drive the RSPWC. 
Following this first review of the data, a summary was issued to participants along with their 
own data set for comparison and, if they wished, amendments to their data could be made 
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at this stage.  This second round data was first analysed in the same way.  More detailed 
analysis was done for components where consensus (as defined above) was not achieved.  
In particular this related to staff groups, where participants had given complex answers 
including more than one staff group completing an activity.  In these cases the staff groups 
were split out and analysed individually. The RAG rating of the data was adjusted after this 
second analysis, where evidence for this change could be demonstrated.  
 In relation to the time a task took, where consensus was not achieved as described above 
(i.e. >50% agreement with a mode figure) a different approach was taken.  The continuous 
nature of this data meant that consensus was less likely as there were infinite numbers of 
options.  This might have been resolved by grouping data into periods of time  0-4 minutes, 
5-9 minutes etc and consensus achieved that way, but the RSPWC requires a discrete 
number not a range for the algorithm to work and so an alternate approach was taken.  The 
mean time was calculated, using existing local data where provided and triangulated against 
the mode and median figures.  From this a ‘national best representative’ figure was 
identified.   
At this stage the only remaining outliers related to frequency of a small number of activities 
and these were explored using the responses to exemplar patient cases and through the 
qualitative stage of the project. The stability of opinion was also assessed – how much did 
the views change across the two rounds?  This would also indicate if further rounds would 
be required prior to the qualitative process. 
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6.4 Semi-structured interviews – Part 3 
The qualitative element part of the study, Part 3, was initially designed to explore the utility 
of the RSPWC in different settings – what were its applications, benefits and limitations  
During the course of the study it became apparent that this element of the study would also 
allow exploration of the outlying data sets and issues where consensus had not been 
achieved. 
 
6.4.1. Sampling and recruitment 
Traditionally in qualitative research sample size is dependent on data saturation i.e. when 
no new themes are being identified(88). The number of participants is not usually 
predictable and depends on the nature and complexity of the subject being investigated.  All 
participants who remained in the process until the end of the second round Delphi were 
invited to participate in the qualitative stage of the research. As numbers were low, all 
volunteers were selected for interview, as each could offer insight into outlying data or 
areas of non-consensus. 
 
6.4.2. Interview Guide 
The interview guide was developed to give insight into issues not covered by the 
quantitative element of the research and to further explore key themes that arose during 
the data analysis of the first stage.  These included the current challenges they face with 
respect to staffing, their experience of using the RSPWC and, finally, explored the 
participant’s out-lying data (if appropriate) and their views and opinions on the issues where 
consensus had not been achieved (see Appendix 13).  The core questions were prepared in 
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advance of the first interview.  The reflexive nature of this research allowed these to be 
modified in subsequent conversations to allow clarification of issues or further exploration 
of new themes as they emerged. Interviews started with open questions about factual 
elements of the Trust and Department in which the participants worked. This allowed them 
to get into the conversation on comfortable subjects and gave context to the rest of the 
data.  Questions were in no fixed order and not all were specified in the interview guide.  
Minimal prompting was given by the interviewer, allowing the participant to respond in 
their own words and further questions used to probe or clarify initial answers. 
 
6.4.3. Qualitative data collection and analysis 
Conversations were conducted by the principal researcher by telephone or in person, at 
times pre-arranged by email correspondence. Participants were sent separate participant 
information sheets and consent forms (Appendices 14 and 15) for the qualitative part of the 
research prior to commencing the interviews. All interviews were conducted in October and 
November 2016 and ran concurrently with parts 1 and 2 of the study.  These sessions were 
recorded using a digital recorder and transcribed verbatim by a professional transcribing 
service.  These transcripts were read alongside the recording and further details added 
where necessary (e.g. where recording quality was poor) by the researcher from notes 
made at the time of the interview and in post-interview reflections. Following final 
preparation of transcripts a detailed review of the data was conducted allowing the 
familiarisation of the researcher with the detail of their contents.  Subsequently a thematic 
framework was developed (as described in section 4.5.3) and the data then coded against 
this structure.  The final step prior to analysis was the charting of the data into a matrix to 
allow a holistic view of the data and to facilitate the emergence of connected and disparate 
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themes.  The analysis was conducted to extract the key themes and ideas from the data.  
These gave greater richness to the quantitative data and explanation of non-consensus 
which informed the final version of the RSPWC.  In addition this data gave insight into the 
application and future developments of the tool. 
6.5 Summary of main study methods 
A mixed methods approach was taken for this validation study.  The research utilised 
electronically distributed questionnaires and semi-structured interviews.  Participants were 
recruited through professional forums and networking.  The results of this study are 
presented in the following chapter. 
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7. Results 
The delivery of this study was achieved through three distinct parts.  The results of each of 
these are reported in turn in this chapter.  The context for these results is provided first in a 
summary of study participant demographics. 
7.1 Demographics 
Through the recruitment process described in Chapter 6, 37 participant sites were identified 
and sent study documentation and the first round Delphi questionnaire.  From this cohort 
questionnaires were returned by 23 (62%) sites.  It is from this sample that all data for this 
study was received (this includes the participants from the feasibility study as data was 
comparable).  Participating Trusts are listed in Appendix 16. This sample included those sites 
who had participated in the feasibility study, as data sets were comparable.  One site, whilst 
returning the study documentation was unable to provide data for the study as they felt 
that their service delivery was so different it did not apply.  This is explored in Part 3 results.  
Another site returned data but the electronic file was corrupted and the participant failed to 
respond to all requests for a second delivery attempt.  Therefore analysable data was 
returned by 21 sites (57%).  Not all sites returned data for all questions and ‘n’ values are 
shown throughout. As expected with Delphi studies(88) participation fell away as the study 
progressed.  Study participant numbers in each part of the research are shown in Figure 7.1. 
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Figure 7.1 Study participant numbers at each part of the study 
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The consensus and qualitative data that follow need to be considered in the context of the 
populations from which they were drawn.  Demographic details of participant sites are 
shown in Table 7.1.  Of these 21 sites, nine identified themselves as NHS Foundation Trusts 
and three were tertiary referral centres for a number of specialities. Participants were 
drawn from across the UK - 17 English hospitals, three Welsh and one Scottish hospital 
submitted data.  No data was submitted from Northern Ireland despite several different 
approaches to recruitment.  Data was received from one non-UK site in New Zealand. 
Table 7.1 Participant site demographics (n=21) 
Type of setting Number  
Teaching hospital 11  
District General Hospitals (DGH) 8  
Mental health unit 1  
Intermediate care unit 1   
Size and Staffing Mean Range 
In-patient beds  1072  190-2096 
Pharmacist WTE 51.75 8-160 
Technician WTE 43.85 3-129 
Assistant Technical Officer (ATO) WTE 25.97 0-69 
Beds/Pharmacist 20.72 7.5-38 
Beds/Technician 24.46 10-88 
Beds/ATO 41.29 16-70 
 
From a sample size perspective, the target of 10-15 for each setting was achieved for 
teaching hospitals (eleven) but fell just short for DGH sites (eight). Both of these settings 
deliver acute services for medicine and surgery, so the target was met for “acute hospital 
sites” (nineteen).  Consensus sample size was not achieved for mental health or 
intermediate care beds.  
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It can be seen that staff group/bed numbers vary widely across participant sites. Sub-group 
analysis of this by setting (Table 7.2) shows that teaching hospitals have almost double the 
staffing levels of their DGH counter parts for only a third more beds. 
Table 7.2 Sub-group analysis of staffing levels 
Type of 
hospital 
Demographics (mean) 
Beds Pharmacists 
Beds/ 
Pharmacist 
Technicians 
Beds/ 
Technician 
ATOs 
Beds/ 
ATO 
Teaching 
Hospitals 
1172 74.79 19.56 58.28 32.10 34.30 40.30 
DGH 827 37.53 23.66 33.99 25.90 28.82 34.54 
Study 
population 
mean 
1072 51.75 20.72 43.85 24.46 25.97 41.29 
 
Figure 7.2 displays the medical/surgical specialities delivered by the participant Trusts.  It 
can be seen that patient groups cared for by pharmacy staff at participant sites are largely 
consistent across the study population, with the exception of neurology, neurosurgery and 
cardiothoracic surgical specialities. 
Figure 7.2 Speciality services delivered by participant sites  
  
This demographic data suggests that similar patient groups are cared for across all 
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7.2 Part 1: Delphi Round 1 (Questionnaire 1 results) 
The responses from the first round Delphi questionnaire began to form the consensus on 
the tasks, times and frequencies that drive the calculations in the RSPWC and gathered data 
on other elements of the service and staffing issues. 
7.2.1. Round 1: Consensus on tasks, times, frequency & staff groups  
These are the figures which drive the algorithm that calculates the staff resource generated 
by the RSPWC and the first round Delphi explored consensus amongst the participant group 
on these issues.  The first level of analysis was a face value review of the level of consensus 
achieved in this data set. 
For each component task the percentage agreement with the mode response was identified 
and the level of consensus RAG rated as described in the methods (R<50% agreement, A 50-
69% agreement, G>70% agreement.)   Table 7.3 identifies the level of consensus achieved in 
round one for the clinical tasks associated with the delivery of pharmaceutical care to 
hospital inpatients. 
This data demonstrates that consensus was achieved in round one on 33 of 52 (63%) data 
sets which drive the RSPWC.  ‘Green’ data was considered complete and required no further 
validation (unless RAG rating changed in second round).  The amber and red data was 
further explored in round two of the Delphi and parts 2 and 3 of the study. 
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Table 7.3 Delphi round 1 result on tasks, times and frequency (clinical duties) 
Direct patient care 
activities completed 
for each patient 
admission 
% 
Agreement 
with task 
necessity 
n=21 
Staff group 
required to 
deliver task. 
Mode 
response (%)  
n= 21 
Mean time task 
takes in minutes. 
Mode response 
(% and range) 
Frequency which task 
should be done for 
each patient 
admission. 
Mode response 
(% agreement & range) 
Medicines 
Reconciliation 
(pharmacy confirmed 
and signed off) 
100 P / MMT = 
81% 
n= 21                        
10 (29%) & 
20 (29%)                 
6-30 
n=21                                
1(85%)                                  
1-2 
Check of Patients 
Own Drugs (PODs) 
95 P/MMT= 
43% MMT= 
48% 
n=17                           
5 (58%)                      
4-15 
n=20                            
1(65%)                                
1-2 
Clinical Review of 
Notes 
90 P=81% n=18                            
5 (66%)                     
2-10 
n=20                      
“Depends” (45%)                  
Daily - 7 
Review of Blood 
results 
90 P=81% n=17                           
5 (35%)                     
1-5 
n=19                       
“Depends” (52%)                  
Depends-3 
Initial review of Drug 
Chart 
100 P=38% 
P/MMT=57
% 
n=18                           
5 (50%)                     
2-5 
n=19                                      
1 (79%)                   
Depends-1 
Initial endorsing of 
Drug Chart 
95 P=43% 
P/MMT=48
% 
n=17                            
5 (40%)                     
1-10 
n=17                                      
1 (82%)                   
Depends-1 
Subsequent review of 
Drug Chart 
95 P=33% 
P/MMT=57
% 
n=17                           
5 (41%)                     
1-5 
n=18                      
“Depends” (44%) 
Depends-Daily 
Subsequent 
endorsing of Drug 
Chart 
90 P=38% 
P/MMT=47
% 
n=17                      
2 (30%)                      
0-5 
n=17                      
“Depends” (41%)    
Depends-daily 
Completion of 
Paperwork 
(Pharmacy 
handover/care plans 
etc) 
86 P=14% 
P/MMT=47
% MMT=5% 
n=9                             
5 (66%)                     
1-5 
n=11                            
“Depends” (27%)       
Depends-Daily 
Ordering of Non 
Stocks 
90 P/MMT=43
% 
MMT=29% 
n=16                      
5 (44%)                       
1-5 
n=17                       
“Depends” (47%)        
Depends-3 
Clinical Check of 
Discharge 
prescription 
100 P=76% n=21                      
5 38%)                      
2-17 
n=21                                      
1 (100%) 
Talking to patient 
about their medicines 
95 P/MMT=81
% 
n=17                            
5 (47%)                      
1-15 
n=17                                     
1 (40%)                   
Depends-2 
Making interventions 
on patient care 
100 P=33%          
P/MMT 
=67% 
n=16                           
5 (56%)                     
1-10 
n=19                       
“Depends” (57%)       
Depends-Daily 
Key: P=pharmacist     MMT=medicines management technician    PODs=patient’s own drugs 
P/MMT = pharmacists or MMTs             “depends”=depends on patient characteristics 
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Four sites identified the use of electronic prescription and medicines administration systems 
(ePMA).  The impact of this application of IT in terms of task times was considered and is 
shown in Table 7.4 though the limitation of a small sample size needs to be recognised. 
Table 7.4 Comparison of task times between ePMA and non-ePMA sites 
 Mean time task takes (minutes) 
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Yes (n=4) 19.50 5.50 3.75 9.00 6.00 3.75 2.00 3.50 10.75 
No (n=7) 29.17 5.00 3.33 5.50 4.00 3.33 2.33 3.33 7.00 
Limited 
(n=1) 
30.00 5.00 5.00 5.00 2.00 5.00 5.00 5.00 15.00 
Not 
reported 
(n=8) 
13.63 4.29 2.43 5.00 3.29 3.00 2.13 3.29 7.00 
Study 
mean 
20.63 4.81 3.13 6.13 3.93 3.38 2.33 3.47 8.21 
 
This data would suggest that MR activities are quicker with ePMA but chart review – 
whether in-patient or TTO appears to take longer 
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7.2.2. Round 1: consensus on tasks and timings for dispensary tasks 
The dispensary tasks required for service delivery were also reviewed and are shown in 
Table 7.5. Once more it can be seen that full consensus is reached on these tasks, with the 
exception of tracking in of inpatient dispensing which demonstrated a moderate consensus. 
Table 7.5 Dispensing tasks consensus 
Dispensing Activity 
% Agreement with task 
necessity n=21 
In-patient Dispensing 
 Booking on to tracker system 67 
Dispensing 100 
Checking 100 
Discharge Dispensing 
 Booking onto tracker system 76 
Dispensing 100 
Checking 100 
 
The times these tasks take proved to be difficult to collect in the feasibility study due to 
interpretation of ‘per admission’ and so for the main study more specific questions were 
asked relating to the number of items and time taken to dispense and check a single item 
(see Appendix 7).  Data from this section of the questionnaire is shown in Table 7.6 
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Table 7.6   Dispensing and checking times (minutes) for a single item 
 
Dispensing  Accuracy checking 
 
S CD MDS  S CD MDS 
RSPWC time 2.13 6.48 2.35  0.82 3.1 1.15 
Average time from data set 2.68 5.62 4.79  1.61 2.42 2.58 
Average time including RSPWC 2.4 6.1 3.6  1.2 2.8 1.9 
Data set (n=) 14 12 7  14 12 6 
Key: S= standard item 
 
   CD= controlled drug  MDS= monitored dosage system 
 
Eleven sites identified the use of automated systems (dispensing robots) within their 
dispensaries.  The impact of automation was considered on this data and is shown in Table 
7.7.  This shows that reported times for dispensing at automated sites takes longer than at 
non-automated sites.  This applies to CD and MDS dispensing too which in most cases would 
not be impacted by automation. It might be, therefore, that these sites have other 
components to their process which increases the time for dispensing.  This was outside of 
the scope of this study. 
Table 7.7 Impact of automation on dispensing/checking times (excluding Royal Stoke data) 
 
Mean time to dispense Mean time to accuracy check 
Automated 
Dispensing 
Standard 
Item CD Item MDS item 
Standard 
Item CD Item MDS item 
No (n=6) 2.40 4.88 2.50 2.30 2.13 2.50 
Yes (n=11) 2.83 6.00 5.17 1.23 2.56 2.60 
Combined 2.68 5.62 4.79 1.61 2.42 2.58 
 
  
127 
 
7.2.3. Round 1: Additional pharmaceutical care tasks identified by 
participants  
The tasks included in the first round Delphi were those that were already identified in the 
RSPWC and represented the existing practice standards at RSUH.  The existence of 
additional activities required for patient care was considered and respondents were asked 
to identify what, if any additional activities were routinely delivered as part of 
pharmaceutical care within their service delivery models.  Additional tasks were identified 
by respondents and are shown in Table 7.8.  Tasks identified by more than one respondent, 
highlighted within the table as shown, were added to the second round Delphi 
questionnaire for wider review of consensus (see Appendix 8) 
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Table 7.8 Additional pharmaceutical care tasks identified in first round Delphi 
Additional task description 
No. of participants citing as routine 
practice 
MR on ePMA 1 
Discharge prescribing 2 
CQUIN related activity 1 
Discharge counselling and compliance aid completions 1 
Post take ward rounds  2 
Referral to primary care for follow up post discharge 4 
Reporting clinical incidents 1 
Education of ward staff 1 
Pharmacist prescribing 3 
Antibiotic and MR audits 1 
Complex MR 1 
Lithium register referral 1 
Clozapine clinic 1 
TDM 1 
Pharmaceutical care plan 1 
Smoking cessation 1 
 
7.2.4. Round 1: Staffing questionnaire Identification of ‘unavailable time’ 
A key element in the algorithms used to calculate staffing time(23,40) is identification of the 
fraction of employed hours which are ‘unavailable’ for clinical care.  The literature gives 
examples of these being annual leave, sickness and training.  This was explored in Part 1 of 
this validation study (see Table 7.9).   
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Table 7.9 Mean employed time unavailable for clinical duties by grade 
  Non-operational activities (mins/week) reported by particpant sites As per NHS policy   
AfC 
grade 
Travel  
Mandatory 
training 
Professional 
training 
Meetings  
Rest 
Time 
Other 
Total 
Additional 
time(mins/ 
week) 
Total 
Additional 
time(hrs/ 
week) 
Non-
operational 
employment 
time (WTE) 
Annual leave 
(WTE) 
Sickness 
(WTE) 
Total  
8a 90.00 14.00 71.95 179.75 5.56 112.36 473.62 7.89 0.21 0.10 0.03 0.34 
7 108.33 14.37 86.22 94.17 10.30 47.15 360.54 6.01 0.16 0.10 0.03 0.29 
6 103.44 14.99 106.25 64.38 8.43 21.57 319.06 5.32 0.14 0.10 0.03 0.27 
5 127.50 16.07 21.39 35.50 0.00 11.11 211.57 3.53 0.09 0.10 0.03 0.22 
4 101.75 14.00 19.47 28.42 0.00 11.41 175.05 2.92 0.08 0.10 0.03 0.21 
2&3 101.76 16.71 36.18 28.24 0.00 12.13 195.02 3.25 0.09 0.10 0.03 0.22 
 
Key:  Travel – denotes travel time from ward to department. Meetings – staff meetings/MDT. Rest time - compensatory rest time for out of hours duties 
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Sites were asked to identify this time by grade of staff.  Data was returned for all grades and 
the average unavailable time by grade is shown in Table 7.9 (page 124). To this was added 
expected absence for sickness and annual leave as per NHS policy. 
Time allowed for mandatory training is consistent across the grades, which is in line with 
NHS employment regulations.  It is noted that the ‘unavailable’ time increases with staff 
grade, which reflects training (highest for Band 6) and meetings (highest for Band 8a).   The 
‘other’ categories included teaching, audit, weekend working and directorate work.   
These values are used to calculate the WTE required to deliver a service sustainable 52 
weeks of the year and will add to the standard ‘on-cost’ which is routinely added in business 
cases which covers pensions and national insurance costs (22%). 
7.2.5. Round 1: Staffing questionnaire - Staff resource requested for scenarios  
Participants were asked to identify the resource they would request for specific scenarios 
(see Table 7.10).  Eighteen sites returned data in this section and the results (shown in Table 
7.11) demonstrate a disparate range of values. Most challenging though was Scenario 3 for 
which half of the respondents did not identify a resource but submitted only a narrative 
discussing issues. 
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Table 7.10 Service scenarios 
Scenario 1 
A new general medical ward is planned to open. This will have 28 beds and an average length of 
stay of 5 days. The average number of items on an in-patient prescription is 8. You have to 
identify the pharmacy staff (WTE) required to deliver a standard ward based service to this new 
ward 
Scenario 2 
An existing 28 bed general medical ward with average length of stay of 4 days (average items 8) is 
being converted to a short stay (48 hour) unit.  What impact will this have on your pharmacy 
service and what if any additional staff would you request 
Scenario 3 
Finally, you are approached by a directorate manager about to submit a business case for 200 
new bariatric surgical patients.  No new beds will be opened, but these cases will go through and 
existing 28 bed surgical ward with a length of stay of 3 days.  These patients have an average of 6 
items on their prescription.  He asks what resource implications this will have for you and what he 
should include in the business case 
 
Table 7.11 Staffing resources requested for service scenarios 
Value of staff resource requested Scenario 1 Scenario 2 Scenario 3 
Mean £58,347 £34,812 £30,795 
Median £51,806 £28,204 £17,461 
Minimum £15,680 £0.00 £0.00 
Maximum £150,000 £81,732 £93,583 
Differential (max-min) £134,320 £81,732 £93,583 
n= 18 16* 9* 
*remaining sites gave no value but submitted a narrative about approach 
This data suggests there is a lack of consistency in the staff resource requested for the 
delivery of the same service across the country. Yet from earlier data (see Table 7.3) there 
appears to be broad consensus on the required tasks, how long they take and the frequency 
with which they should be done. 
Data was analysed by sub-groups to identify if there were differences in staffing resources 
requested between DGH, teaching trusts and foundation trusts.  This is shown in Table 7.12.  
132 
 
It suggests that teaching trusts request 35% more resource for a standard ward service than 
non-teaching trusts which explains the reason for the staffing levels shown in the 
demographics (see Table 7.2), though for the other scenarios the difference is smaller or 
reversed.  This might suggest that they ‘front load’ their staffing and then have capacity to 
absorb change more effectively than their non-teaching counterparts.   
Table 7.12 Comparison of resource requests by hospital type 
  Scenario 1 Scenario 2 Scenario 3 
  Non-TH TH Non-TH TH Non-TH TH 
Mean £42,092 £64,767 £28,627 £32,854 £32,404 £11,938 
Minimum £13,634 £31,338 £0 £0 £10,908 £0 
Maximum £81,534 £150,000 £66,040 £81,732 £98,763 £23,876 
Median £37,290 £58,615 £26,360 £30,049 £17,690 £11,938 
n= 10 8 10 7 5 3 
Key:  n= number of sites stating figure, other sites returned narrative only   
 TH=teaching hospital  Non-TH= non teaching hospital   
 
7.3 Part 1: Delphi round 2 (Questionnaire 2 results) 
As discussed in section 6.3 of the main study methods, following receipt of all round 1 data, 
the results were summarised and returned to the participant sites for a second review.  
They were shown their data and a summary of that of the group.  They were asked to 
consider their own data in the light of the results generated and given the opportunity to 
revise their data set.  In addition they were asked to consider the additional tasks identified 
in round one.  Finally, in response to the consensus on several of the task frequencies being 
‘it depends on the patient’,  respondents were asked to identify patient characteristics 
which would result in more frequent pharmacy input and also to identify the 
pharmaceutical care requirements of exemplar patients. 
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7.3.1.  Delphi round 2 respondents 
Of the original 21 participants only 11 sites returned data for round two.   This population is 
small for the other non-consensus aspects and so results cannot be statistically analysed. Of 
the 11 respondents to this round, five chose to amend their original data in response to 
their review of the study summary.  Each of these was single item changes to the task, time 
and frequency data and none altered the consensus identified in the first round.   
 
7.3.2. Round 2: Consensus on staff groups to deliver services   
In round 1 consensus was not achieved in identifying all the staff groups which should 
deliver the agreed tasks.  This was unchanged by the responses in round 2. The ‘mode’ 
responses fell short of 50% agreement for five of the thirteen tasks.  The research team 
concluded from a more detailed review of this data following round 2 that the agreement of 
participants on individual staff groups, rather than the combined suggestions made in round 
1, would be an appropriate step. For example when considering the staff group who should 
deliver the task ‘check of patient’s own drugs’  43% of respondents stated this could be 
pharmacists or MMTs and 48% stated it should be MMTs only.  It therefore seems 
reasonable to suggest that a consensus has been achieved for the use of MMTs to complete 
this task with 91% of respondents identifying them as a staff group who should be involved 
i.e. some sites would only use technicians for this role, whilst other would use the staff 
group interchangeably.  Using this analysis consensus was achieved for the staff groups 
required to deliver all the tasks. This is shown in Table 7.13. 
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Table 7.13 Consensus on staff groups to deliver identified tasks 
 % Participants’ 
agreement 
n=21 
% Participants’ response/staff 
category 
n= 21 
Medicines Reconciliation 
(pharmacy confirmed and signed off) 
100 P & MMT = 81% 
Check of Patients Own Drugs (PODs) 95 P&MMT= 43% MMT= 48% 
so MMT = 91% 
Clinical Review of Notes 90 P=81% 
Review of Blood results 90 P=81% 
Initial review of Drug Chart 100 P=38% P&MMT=57% 
so P=95% 
Initial endorsing of Drug Chart 95 P=43% P&MMT=48% 
so P =91% 
Subsequent review of Drug Chart 95 P=33% P&MMT=57% 
so P= 90% 
Subsequent endorsing of Drug Chart 90 P=38% P&MMT=47% 
so P= 86% 
(Pharmacy handover/care plans etc) 86 P= 14% P&MMT=47%  
MMT=5% 
so P= 61% & MMT= 52% 
Ordering of Non Stocks 90 P&MMT=43% MMT=29% 
So MMT =72% 
Clinical Check of Discharge prescription 100 P=76% 
Talking to patient about their 
medicines 
95 P&MMT=81% 
Making interventions on patient care 100 P=33% P&MMT =67% 
P=100% 
Key:   P= pharmacist  MMT= medicines management technician  
>70% agreement on first 
analysis 
>70% agreement on second 
analysis 
50-70% agreement on second 
analysis 
 
 
7.3.3. Round 2: Consensus on the time to complete tasks  
Consensus on how long tasks take to complete was achieved for five of the 13 tasks.   As 
previously described, consensus on time is more difficult to identify due to the continuous 
rather than categorical nature of the data.  Grouping the data into time slots might achieve 
consensus but it is not helpful for the purposes of the calculator development, which 
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requires a single discrete figure to allow the algorithm to function.  To validate the 
calculator a time for each task that is representative of current national practice needs to be 
identified.  Therefore where consensus on time was not identified, data was analysed to 
calculate a mean.  To increase the homogeneity of the population from which this mean was 
derived, data from the overseas site and the mental health Trust were excluded. If sufficient 
data sets based on ‘existing local data’ were submitted the mean was calculated from this 
subset.  If inadequate ‘existing local data’ was available this value was based on all data 
submitted including the ‘best guess data’. Following this analysis a ‘best national 
representative figure’ was identified for each task which will be used to drive the validated 
version of the RSPWC.  A summary of this analysis is shown in Table 7.14, with its associated 
‘key’, shown in Figure 7.3.  It should be noted that no timings achieved ‘strong’ consensus 
through this process but ‘moderate’ consensus was achieved for a number of components. 
Figure 7.3 Key to Table 7.14 
    
    
 
 
Strong consensus (>70%) agreed 
through Delphi 
 
 
Moderate consensus achieved through 
Delphi (50-70%) 
 
 
 
No consensus achieved through Delphi 
(<50%) 
 
Source of data used to identify 
national representative time for 
validated version of RSPWC 
 
 
 
*Homogenous data set i.e. Mental Health and overseas participants excluded 
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Table 7.14 Identification of time required to complete tasks  
Data type Time in minutes required to complete task 
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RSPWC study version 20 5 5 1 5 2 2 0.5 2 2 5 5 5 
n (all data) 18 17 18 17 18 17 16 17 9 17 20 17 16 
Mean time (all data) 17.61 6.53 5.11 3.12 6.11 3.94 3.33 2.43 4.00 3.18 7.70 7.18 6.13 
St Dev (all data) 6.71 2.96 2.00 1.65 3.14 2.38 1.50 1.64 1.58 1.63 4.27 3.88 2.94 
Mode (all data) 20 5 5 5 5 5 5 3 5 5 5 5 5 
Mode count 6 11 12 6 10 7 7 4 6 6 8 8 9 
Mode % 33.33 64.71 66.67 35.29 55.56 41.18 43.75 23.53 66.67 35.29 40.00 47.06 56.25 
Median 20 5 5 3 5 5 3 2.5 5 3 5 5 5 
Minimum 10 4 2 1 2 1 1 0 1 0 2 1 1 
Maximum 30 15 10 5 15 10 5 5 5 5 17 15 10 
ELD n= 8 NA NA 1 NA 1 1 1 NA 1 5 1 
 
Mean time (ELD) 20 NA NA NA NA NA NA NA NA NA 9.6 
  
ST DEV (ELD) 8.05 
         
5.02 
  
National 'best 
representative' figure 
20 5 5 3 5 4 3 2 5 3 10 7 5 
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7.3.4. Round 2: Patient characteristic determining frequency of review 
In round 1 the consensus identified for the frequency with which certain tasks should be 
done was that ‘it depends on the patient’.  This is reality but for it to be captured in 
numerical(46) form for the purposes of a calculator requires additional exploration.  If 
frequency of review ‘depends on the patient’ it therefore follows that certain patients 
exhibit specific characteristics that result in them requiring more frequent pharmacy input 
than others.  In round 2 of the Delphi study, respondents were asked to identify what 
patient characteristics these might be. 
The data collected was compared to the Scottish prioritisation tool(46) discussed in the 
literature review (see section 2.5) to identify if the characteristics identified by this study 
population matched those in the tool (see Table 7.15) 
Table 7.15  Patient characteristics requiring more frequent review 
Patient characteristic 
Number of sites 
identifying 
characteristic 
% sites 
identifying 
How characteristic rated by 
prioritisation tool(46)(RAG) 
Complex Rx 7 87.5 
 
TDM 5 62.5 
 
AKI 5 62.5 
 
High risk meds 3 37.5 
 
Multi-morbid 3 37.5 
 
Hepatic impairment 3 37.5 
 
NBM 2 25 
 
Poor compliance 1 12.5 
 
Frailty 1 12.5 
 
Length of stay 1 12.5 
 
De-prescribing 1 12.5 
 
Interactions 1 12.5 
 
Course of meds 1 12.5 
 
Key to prioritisation tool: 
Red = daily review Green - review at discharge Amber 2-3 days Not mentioned 
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Respondents were also asked to identify how often they would review a patient if they 
exhibited these characteristics.  This data is shown in Table 7.16 
Table 7.16  Frequency of pharmacy review for patients with high risk characteristics (n=8) 
Frequency of review No. of respondents 
Daily 6 
as per RAG rating 1 
2-3 weekly 1 
 
Review of the data in these two tables demonstrates a consistency between professionals in 
identifying ‘priority’ patients and agreement about how often they should be reviewed. It 
should be noted that the only additional characteristic identified in the prioritisation 
tool(46) as ‘Red’ is ‘incomplete medicines reconciliation’ which all participants have already 
agreed is essential to patient care.  That there is no ‘green – review at discharge’ is 
additional intra-professional correlation on patient characteristics requiring review i.e. no 
characteristics were identified in this study that had been deemed low priority by the 
Scottish group 
Anecdotal data from use of this prioritisation tool suggests that 25% patients are ‘red’, 50% 
are ‘amber’ and 25% are ‘green’ in a general hospital patient population.  This would justify 
taking the ‘average’ approach to the frequency in the RSPWC and the final section of round 
2 explored what this ‘average’ might be. 
7.3.5. Round 2: Pharmaceutical care requirements of exemplar patients 
If the ‘average’ patient is the basis of service calculation, frequency of review of typical or 
‘average’ patients should give an indication as to the time requirement per patient.  
Participants were asked to indicate for different patient cohort what activities they would 
typically perform and when they would perform them for an ‘average’ patient in each 
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cohort.  Data for these responses is shown in detail over the following tables (Tables 7.17-
7.22). Seven of the eight participants provided data for this section. Full data, rather than 
summarised data is displayed as the reader needs to see the pattern of responses from the 
7 sites which conveys the lack of consistency in approach.  The key for the following tables is 
shown in Figure 7.4 
Figure 7.4 Key for exemplar patient results tables 
MR Medicines Reconciliation 
L2 Level 2 check – clinical review of medical notes, blood results and drug chart 
L1 Level 1 check – safety review of drug chart 
POD Check of patients own drugs 
TTO Supply of discharge medicines 
LOS Length of stay 
 
  
140 
 
Table 7.17 Pharmaceutical care activity of a typical respiratory patient 
Typical respiratory patient - activities/day of in-patient stay 
Site Day of admission 
 
Summary (LOS 5 days) n=7 
 
1 2 3 4 5 
 
Activity Count 
mean 
frequency/ 
admission 
5 
MR  
L2  
POD  
L2 
TTO 
POD 
L2   
MR 7 1.00 
7 
MR  
L2  
POD 
L2 
 
L1 
TTO 
POD 
 
L2 19 2.71 
8 
MR  
L2  
POD  
L2 
 
L2 
TTO  
L1 6 0.86 
17 
MR  
L2  
POD   
TTO 
POD 
  
TTO 7 1.00 
22 
MR  
L2  
POD 
L1 L2 L1 
L1 
TTO 
 
POD 11 1.57 
26 
MR  
L2  
POD 
L1 L2 L1 
L2 
TTO 
POD     
35 
MR  
L2  
POD 
L2 L2 L2 
TTO 
L2 
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Table 7.18 Pharmaceutical care activity of a typical hysterectomy patient 
Typical hysterectomy patient - activities/day of in-patient stay 
Site Day of admission 
 
Summary (LOS 4 days) 
 
1 2 3 4 
 
Activity COUNT 
mean 
frequency/ 
admission 
5 L1
≠ 
  
TTO 
L1 
 
MR 6 0.9 
7 
MR 
L2 
POD 
L1 
L1 
TTO 
POD 
POD 
 
L1 13 1.9 
8 
MR  
L2  
POD   
TTO 
 
L2 3 0.4 
17 
   
TTO 
 
POD 6 0.9 
22 
L1 
MR 
L1 L1 
L1 
TTO  
TTO 7 1.0 
26 
L1 
MR 
L2 
POD 
  
L1** 
TTO** 
    
35 
MR  
L1 
POD 
L1 
 
TTO 
L1 
    
±MR/L2  done in pre-admissions **Only if supply required 
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Table 7.19 Pharmaceutical care activity of a typical elderly patient 
Typical elderly longer stay patient - activities/day of in-patient stay 
Site Day of admission 
 
Summary (LOS 10 days) 
 
1 2 3 4 5 6 7 8 9 10 
 
Activity Count 
mean 
frequency/ 
admission 
5 
MR 
L2 
POD 
 
L1 
 
L2 
 
L1 
 
TTO 
L2 
POD 
  
MR 8 1.1 
7 
MR 
L2 
POD 
L2 
L1 
POD 
L1 L1 
L1 
POD 
L1 
L1 
TTO 
L1 
POD 
POD 
 
L1 22 3.1 
8 
MR 
L2 
POD 
  
L2 
   
L2 
 
L2 
POD  
L2 19 2.7 
17 
MR 
L2 
POD 
      
MR 
L2 
POD 
TTP 
POD   
TTO 0 0.0 
22 
MR 
L2 
POD 
L1 L1 L1 L1 L1 L1 L1 L1 
L1 
POD 
TTO 
 
POD 16 2.3 
26 
MR 
L2 
POD 
 
L2 
 
L2 
  
L2 
 
L2 
    
35 
MR 
L2 
POD 
L2 L2 L1 L1 L1 L1 
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Table 7.20 Pharmaceutical care activity of a typical short-stay patient 
Typical short stay  - activities/day of in-patient stay 
Site Day of admission 
 
Summary (LOS 3 days) 
 
1 2 3 
 
Activity COUNT 
mean 
frequency/ 
admission 
5 
MR 
L2 
POD  
L2 
POD 
TTO  
MR 7 1.0 
7 
MR 
L2 
POD 
L1 
TTO 
L1  
L1 5 0.7 
8 
MR 
L2 
POD  
TTO 
 
L2 10 1.4 
17 
MR 
L2 
POD  
TTO 
 
TTO 6 0.9 
22 
MR 
L2 
POD 
L1 
TTO 
L1  
POD 9 1.3 
26 
MR 
L2 
POD 
L2 
L2 
POD 
TTO     
35 
MR 
L2 
POD 
L1 L1 
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Table 7.21 Pharmaceutical care activity of a typical vascular patient 
Typical vascular patient - activities/day of in-patient stay 
  
Site 
Day of 
admission 
   
Summary (LOS 6 days) 
  
1 2 3 4 5 6 
 
Activity Count 
Mean 
frequency/ 
admission 
5 
MR 
L2 
POD   
L1 
 
TTO 
POD  
L2      
7 
MR 
L2 
POD 
L2 L1 
 
L2 
L1 
POD 
POD 
    
8 
MR 
L2 
POD  
L2 
 
L2 
 
L2 
TTO 
 
MR 7 1.0 
17 
MR 
L2 
POD   
L2 
 
TTO 
POD 
  
L1 13 1.9 
22 
MR 
L2 
POD 
L1 L1 L1 L1 L1 
TTO 
POD 
L1  
L2 21 3.0 
26 
MR 
L2 
POD 
L2 L1 L2 L1 
 
L2** 
TTO
**  
TTO 6 0.9 
35 
MR 
L2 
POD 
L2 L2 L1 L1 L1 TTO 
 
POD 12 1.7 
** if supply required 
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Table 7.22 Pharmaceutical care activity of a typical complex medical patient 
Typical respiratory patient - activities/day of in-patient stay 
  
Site Day of admission 
   
Summary (LOS 7 days) 
Site 1 2 3 4 5 6 7 
 
Activity COUNT 
mean 
frequency/ 
admission 
5 
MR 
L2 
POD 
L1 L2 L1 L2 
TTO 
POD 
L2      
7 
MR 
L2 
POD 
L2 L1 L1 L2 
L1 
TTO 
POD 
    
8 
MR 
L2 
POD  
L2 
 
L2 
 
L2 
TTO  
MR 7 1.0 
17 
MR 
L2 
POD  
L2 
  
TTO 
POD 
  
L1 4 0.6 
22 
MR 
L2 
POD 
L2 L2 L2 L2 L2 
TTO 
POD 
L2  
L2 31 4.4 
26 
MR 
L2 
POD 
L2 L2 L2 L2 
 
L2 
TTO 
POD  
TTO 7 1.0 
35 
MR 
L2 
POD 
L2 L2 L2 L2 L2 
TTO 
L2 
 
POD 11 1.6 
 
From reviewing this data it can be seen that the consensus on MR, POD and TTO that has 
already been identified in the Delphi section of the study (see Table 7.3) is confirmed by this 
data.  The tasks for which consensus was either not achieved or identified as ‘depends’ on 
the patient  were the review and endorsement of drug charts and the review of notes and 
blood results.  This was explored in more detail in this data set which demonstrates the lack 
of standardisation of approach. For the purposes of the construction of the ‘validated’ 
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version of the calculator this data is summarised in table 7.23 as the mean frequency of 
these tasks for each patient type and length of stay. 
Table 7.23 Frequency of activity by length of admission 
LOS 2 5 4 7 7 10 
Type of patient Medical Medical Surgical Surgical Medical Medical 
Clinical review of 
chart and endorsing 
2.1 3.6 2.3 4.9 5.0 5.9 
Clinical review of 
notes/bloods 
1.4 2.7 0.4 3.0 4.4 2.7 
Chart & 
endorsing/LOS 
1.1 0.7 0.6 0.7 0.7 0.6 
Notes & bloods/LOS 0.7 0.5 0.1 0.4 0.6 0.3 
 
If the summary data is further summarised (as shown in Table 7.24) it can seen be seen that 
some differences begin to emerge for medical and surgical patients with respect to the 
notes and bloods review frequency  
Table 7.24 Summary data of mean times tasks done per day of admission by patient type 
Tasks 
Mean number of times 
task done per day of 
admission ALL patients 
Mean number of times 
task done per day of 
admission for MEDICAL 
patient 
Mean number of times 
task done per day of 
admission for 
SURGICAL patient 
Review of chart and 
endorsing 
0.7 0.77 0.63 
Review of notes and 
endorsing 
0.4 0.54 0.3 
 
The data set for this part of the study is very small.  However, if this limited data is plotted in 
a scatter chart a linear pattern appears to begin to emerge though this cannot be 
statistically confirmed. For medical patients (Figure 7.5) the linear pattern appears to peak 
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at 7 days at which point the frequency of activity appears to reduce as length of stay 
progresses. This might be explained by the continued stay in hospital beyond 10 days often 
being due to delays in care package availability rather that active acute illness. 
Figure 7.5 Medical patient activity frequencies 
 
 
 
For surgical patients, (see Figure 7.6) the limitation of two data sets makes interpretation 
even less robust.   Two data points will always give a straight line.  Of note, however, is the 
point at which these lines would cross the x axis as it suggests that for less than two days 
limited clinical input is given beyond MR. This reflects current practice for day case surgery. 
Long length of stay in surgical patients is often associated with complexity of surgery and 
the need for closer review post operatively which would explain the need for this continued 
pharmacy input, though, as for medical patients a peak would be expected at some point. 
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Figure 7.6 Surgical patient activity frequencies  
 
For robust conclusions to be drawn further research is required for both areas.  However 
the impact of these potential variations on resource calculated needs to be considered – 
does it matter or is this just semantics? To explore this the different variables were used to 
populate the RSPWC  to understand the different values that were produced and the impact 
on the resource that it generates for a 28 bed ward with a length of stay of four days 
(Scenario 1). This analysis identified that the study version of the RSPWC generates a lower 
resource value than any of the versions using frequencies suggested by the results of the 
research.  This is explained by the fact that the study version was based on UHNM minimum 
standards of practice rather than the average which has been suggested as appropriate 
through this research. However, as shown in Table 7.25 when the average for all patient 
groups is compared to those for medical and surgical specific data it can be seen that the 
difference calculated amounts to at most £5,000 (5.4%) of the value and 0.11 WTE 
pharmacist, with no difference in the other staff grades.  The differential between minimum 
and maximum resource requests in this exercise is £8k, compared to the variability in 
resource requested by participant sites for this same scenario in Part 1 (£138k).  Whilst this 
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data is from a small sample set it demonstrates greater accuracy than the RSPWC in its post-
study form and though there may be nuances between surgical and medical patient in 
resource requirements, in general terms, the calculator generates adequate resource.  To 
increase the accuracy of this tool further research is required. 
Table 7.25 Comparison of resource requirements for a 28 bed ward using speciality variables 
Value calculated using study version of RSPWC 
REQUIRED STAFF GROUP WTE REQUIRED  COST 
ATO 0.05 £1,003.17 
Technician 0.37 £9,431.41 
MMT/Pharmacist 0.63 £20,342.66 
Pharmacist 1.05 £46,356.87 
 Total resource value 
£77,134.12 
Value calculated using study data for ALL patient using mean frequency of activity/day of 
admission 
REQUIRED STAFF GROUP WTE REQUIRED  COST 
ATO  0.05 £1,003.17 
Technician 0.37 £9,431.41 
MMT/Pharmacist 0.80 £25,724.56 
Pharmacist 1.23 £54,324.46 
 
Total resource value £90,483.61 
Value calculated using study data for MEDICAL patient using mean frequency of activity/day of 
admission 
REQUIRED STAFF GROUP WTE REQUIRED  COST 
ATO  0.05 £1,003.17 
Technician 0.37 £9,431.41 
MMT/Pharmacist 0.80 £25,724.56 
Pharmacist 1.34 £59,225.73 
 
Total resource value £95,384.88 
Value calculated using study data for SURGICAL patient using  mean frequency of activity/day of 
admission 
REQUIRED STAFF GROUP WTE REQUIRED  COST 
ATO  0.05 £1,003.17 
Technician 0.37 £9,431.41 
MMT/Pharmacist 0.80 £25,724.56 
Pharmacist 1.14 £50,582.11 
 
Total resource value £86,741.26 
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7.3.6. Round 2: Consensus on the additional tasks identified in Part 1 
Tasks identified by more than one respondent in Part 1 were summarised and included in 
Part 3 for participant review.  They were asked to consider if these activities, identified by 
their peers were required for delivery of routine patient care. The responses are shown in 
Table 7.26 and suggest that no additional duty identified in Part 1 met the required level of 
agreement to reach consensus at this time and so the list of tasks in the RSPWC should 
remain unchanged. 
Table 7.26 Review of sites in agreement with additional routine duties 
 
Round 2 responses 
    
Additional duty 
in routine 
practice 
Yes No Maybe 
No. of 
Round 1 
sites in 
agreement 
New sites 
in 
agreement 
 Round 2 
Total No. 
sites in 
agreement 
across 2  
rounds 
% 
agreement 
across 2 
rounds 
Pharmacist 
prescribing 
discharge 
medicines 
2 4 1 2 2 4 19 
Post-take Ward 
Rounds 
6 1 0 2 5 7 33 
Referral to 
community 
pharmacy on 
discharge 
4 3 0 4 3 7 33 
Pharmacist 
prescribing in-
patient 
medicines 
6 1 0 3 4 7 33 
 
 
7.4 Part 2: Operator evaluation 
Eleven of the original 21 sites (52%) returned the operator evaluation questionnaire (see 
Appendix 9). This part of the study focussed on the transferability of the tool to other 
operators and began to explore their opinions of the utility of the tool for their setting. 
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7.4.1. Transferability of tool between operators 
The same 3 scenarios were presented as in Part 1 (see Table 7.10). Participants were given 
basic instructions on how to use the RSPWC (see Appendix 12) and asked to apply it to these 
scenarios.  Table 7.27 shows the summary of responses received from participants using the 
RSPWC compared to the resources they requested in Part 1 of the study. 
Table 7.27 Resource requested for staffing scenarios: Part 1 data cf operator use of RSPWC 
 
Scenario 1 Scenario 2 Scenario 3 
Value of staff resource 
requested 
Part 1 
data 
Using 
RSPWC 
Part 1 
data 
Using 
RSPWC 
Part 1 
data 
Using 
RSPWC 
Mean £58,347 £75,824 £34,812 £75,165.00 £30,795 £33,445 
Min £15,680 £62833 £0.00 £35,3174 £0.00 £6488 
Max £150,000 £78336 £81,732 £92,674 £93,583 £117,014 
Differential (max-min) £134,320 £15,503 £81,732 £39,500 £93,583 £110,525 
n= 18 11 16 11 9 11 
 
For Scenario 1 there is a much smaller differential in the value requested which suggests 
that the use of the RSPWC has made this a more consistent response.  The mean value 
requested is substantially more using the RSPWC.  For Scenario 2 the differential is less but 
still sizeable and for Scenario 3 the differential is greater than in Part 1.  This might indicate 
that the use of the RSPWC is not generating consistent resources in the hands of other 
operators.  To explore this effect further, a more detailed review of the data is required.  
This is shown in Table 7.28. With this perspective it can be seen that for Scenario 1, 8 of the 
11 (72%) respondents generated the same value. Two respondents made additional changes 
to the data entered into the RSPWC which matched their service provision.  This was not the 
instruction given to answer the question and so the answer is ‘wrong’ but it demonstrates 
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that the operator understood how to use the calculator.  The final respondent chose to 
provide a narrative on their perspective of the application of the tool for each scenario 
rather than give a numerical answer.  The detail of this is captured in the qualitative data 
analysis.  
When data for Scenario 2 are reviewed six of the eleven (55%) generated the same correct 
answer (as per the RSPWC). One respondent rounded the value up – so the figure appears 
different by a small amount and another gave the value for the ‘post-change’ service rather 
than the difference between the before and after service delivery as requested in the 
question. This skewed the ‘maximum’ value.  Two others used different data sets tailored to 
their settings which generated different values.  
Finally for Scenario 3, once again six operators (though different individuals than for 
Scenario 2) generated the same correct value.  Once more a ‘post-change’ figure was 
quoted by one operator skewing the data and, as for the previous scenarios, one operator 
chose to apply local data to the question rather than that provided in the summary.  
However in this scenario two operators generated incorrect (as per the RSPWC) values 
which could not be explained by examination of the calculation.  
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Table 7.28  Resource requested for staffing scenarios by operators using RSPWC 
  Resource requested (£)   
Key 
Site 
number 
Scenario 1 Scenario 2 Scenario 3 
 
2 77,134.12 92,674.00 6,488.80 
 
Resource as calculated by 
correct use of RSPWC 
7 78,336.19 53,174.00 12,847.00 
 
Rounded up value or correct 
post change value - not 
subtracted baseline figure for 
difference - calculator used 
correctly 
8 77,134.00 75,895.00 6,488.80 
 
13 77,134.00 76,000.00 6,488.80 
 
17 77,134.00 169,898.00 6,488.80 
 
18 Narrative Narrative  Narrative  
 
Value incorrect as used scenario 
1 for baseline but LOS was 
different - calculator used 
correctly 22 77,134.00 75,895.00 117,014.00 
 
25 77,134.00 75,895.00 6,488.80 
 Operator changed % 
prescription type for dispensing 
data and/or  number of items 
dispensed 
27 77,134.00 75,895.00 6,838.00 
 
34 77,134.00 75,895.00 6,488.80 
 
35 62,833.00 75,85595.00 110,525.00 
 
Incorrect - reason unclear 
Mean 75,824.00 75,165.00 34,455.00 
 
Instructions for answering 
question not followed 
 
Overall the transferability of the tool between operators has been demonstrated if the tool 
is used correctly and unchanged 
7.4.2. Utility of tool in different settings 
The operators were asked a number of closed questions around the utility of the tool (see 
Appendix 9) to their setting.  A summary of this data is shown in Table 7.29.  In addition 
participants were given the opportunity to express their views and opinions of the tool and 
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give explanation of their responses in their own words.  This data allowed clarification of the 
quantitative data and was also included in the thematic framework analysis of Part 3. 
Table 7.29 Responses to questions relating to the utility of the RSPWC (n=11) 
Questions Number of respondents 
1. Does the RSPWC generate the workforce to 
deliver pharmaceutical care in your setting? 
Yes No Partly 
 
 
6 4 1 
 
2. How did the value compare with what you would 
have requested without using it? 
More Less Same 
 
 
8 1 2 
 
3. Were the instructions easy to understand? Yes No Other 
 
 
9 1* 1 
 
4. How long did it take you to use the RSPWC to 
calculate the answers 
<10 
minutes 
10- 20 
minutes 
21-30 
minutes 
>30 
minutes 
  4 5 1 1* 
*Same respondent 
Review of Table 7.29 suggests that most (81%) respondents found the instructions easy to 
follow and that the tool was not time consuming to use.  One respondent disagreed and 
wanted additional information to be able to understand the tool’s calculations, though they 
were not one of the participants calculating ‘incorrect’ answers, so had understood how to 
use the tool in practice. 
Most users (73%) identified that the resource requirements generated by the RSPWC were 
greater than they would routinely ask in practice. The one site which identified that it 
generated a smaller value than they would ask for the service acknowledged that this was 
due to their way of completing medicines reconciliation, which this takes longer than the 
RSPWC would suggest is necessary. 
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Of concern in the data, from a validation perspective is that four respondents (around a 
third) reported that the RSPWC overestimated the workforce resource required to deliver 
their services.  Differences in the way that medicines were supplied in their organisation 
were cited as a reason for asking for less resource.  One of these respondents was based in a 
mental health trust and the applicability of the RSPWC in that healthcare setting has already 
been questioned by another respondent from that type of setting. 
In order to explore this data further, to understand the potential limitations of the RSPWC, 
an exercise was undertaken to cross reference resource requirements generated using 
different data sets to populate the RSPWC algorithm for the remaining three sites.  The 
RSPWC in its ‘un-validated’ form which is being explored in this study uses tasks, times and 
frequencies measured previously at the RSUH.  For this exercise the data submitted in Part 1 
of the study by each of the sites in question was used to create a ‘site-specific’ version of 
the RSPWC and the staffing scenarios re-run through the tool to identify the resource 
required for each site based on what their clinical manager believed should be the level of 
service delivery.  These results were then compared to the responses received from each 
site in Part 1 and in the Operator Evaluation ie using the study RSPWC.  The results from this 
exercise are shown in Table 7.30. 
This demonstrates that the RSPWC generates a far greater resource requirement for the 
suggested scenarios than these sites are currently requesting.  However, the resource 
calculated by ‘site-specific’ versions of the RSPWC are much closer match to the RSPWC for 
Site 8 and 22, suggesting that in reality the RSPWC calculates a reasonable resource to 
deliver the defined service.  It should be noted that both sites provided existing local data 
for several of the timings and so this data is evidence based not best guess.   Site 13’s site-
specific data suggests the need for almost twice the value of that generated RSPWC (and 
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the other versions too) and almost four times what they would request.  All of these sites 
generated outlying data in other elements of the research and so are included in the 
qualitative stage of the study in Part 3.  
Table 7.30 Resource requirements generated by site-specific RSPWC compared to local methods  
 
Resource requested by 
site lead using current 
methods 
Resource requested by 
site lead using RSPWC 
(study version) 
Resource required if 
site-specific version of 
RSPWC used 
Site 8 
   
Scenario 1 £20,370 £77,134 £69,171 
Scenario 2 £16,964 £75,895 £84,200 
Scenario 3 narrative £6,489 £6,146 
Site 13 
   
Scenario 1 £31,371 narrative £108,118 
Scenario 2 £0* narrative £135,149 
Scenario 3 £0* narrative £10,157 
Site 22 
   Scenario 1 £15,680 £77,134 £76,099 
Scenario 2 £22,113 £75,895 £75506 
Scenario 3 £10,908 £6,884 £5,937 
*would be expected to redistribute resource 
7.5 Part 3: Qualitative data results 
As a final stage in the research, qualitative data was collected in Part 3 of the study to 
explore the utility of the RSPWC in different settings, to gain greater understanding of 
outlying quantitative data and to explore the issues of patient acuity.  There were seven 
participants in this part of the study, three from teaching hospitals, three from district 
general hospitals and one mental health trust.  There were five male and two female 
participants.  Interviews were predominantly conducted by telephone, with one exception 
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which was done in person, recorded using a digital recorder and transcribed verbatim.  Data 
saturation was reached with no new themes presented over the final 2-3 interviews.  The 
themes identified from the participant in the one mental health unit, reflected those of the 
acute settings, but the details clarified earlier outlying data sets relating to tasks and timings 
which may indicate that the activity standard in the RSPWC is not applicable in this setting.   
Data from these interviews was drawn into a thematic framework analysis.  This allowed 
consideration of the key themes that emerged from the study. 
Figure 7.7 depicts the key themes and ideas which will be discussed in further detail in this 
section.  The headings reflect the structure of the interview guide (see Appendix 13) which 
guided the following analysis of the data.  Quotes are attributed to participant numbers e.g. 
[P1] = participant 1, with the anonymity of participants being maintained throughout.  
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Figure 7.7 Summary of framework analysis of qualitative data 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.5.1. The delivery of pharmaceutical care to in-patients 
There was much similarity in all the experiences reported by participants. They described 
skill-mixed, team approaches to ward-based pharmacy, with senior pharmacists (Bands 8a 
and 7) leading geographically located teams, including technicians and tasks delegated to 
different staff groups.  
Delivery of pharmaceutical 
care to inpatients 
Perspectives on the RSPWC Patient 
acuity and 
how to 
identify it 
 
 
Structure of 
ward services 
Staffing 
challenges 
Advantages
/ 
applications 
of RSPWC 
Disadvantages 
/limitations of 
RSPWC 
Providing 
services 
across 7 
days  
Recruitment 
challenges 
greater than 
lack of 
resource 
 
Skill mixed 
teams of 
pharmacist 
and 
technicians 
working in 
geographical 
areas within 
hospital 
Services 
based on 
historical 
funding not 
patient need 
How to 
prioritise or 
not prioritise 
and the need 
for 
technology 
to do it 
effectively 
 
 
Use as 
bench-
marking 
tool in 
Carter Era 
 Objective 
not 
subjective 
Identifies 
the correct 
resource 
 
Doesn't 
reflect 
local 
nuances 
Impact of 
pharmacis
t 
prescribin
g 
 
 
Patient 
characteristics 
are a guide 
but each 
individual 
patient 
requires 
review by a 
pharmacist 
 
  Themes from interviews                                                                                       
 
  Key:   Interview guide subjects        
  Sub-categories of questions                                                                                     
 
159 
 
“...we have teams of pharmacists working in ‘clusters’...” [P1] 
 They reported a reliance on the technical staff to complete the information capture 
element of medicines reconciliation and facilitating the availability of medicines on the 
wards for patient use.   
“...technicians gather a lot of information in terms of medication history and 
then sort out stuff in terms of patients on drugs and what formulations they 
might need”   [P3] 
Pharmacists were reported to undertake clinical reviews of patients to optimise medicines 
use and there were reports of increased used of pharmacists as prescribers. A number of 
managers reflected that it was likely that this would, in time, change the structure of the 
service around those practitioners, but that as yet, that was ill-defined. Participants also 
described how the team-based approaches facilitated the supervision and development of 
junior colleagues to give governance assurances regarding the safety and quality of service. 
“...depending on which clinical scenario they [senior pharmacist] will either be 
working closely with that junior on the ward or will be remotely supervising 
from the kind of ward next door..”  [P4] 
Along with the acceptance of the need to skill mix, it was also reported that there were 
situations, particularly where a Trust has sites spread across a wide geographical area, the 
distances preclude skill mixing.  This was primarily because of the financial and operational 
time lost in multiple staff travelling, when one staff member (i.e. pharmacist) could do the 
job alone. 
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“...where we’d like to skill mix, sometimes we can’t just because actually 
sending three people 40 minutes up the road doesn’t make sense.” [P5] 
Another common theme, which appeared to be a source of frustration in a number of 
individuals, was the historic nature of some of the service structures.  It was repeatedly 
reported that services were often delivered to different specialities based on the level of 
funding received a number of years previously, rather than on the needs of the current 
patient population.  None of the participants described having taken action to resolve this 
issue, either in terms of seeking funding, or in redistributing existing resource more 
effectively. 
 “... we have three levels of service we offer.....bronze silver and gold....like your 
basic Kardex® check, you’re keeping the patients safe basically, silver keeping 
the patients safe and a bit of meds rec, perhaps not every day .... and your gold 
is like the all singing all dancing skill mixed pharmacy service on the ward.....so 
some of it is driven by what the service will pay for rather than the patient.”  
[P5] 
The role of the pharmacy team in facilitating ‘patient flow’ through NHS hospitals was 
widely identified and the need for close working with the MDT to achieve this flow was 
described.  These were new activities (e.g. board rounds which are a multi-disciplinary team 
meeting held at the patient-list board to discuss individual patient’s progress and problems 
requiring review, to facilitate discharge) and delivered within existing resource. 
“we send techs  or pharmacists to the board round every morning” (P3) 
The activities that should be done for each patient have been described earlier (see Table 
7.3) and with almost full consensus achieved on these.  However, it was also commonly 
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reported in the interviews that there are not generally enough staff to do all activities for all 
patients and that the advent of 7-day pharmacy services has stretched this further. Different 
Trusts appeared to approach this shortage in different ways with often diametrically 
opposed approaches. 
“We have to see every chart every day and just do a safety check.......to prevent 
the catastrophic errors where there’s a gentamicin overdose or omission of 
immunosuppressants and a transplant is rejected....rather than a mega 
intensive pharmaceutical review.” [P6] 
“We are trying to triage everyone on admission so there’s a relatively high in-
put to the admissions unit.......we use a standard triage tool red amber 
green....the idea being you go to the patients who need in put rather than going 
around everyone many of whom don’t actually need much.” [P2] 
 
Participants suggested that the prioritisation of patients would be much improved by better 
access to technology which allowed a real time ‘pharmacy-need’ status for each patient to 
be identified.  This in turn would facilitate a more efficient and targeted service. Only one 
participant identified the availability of this technology and it was key for their service 
provision. 
“the key challenge is use of information technology and real time information 
about what patients you need to see and where are those patients because 
otherwise you’re back to the old scooting around to identify it before you 
actually do some work” [P3] 
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7.5.2. Pharmacy staffing challenges 
Staff resource seemed to be a substantial challenge faced by all participants.  None of those 
interviewed suggested they were adequately staffed to provide the service they felt was 
required.  Whilst the issue of funding of staffing establishment was identified as a challenge 
by several of the participants  
“one of the key challenges is workforce and finance for workforce” [P3] 
it was not was not considered to be the only challenge they faced.  Indeed more than one 
participant identified that increasing available funding would not have entirely resolved the 
staffing issues.  A number of themes emerged. 
One theme, common to several of the participants interviewed, was the difficulty in 
recruiting suitably trained staff, across all grades.  The concept of ‘growing your own’ was 
described as one solution, but it was reported that this does not happen quickly enough. 
“...but it’s not just having quantity; it’s about having them all at a standard that 
is useful for the  department.” [P6] 
“We could have recruited sort of 12 Band 7 or Band 8a pharmacists but they’re 
just not out there in those sort of numbers.” [P3] 
“We don’t have the facilities to train enough technicians to actually meet the 
demand that we have of the kind of increase in service.”  [P4] 
 
Participants were drawn from across the UK and for some departments geographical 
location provided the greatest challenge in attracting and retaining staff.  Whilst ‘location’ 
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was defined as the ‘problem’ the issue took a variety of forms. Remote locations in the UK 
prove challenging either for attracting people to move to them or trying to find the resource 
from within the existing population. 
“We’ve had to advertise three times in [town name], actually looking for 
somebody who lives in [town name] as it’s so far away from anywhere else. You 
wouldn’t want to commute there really” [P5] 
However, being within proximity, yet not part of, large centres of population also produces 
challenges. It was reported that staff seem to be often lured either by the social 
opportunities of city life or the professional variety that larger NHS organisations seem to 
offer. 
“We are just a little bit too far away from the bright lights of  ......... so it’s 
getting staff to stay here.............will travel for two years and maybe stay on for 
a year but then get fed up of the travelling” [P7] 
“...because of the location we are, a large majority of the band 6s in the region 
will go to the tertiary centres and so we have struggled with kind of recruitment 
of Band 6s” [P4] 
The other staffing challenge described by the participants was that of staffing a 7-day 
service.  Several participants expressed the difficulty of trying to stretch existing resource 
across the full week reporting the limiting of services in some areas or struggling to maintain 
the specialist level of cover throughout the week.  Different approaches were described to 
address these challenges resulting in variation in the services offered. 
164 
 
“we didn’t get any extra money for developing a seven day service....... The 
challenge that that then provides is what resource you’ve actually got 
remaining to provide as service to the district general sites ........ sometimes you 
might just have a few pharmacists and a few technicians and sometimes even 
less than a few and you’ve got a number of wards to cover” [P3] 
In addition the majority of participants expressed the view that that delivering 7-day 
services places a burden on the work-life balance of their team.  The drive for this extension 
of service came around the same time as funding being made available for pharmacists to 
work in GP practice posts which, at present, do not have the weekend commitments.  A 
number of participants reported that their staffing levels had been adversely affected by the 
increased availability of these perhaps more attractive roles. 
“ big increase in the GP recruitment of pharmacists in particular.  We’re trying 
to run a 7/7 service and those jobs are very attractive.  Just recently we have 
lost 4 or 5 of our more senior pharmacists.” [P1] 
In summary, when considering the phenomenon of ‘delivery of pharmaceutical care’ the 
results of this study suggest that there may be a common approach and understanding of 
what this entails.  The variation that is described here and in the work for the Carter 
report(21) may have arisen from different approaches taken towards service delivery in the 
light of insufficient staff resource to deliver the ‘full’ service to each patient.  Staff resource 
might have been limited historically by lack of funding, which may be exacerbated by the 
need to extend services across the whole week.  However, the impact of changing roles for 
pharmacists seems twofold, firstly in stripping resource from traditional services and 
secondly in generating  skills gaps in the profession which will take time to fill. 
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7.5.3. Perspectives on the RSPWC 
The challenges of delivering pharmaceutical care in a modern health service have been 
described above and the fundamental impact that staffing resource adds to that challenge 
have been outlined.  The next part of the qualitative research explored participant 
perspectives on the RSPWC, its applications and advantages, its limitations and 
disadvantages.  Participants expressed understanding of the variation in service delivered 
between Trusts and that this would not be acceptable in the future.  Participants suggested 
that it would be useful to have a tool which facilitated a standard approach to staffing. 
“in this era of standardisation, rationalisation, benchmarking and Carter it [the 
RSPWC] will support some agreed standardisation of pharmacy so it fits nicely 
in the political context” [P1] 
  
In particular, with the advent of Strategic Transformation Partnerships (STPs), having a more 
standardised approach may allow more effective comparison of services between sites and 
facilitate more effective decision making. 
“we are maybe going to be working more closely with neighbouring Trusts and 
then we can have a closer understanding about what our service make-up is to 
then be able to kind of join up services in that new STP kind of environment” 
[P4] 
 
It was identified that historically workforce resource requirements have been largely 
identified subjectively and may not have changed as services developed.  The ‘best guess’ 
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approach to resource calculation and the subsequent rejection or reduction of requests by 
business managers, was articulated by many of the interviewees.  
“I think historically capacity and demand planning have been very much feeling 
based, but it’s nice to have something that either backs up that feeling or 
completely challenges it I guess” [P5] 
 
This then expanded into the main advantage of the RSPWC, which is the more objective, 
rather than subjective nature of its function, which makes its output much more tangible.  
There was a recognition that once validated this would become an even more powerful 
tool. 
 “I think the main thing is that it’s based on, it’s not sort of made up and it’s not 
the usual thing sort of finger in the air or based on sort of well, ‘in my 
experience type of thing” [P4] 
 
“...so I think in that sense particularly if it’s recognised as a validated tool it 
gives you something to say well ‘I’ve used this calculator” [P3] 
 
Interviewees discussed their experience of using the RSPWC and their opinions as to the 
value of the resource it calculated.  Several of them, following their responses to the study 
questions, had applied it to issues in their own settings and expressed satisfaction that the 
output was reasonable as a core requirement for a pharmacy service 
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 “I did try it just for a ward we’ve got at the moment and one that I thought was 
reasonably functional and it came out with roughly what we’ve got” [P7] 
 
Potential limitations or disadvantages of the tool were also explored.  The main theme in 
terms of disadvantages relates back to the current non-standardisation of services across 
different sites i.e. that the tool may not quite ‘fit’ their service model in terms of skill mix. 
 “.....whether it takes into account the nuances of our service” [P1] 
 
Specifically these related to the supply functions which are included in the tool and 
particularly in relation to Carter(21) which suggests that supply is an ‘infrastructure’ activity 
that should be outsourced or done collaboratively.  Some participant reported having 
already taken these steps and so questioned the inclusion of this staffing resource. 
“...there was a lot of staffing tied to the operational type dispensary type tasks 
which we don’t do” [P5] 
 
“....for example we’ve got heavy dependence on over labelled pre-packs so 
we’ve got 30 odd automated cabinets in the trust .......some of these things are 
coming through Carter as well as to how much time you spend on the 
operational side” [P3] 
 
Some concerns were raised about the robustness of the calculation and the need to trust 
the tool if it were to be used so that its output could be defended or justified.  It was 
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suggested that greater detail relating to the functioning of the tool should be issued so that 
questions are answered and users reassured. 
“I felt a little bit unsure about how it was calculating everything via the Excel 
spreadsheet...at a glance I couldn’t figure it out quickly.... ” [P6] 
 
Several participants commented that the out-put from the tool is a numerical and cautioned 
that it should not be used as a “magic answer” [P3].  They recognised that this needed to be 
applied to the context of the relevant Trust and used as a starting point to demonstrate the 
correct ‘ball park’ figure. 
“as long as I am aware of what numbers we’re putting in there and how that 
compares with how we currently deliver anything, in other words you can sense 
check it, then I don’t think that’s a great disadvantage in that sense” [P3] 
 
Finally a caution was raised that the research was largely based on the experience of senior 
pharmacy managers and their ‘best guess’ on timings would be based on their own practice 
and might not reflect that of service delivery by a more junior team.  
The overall response to the tool was very positive with the managers identifying its benefits, 
particularly in the current political context. 
“I think I generally thought this could be really useful” [P4] 
“I think it’s a fab tool” [P7] 
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Potential applications of the tool in practice were seen to be twofold. Firstly in giving a 
baseline resource requirement for new or changed services, which could then have local 
nuances applied, particularly around developing junior staff resource 
 “if you’ve got a new commissioned ward or if you’ve had some change in ward 
configuration it allows you to say well what’s the impact upon service” [P6] 
 
The second application would be using the tool ‘backwards’ i.e. if a fixed amount of funding 
was made available which is insufficient for a full service the tool could be used to 
demonstrate what tasks are possible within the available funding envelope 
“it will be really useful to then be able to go back to kind of care groups and say 
that with the amount of resource you have provided we could then provide this 
service” [P4] 
 
However other participants commented that tailoring the tool to specific local situations 
reduces its validity and that not over complicating it at this stage was probably the best 
approach. 
“The strength of it is that you’ve got a validation to it haven’t you? And if we 
have it so it’s too kind of changeable then we lose that validation..... so then all 
that comes is a local tool to then develop  which is not as powerful” [P4] 
“....you could get drawn into the tool doing too many things for too many 
people and I wouldn’t go that far” [P1] 
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7.5.4. Pharmaceutical acuity – patient characteristics 
Through the Delphi study consensus was largely achieved on the tasks required to deliver 
pharmaceutical care and the time it takes to complete these.  However, the consensus on 
how often these tasks should be completed was frequently ‘it depends on the patient’.  This 
may be so but is not helpful for calculation purposes that require a finite figure to drive the 
algorithm.  This was explored further in the earlier results (see Tables 7.17 – 7.22) 
confirming further disparate results.  This qualitative part of the study also explored the 
issue to try to add greater detail. Interviewees were asked to describe what they believed to 
be patient characteristics which would generate the requirement for increased pharmacy 
input. Responses were similar and remained in the same broad categories identified in the 
second round of the Delphi study in Part 1 (Table 7.15).  However several participants 
articulated that it is often not possible to predict which patients you need to see.  Whilst the 
use of prioritisation tools is becoming more widespread, it was identified that these are not 
infallible.  This reflects the recent work in Manchester(47) and Birmingham(45).  Overall 
these interviews identified the ‘art’ of clinical pharmacy which makes it difficult to quantify 
in tangible numbers 
 “I’m a scientist but sometimes it comes down to clinical judgement” [P3] 
 “I think that is perhaps why kind of pharmacy is quite interesting because of 
the nature of, you could list everything down but it doesn’t kind of give you the 
whole picture of that patient because you have got a squidgy human in the 
middle of it who it actually all revolves around and that’s what makes it 
challenging or so interesting” [P4] 
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7.6 Main study results summary 
Through the Delphi process consensus was identified for the majority of elements of the 
RSPWC.  Where consensus could not be achieved data analysis identified a ‘national best 
representative’ figure for inclusion in the calculator.  For several activities relating to the 
delivery of pharmaceutical care the consensus on frequency was that ‘it depends on the 
patient’.  This was explored in more detail in a small sub group of the original study 
population and allowed the generation of average frequencies of activities for the purposes 
of a calculator tool.   
The qualitative data identifies that Pharmacy workforce is at a challenging point nationally 
due to the current political arena and, whilst funding is important, it is not the only 
challenge currently facing pharmacy managers, recruitment of staff with the correct skills in 
sufficient numbers often being the limiting factor in service provision. 
The RSPWC is identified as a potentially very useful tool and the resource requirements it 
generates are considered reasonable.  A number of applications of the tool in acute health 
care settings were identified.  The applicability of the tool in mental health and community 
hospital settings has not been established. Indeed there is some evidence to suggest that, in 
its current format, it would not apply to mental health units due to differing requirements 
of tasks relating to the delivery of pharmaceutical care in these settings, which are driven by 
compliance with various elements of the Mental Health Act 2007(125). 
Finally, finite conclusions on how much pharmacy time is needed to deliver patient care may 
never be achieved because of the intangible nature human response to medicines which 
impacts on the individual patient’s requirement for pharmaceutical care. 
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8. Validation of the RSPWC 
The final objective of this research was to explore whether it was possible to develop a 
validated pharmacy workforce calculator.   This chapter explores the extent to which this 
has been achieved by revisiting the various elements of validity and reliability outlined in 
the methodology (see section 4.4) and discussing the study results within the context of 
these issues.  The summary of validity, as presented by Sim and Wright(100) will form the 
basis of this review. 
8.1 ‘Face’ validity 
Face validity is the extent to which the tool ‘appears’ to be valid when assessed by impartial 
‘experts’.  This is important for the credibility of the data generated – if it does not ‘look 
right’ then its out-put will not be believed.  Face validity for the RSPWC was achieved 
through presentation at conference.  This peer review suggested that at ‘face value’ the tool 
was worth developing 
8.2 ‘Content’ validity 
Content validity measures the extent to which any tool addresses the full scope of the 
phenomenon being measured.  The RSPWC is calculating resource for the delivery of ward 
based pharmaceutical care.  In order to demonstrate content validity it needs to measure of 
all elements of a ward based pharmacy service.  As discussed in the introduction and 
identified through the literature review, there is no accepted standard model for service 
delivery.  The study sought to identify a consensus nationally on what tasks are necessary 
for the delivery of pharmaceutical care, how long they take and how often they have to be 
performed, by which staff groups i.e. to establish an ‘activity standard’ for the delivery of 
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pharmaceutical care. The RSPWC algorithm comprises of 74 individual figures. Content 
validity is robustly demonstrated through the consensus study data for 48 of these (65%) of 
the elements of the tool on which the algorithm is based this is shown in the green 
highlighted sections of Table 8.1.   
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Table 8.1 Content validity of RSPWC 
Royal Stoke Pharmacy Workforce Calculator© University Hospital of North Midlands NHS Trust. All rights reserved 2016
Template for Pharmacy time for delivery of pharmaceutical care to hospital in-patients
28.00 beds
Average length of stay 
Number of patients per year based on beds and length of stay 2044.00 per year
0 per year 0.00 per week
0 per year 0.00 per week
2044 per year 39.31 per week
8
Standard item Controlled Drug Monitored dosage system
Percentage of items in category 85% 10% 5%
Dispensing time (mins) 2.4 6.1 3.6
Checking time (mins) 1.2 2.8 1.9
ACTIVITY
STAFF GROUP REQUIRED TO 
PERFORM ACTIVITY
TIME TAKEN ON 
AVERAGE (per 
prescription in 
ESTIMATED NUMBER OF OCCASIONS  
ACTIVITY TAKES PLACE PER 
ADMISSION
TOTAL TIME 
REQUIRED FOR 
ADDITIONAL 
TOTAL TIME REQUIRED FOR 
ADDITIONAL CASES PER WEEK 
(hrs)
Obtaining Drug History  MMT 16 1 628.92 10.48
Check of Drug History Pharmacist 4 1 157.23 2.62
Check of PODs MMT 5 1 196.54 3.28
Clinical Review of Notes Pharmacist 5 2.00 393.08 6.55
Review of Blood results Pharmacist 3 2.00 235.85 3.93
Initial review of Chart Pharmacist 5 1 196.54 3.28
Initial endorsing of Chart Pharmacist 4 1 157.23 2.62
Interventions Pharmacist 5 1 196.54 3.28
Subsequent review of  Chart Pharmacist 3 2.5 294.81 4.91
Subsequent endorsing of Chart Pharmacist 2 2.5 196.54 3.28
Completion of Paperwork Pharmacist 5 5 982.69 16.38
Ordering of Non Stocks Pharmacist 3 1 117.92 1.97
Counselling MMT 7 1 275.15 4.59
Clinical Check of TTO Pharmacist 10 1 393.08 6.55
TOTAL 4422.12 73.70
Booking in ATO 2.5 1 98.27 1.64
Dispensing time (mins) ATO or Technician 22.64 1 756.44 12.61
 Accuracy Checking (mins) ACT 11.16 1 372.87 6.21
TOTAL 1227.58 20.46
GRAND TOTAL 5649.69 94.16
REQUIRED STAFF GROUP
GRADE  REQUIRED 
(According to speciality 
needs)
TOTAL TIME 
REQUIRED FOR 
ADDITIONAL 
BEDS PER 
WEEK (mins)
TOTAL TIME REQUIRED FOR 
ADDITIONAL BEDS PER WEEK 
(hrs)
WTE REQUIRED 
FOR 
ADDITIONAL 
ACTIVITY 
(24/7/365)
MID POINT OF AfC GRADE 
(+22% oncost)
Administrative tasks - ATO 2 98.27 1.64 0.05 19973
Dispensing tasks -TECHNICIAN 4 756.44 12.61 0.40 25683
Accuracy checking and drug history 
- MMT/PHARMACIST
5 1473.49 24.56 0.80 32090
Clinical activities - PHARMACIST 7 3321.50 55.36 1.90 44225
CLINICAL STAFF TOTAL
121,283.02£                                   
0.07
Number of beds on ward
5.00
Extra number of elective patients per year as a result of business case:
Extra number of emergency admissions per year as a result of business case
Extra number of elective patients & emergency admissions per year as a result of business case
Average number of prescribed items on drug chart
CLINICAL ACTIVITY
WTE REQUIRED FOR ADDITIONAL 
ACTIVITY
CLINICAL ACTIVITIES
0.28
0.17
0.09
0.17
0.10
0.09
0.07
0.09
0.13
0.09
0.44
0.05
0.12
84,218.85£                                                        
1.97
DISPENSING ACTIVITY
0.04
0.34
0.17
0.55
2.51
COST
1,064.24£                                                          
10,361.37£                                                        
25,638.56£                                                        
TOTAL COST FOR CLINICAL PHARMACY SERVICE
VALUES ENTERED BY OPERATORTO DEFINE SERVICE 121,283.02£                                                     
VALUE CONFIRMED BY CONSENSUS ACHIEVED THROUGH DELPHI STUDY
VALUE DERIVED FROM MEAN OF STUDY SAMPLE
VALUE EXTRAPOLATED FROM EXEMPLAR PATIENT SCENARIOS ( AVERAGE/DAY OF ADMISSION)
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For a further 18 (24%) components of the algorithm, relating to timing of tasks, 
consensus proved more difficult to determine on a single figure which is required for the 
functioning of the algorithm.  Values for the RSPWC were confirmed using data values 
from the study population (amber highlight in Table 8.1).  The robustness of this data 
may be challenged due to the relatively small sample size.  The study achieved 
participant numbers which were sufficient for meaningful consensus data(96) but is 
underpowered for quantitative and inferential statistical analysis.   
The remaining eight (11%) components, relating to the frequency of ongoing review of 
patients during their hospital admission, achieved a consensus which was ‘it depends on 
the patient’.  Suggesting that it was not possible to put a single figure to ‘how often’ a 
task should be completed.  This is due to the unpredictable nature of patient response 
to medicines and the requirement of professional judgement on the part of a 
pharmacist in assessing the need for subsequent pharmaceutical review.  This 
phenomenon is also recognised by Suggett and Marriott(45).  Their work investigated 
the potential to develop a risk score to identify patients that require pharmaceutical in-
put by using patient characteristics e.g. age, renal function, drugs prescribed,  for 
patients in whom pharmaceutical interventions had been made.  Their review of over 
59,000 admissions and the characteristics of the patients involved concluded that whilst 
a numerical figure could be allocated to each patient, it was neither specific nor 
sensitive enough to accurately predict pharmaceutical care need.  This was reflected in 
the words of one participant during the semi structured interviews of this study 
“you could list everything down but it doesn’t kind of give you the whole 
picture of that patient because you have got a squidgy human in the middle 
of it who it actually all revolves around and that’s what makes it 
challenging”  [P4] 
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This is also identified in the paper by Scott(75) which identified that normal productivity 
measures do not apply to medical practice as patient response is often not predictable 
or reproducible.  
This issue is the subject of much debate in pharmacy network meetings, with a divide in 
practitioner views as to whether one should see every patient every day, to what level 
that review should be done or whether one should prioritise those patients to be seen, 
by what method and what risks either approach produces.  This is reflected in the data 
returned on the exemplar patient section of Part 3 of the study. 
It, therefore, seems that defining this part of pharmaceutical care in finite numerical 
terms may not be possible.  For the purposes of development of the RSPWC though a 
figure is necessary.   This study began to explore how often the ‘average’ patient was 
reviewed and the values for these elements (red highlighted frequencies in Table 8.1) 
are derived from an extrapolation of that data.  This is again limited by sample size and 
the recognition that there is no agreement amongst experts as to what these values 
should be. 
What must be recognised is that even data from the two extremes of service delivery i.e. 
no subsequent review of patient to full daily review of patient, are applied to the tool 
the differential in out-put from the calculator is almost 2.4 times less of that identified 
from current manager best guess (£57k for no subsequent review v £134k for daily 
review).  So whilst this ‘average’ might not be absolute it generates a greater level of 
accuracy of resource requirement that the current available methods. 
On the basis of this summary the content validity of the RSPWC has been demonstrated 
within the identified limitations. Further research on identification of patient need for 
pharmaceutical care may improve the accuracy of the tool. 
177 
 
8.3 Criterion validity 
Criterion validity covers three types of validity; ‘concurrent’, ‘predictive’ and diagnostic’ 
validity.   
8.3.1. Concurrent validity 
This compares a tool with an existing ‘gold standard’.  The development of the RSPWC 
has followed the WISN(23) process.  WISN is the WHO ‘gold standard’ approach to 
calculation of workforce requirements and as such the RSPWC can be considered a ‘gold 
standard method’ for the task in hand.  There is no current ‘gold standard’ calculation 
for pharmacy resource with which to compare the output of the RSPWC. The ‘Purkiss 
Model’(38) is not reflective of current practice.  Direct comparison of the RSPWC with 
current literature requires presentation of results to indicate the number of beds per 
pharmacist.  Following this extrapolation it can be seen in Table 8.2 that the output of 
the RSPWC matches two of the three reference sources.  The outlier in the data set is 
the figure identified from NHS benchmarking 2015/16(22).   
Table 8.2 Comparison of staff resource requirements identified in the published literature   
Reference source Beds/WTE 
pharmacist  
O’leary, Stuchberry & Taylor(40)  
(Average hospital- wide, average LOS 6 days) 
19.5  
Onatade, Miller & Sanghera(36)  
(average across 7 London sites) 
18.19 
NHS Benchmarking(22) 55 
RSPWC  (24 bed ward, LOS 6 days, 5 day service) 22 
NB For a 28 bed ward with average LOS of 6 days 
8.3.2. Predictive validity  
This relates to how the prediction of a tool is borne out in reality.  Does the RSPWC 
generate the resource required for the consistent sustainable delivery of a clinical 
pharmacy service?  It was recognised that the study version of the RSPWC 
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underestimated the required resource as it was based on minimum service standards 
and did not include the ‘unavailable’ time recognised as necessary in all workforce 
calculations.  These elements have been addressed and included in the validated tool.  
Data gathered (Tables 7.29 and 7.30) suggests that the tool does generate the resource 
needed for service delivery.  Predictive validity has been demonstrated. 
8.3.3. Diagnostic validity 
This considers whether a tool identifies true or false positives/negatives which is not 
applicable to the RSPWC as that is not the nature of its out-put and so has not been 
considered in this study. 
8.4 Construct validity 
Construct validity is demonstrated if out-puts of some elements of the tool can be 
correlated with values calculated by different methods.  This is particularly important if 
the tool being validated is theoretically novel and this is directly relevant to the 
validation of the RSPWC.   
This has been demonstrated in a number of ways.  As previously shown (Table 2.1.) 
some elements of the RSPWC have construct validity in comparison with the literature.  
This is particularly relevant for medicines reconciliation which is the single longest task 
completed for pharmaceutical care and has the greatest influence on the value 
generated by the tool as it is required for all patients and done consistently in the same 
frequency.  The same can be demonstrated for clinical check of a prescription.  Within 
this study data collection several elements were corroborated by different sources e.g. 
the consensus established on the activities of MR, POD check and TTO supply within the 
Delphi part of the study were confirmed and replicated within the exemplar patient 
section of the research.   Construct validity of the RSPWC has been demonstrated. 
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8.5 Internal and external validity 
8.5.1. Internal validity  
This requires the computational elements of the model to be proven i.e. are the 
calculations correct.  The algorithm which drives the RSPWC has been checked by an 
independent reviewer and confirmed to be accurate.  These calculations are made 
available to users for their own verification, as the formulae within the Excel® worksheet 
are visible to any operator   
8.5.2. External validity 
For this to be demonstrated the forecasts of a model have to be proved in reality so that 
its output can be seen to generate realistic figures.  This remains difficult to achieve in 
the case of the RSPWC as the pharmacy workforce has not been thoroughly described 
and agreed upon previously.  With no agreed formula to quantify staffing need, the tool 
cannot be checked against reality.  The results of the study suggest that the RSPWC 
generates a greater resource requirement than is currently identified by many pharmacy 
managers; however that does not necessarily make it invalid.  In general the managers 
involved in the study felt that the resource requirements identified by the RSPWC were 
realistic in terms of need, though a number questioned their ability to recruit to that 
level.  If required staffing levels are not achieved, the question is then raised as to what 
service you deliver and how that should be risk assessed.  
8.6 Transparency 
In the field of validation Eddy et al.(101) required a further element of ‘transparency’, 
requiring the developer to provide users with technical details of how to utilise the tool 
so they understand the way in which the calculation works and provide sufficient detail 
so that the computational basis can be checked or developed.  This is covered in the 
case of the RSPWC as instructions for use are provided to a user in the form of a step 
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wise guide.  The majority of users found this easy to follow and the tool quick and 
straight forward to use.  One user was concerned about how the spreadsheet worked 
and felt that without having full understanding it would be difficult to ‘sell’ to peers 
within his organisation.  In response to this, further clarity will be provided with the 
release of the validated tool, along with the summary of the validation results to give 
confidence to a user of their credibility. 
8.7 Reliability 
The consistency and reproducibility of the data generated by a tool represents its 
reliability.  The two types of reliability relevant to this setting are considered in the 
context of the RSPWC. 
8.7.1. Equivalence  
The tool has to produce consistent measurements in the hands of two or more 
investigators for equivalence to be demonstrated.  Part 2 of this study considered this 
element.  To increase the reliability of the tool the bulk of the spreadsheet was locked 
from editing purposes – allowing the user to manipulate the minimum required fields 
and yet allow the tool to function correctly.  Equivalence was demonstrated between 
users of the RSPWC.  The risk to validity of allowing operator manipulation of the tool 
was also illustrated, as the outputs from some operators were not exact due to changing 
fields within the calculator which were not part of the instructions for the study.  
However, this manipulation did demonstrate their understanding of how it worked and 
their ability therefore to apply it appropriately in their setting. 
The need to be able to ‘bespoke’ the tool to a specific setting is a point for ongoing 
discussion.  The ‘validated’ tool requires limited manipulation by an operator.  However, 
one of the applications of the calculator that has been identified is ‘using it backwards’ 
i.e. rather than using the calculator to identify the resource needed to deliver the 
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service, use it to identify what service can be delivered within a defined resource.  This 
will require a version with increased numbers of unprotected cells to be issued and this 
needs then to be used with caution as the validity of the tool may be diminished in 
individual hands.  Prospective users need to be aware of this risk. 
8.7.2. Stability  
This element of reliability – that results produced by one operator remain stable over a 
period of time - has already been established through routine and regular application at 
the Royal Stoke.  A key assumption of reliability though is that that the phenomenon 
being measured remains the same between measurements.  For the RSPWC this has the 
implication that as technology progresses and pharmacy practice changes the tool will 
need to be recalibrated – it will not be a one-time process.  In this era of post-Carter 
Report practice, those responsible for the delivery of pharmacy services are challenged 
with transforming the service and doing things differently.  However, Trusts are not all 
starting from a level playing field and the value of the RSPWC will largely be in 
establishing what should be the baseline resource upon which transformation of service 
is based.  It will need to be reviewed when extended pharmacy practice becomes the 
‘norm’ and the impact of the practice of increased numbers of pharmacist prescribers is 
understood and how that changes the pharmacy services within that model. 
8.8 Validity within different healthcare settings 
The research question being posed was  
“Can the resource required to deliver pharmaceutical care to hospital in-patients be 
calculated by a single tool applied to multiple settings?” 
The outcomes of this study suggest that the answer to this is ‘Yes’ but only for acute 
hospital sites. 
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The tool has been demonstrated as transferable and applicable across district general 
and teaching hospital settings delivering acute medical and surgical care.  This is based 
on the level of consensus achieved in a homogenous sample of an acceptable size.  For 
other settings e.g. mental health units and community hospitals the tool has not been 
fully validated.  Inadequate numbers of sites were recruited from those settings to 
generate a consensus, although within the limited sample available it became apparent 
that processes of service delivery are substantially different. In mental health in 
particular, due to requirements for compliance with elements of the Mental Health Act 
2007, and so different values for the ‘activity standard’(23) in the algorithms are 
required.   The development of those could be done with a repetition of this study in a 
mental health cohort with some minor modification, but is outside the scope of this 
study. 
In addition the tool is also not validated for application in critical care or renal medicine 
settings.  It is recognised that these complex medicines use areas require a different 
level of pharmaceutical in-put and prior to the development of the RSPWC, nationally 
accepted patient/pharmacist ratios had been established and continue to be applied.  
For this reason these areas are excluded from its application.  It may be argued that in 
some tertiary referral centres, general wards have more complex patients than the 
calculator provides for.  This will require local, case by case consideration.  Again this 
identifies the need for the opportunity to ‘bespoke’ the tool and the need for further 
research to explore the ‘it depends on the patient’ element of frequency of review. 
8.9 Validation summary 
Following review of the results of this study the RSPWC has demonstrated most 
elements of validity in calculating the resource required to deliver pharmaceutical care 
to hospital in-patients in acute hospital settings.  The out-put from the tool is however 
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only a model and should be interpreted in the context of the situation in which it is 
being applied.   
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9. Discussion 
The overall aim of this study was to explore whether a tool, developed to calculate the 
staff resource required for delivery of pharmaceutical care to  in-patients at a RSUH, 
could be applied to equivalent services delivered at other hospital sites (see Chapter 3, 
page 60 for aims, objectives and research questions of this study) .   A number of 
research questions were posed around the equivalence of the pharmacy service at RSUH 
to those in other hospitals. The results presented of this study in Chapter 7 have 
demonstrated that the service model on which the RSPWC is based is representative of 
those in other sites.  Where consensus was achieved on tasks, times and frequencies, 
these matched the RSPWC.  In those areas where sufficient consensus could not be 
achieved from the study population, the components of the RSPWC were amended to 
reflect national best representative figures.  This allows the RSPWC to be used to 
calculate resource in different acute hospital settings, both district general and teaching 
Trusts.  The applicability of the RSPWC to other settings e.g. mental health and 
community hospitals was not established and there is some direct evidence to suggest 
that it may not apply in mental health trusts.  However, the model could be adapted, 
through establishment of different activity standards.  The validation of the RSPWC was 
covered in detail in the previous chapter. 
This chapter will discuss the results in the context of the study objectives and research 
questions, in relation to the wider literature and assess the place of the tool in the 
context of the current political landscape. In addition, limitations to both the study and 
the tool itself will be considered, along with the implications of reflexivity and the role of 
the ‘researcher-practitioner’ in this type of research.  Finally further work suggested by 
these findings will be described. 
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9.1 Discussion of results in the context of the study objectives 
The study objectives fell into two sections.  The first two study objectives related to the 
development of an evidenced-based pharmacy staffing calculator using the WISN (23) 
methodology and the remainder of the objectives related to the validity and 
transferability of the resultant tool in different settings.   
9.1.1. Objective 1: The development of an ‘activity standard’ for 
pharmaceutical care 
The first objective  in developing a staffing calculator based on the WISN(23) approach is 
identifying an ‘activity standard’ for pharmacy i.e. a description of the tasks required to 
complete the ‘job’ for one patient so that it can be extrapolated for all patients in the 
specific population.  WISN requires this activity standard to be agreed by ‘experts in the 
field’ and this approach has been applied to other professions in the NHS(18,20) but has 
not been previously been applied to pharmacy services. The method was utilised in this 
study by creating a ‘virtual’ panel of experts and establishing their consensus in an 
electronically-applied, two-round Delphi consensus study(52).  The study population 
met the accepted size for consensus to be established within homogenous 
groups(96,97). It can, therefore, be demonstrated that the process of establishing the 
activity standard was evidence-based and recognised in national and international 
approaches to staffing calculations. 
When considering the detail of the ‘activity standard’, consensus was achieved on more 
than two thirds (65%) of the components of the clinical pharmacy service and the list of 
tasks and the staff groups to deliver them were almost unanimously agreed. A number 
of additional tasks were identified by the participants that were not included in the 
RSPWC, but none of these reached the predefined level of consensus to be included in 
the calculator at this stage.  However, two of the identified tasks, namely referral to 
community pharmacies post-discharge and pharmacist independent prescribing,  were 
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included in the ‘Carter metrics’ i.e. activities that are to be measured as part of progress 
in the Hospital Pharmacy Transformation Plan(21).  This will require review over the next 
couple of years as it is likely that these activities will become more common-place in 
clinical pharmacy services, if they form part of the measurement of ‘what good looks 
like’.  However, during that time other duties (particularly relating to supply functions) 
might be lost through out-sourcing or collaboration and the resultant time for the 
activity standard remains fairly constant i.e. one task is simply replaced by another.  The 
‘activity standard’ will then require review and possible updating. 
The time the tasks should take was more challenging due to the continuous rather than 
discrete nature of time data and the need to identify a specific number for the purpose 
of developing an algorithm.  Consensus was reached on a specific number for several 
tasks but for others it was necessary to triangulate two or more of data sources to 
generate a ‘national best representative’ figure.  It was the ‘frequency’ of the tasks that 
proved the most difficult to identify for an activity standard and consensus, or at least 
plurality, was achieved for all task frequencies.  In multiple cases, however, that 
consensus was that it ‘depends on the patient’.  Again this proved problematic for the 
purpose of identifying a specific figure for an algorithm, but this was explored further 
using exemplar patient management (participants identifying frequency of activities for 
different patient cohort scenarios) and qualitative interviews to understand the 
participants’ perspectives on the management of the ‘typical’ or ‘average’ patient.   
From this process a ‘frequency’ was derived for each task and the activity standard for 
the delivery of pharmaceutical care identified.   This could be criticised on the grounds 
of using small respondent numbers but there are a number of defences to such criticism, 
supported by the literature.  Firstly, the subject of patient acuity and prioritisation is of 
increasing interest to the pharmacy profession, with several research teams trying to 
identify the ‘magic’ number(45) or a successful tool to direct pharmacist activity(47) 
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with little current success.  The work by Suggett and Marriott(45)  considered 59,000 
admissions - sample size was not their limitation - but their work demonstrated that the 
‘magic number’ was at best elusive.  The work by Hickson(47)  et al. suggests that, even 
if a tool to direct pharmacist activity were developed, pharmacists do not necessarily 
follow it because their use of  ‘professional, clinical judgement’ which has not been fully 
described.  Indeed, as this study identified, whilst delivered by scientists, there appears 
to be an “art” to clinical pharmacy, the “squidgy human in the middle of it ..... makes it 
challenging” (P4) and this phenomenon is not yet fully understood.  This part of the 
study could have included further participants, but the evidence suggests that the 
‘magic number’ might still have proved elusive(45).  Pharmacists may be, by nature and 
training, focussed primarily on accuracy and detail; it is what makes them safe and able 
to fulfil their professional role.  The difficulties faced in identifying a specific number for 
the frequency with which some tasks are completed for patients might result in it being 
put into the ‘too hard’ pile by some members of the profession  This might lead to the 
RSPWC being discounted.  However, as was identified by Ghosh and Cruz(27), whilst 
striving for perfection and precision in identification of staffing levels, there is a need for 
a pragmatic solution to act as a starting point in the here and now.  Such a pragmatic 
approach was taken with RSPWC and the resource generated by the algorithm, using the 
activity standard identified through this extrapolation, produces resource results which 
appear to sit comfortably within the range of those already being requested in reality by 
pharmacy managers nationally.  So the view could be taken that the challenge to 
dissenters should be to disprove these figures, as there is no other method currently 
available.  This should either generate a more accurate calculator or confirm the figures 
in the RSPWC.  It is therefore suggested that an activity standard for acute hospital 
pharmacy has been identified that can be applied to the relevant patient population and 
therefore the study objective relating to the establishment of an activity standard has 
been met. 
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 The application of the activity standard to pharmacy services in other healthcare 
settings has not been proved for a number of reasons.  Primarily the study population 
did not include sufficient numbers of representatives from mental health or community 
health trusts for consensus to be deemed to have been achieved for these types of 
settings. Moreover, those participants from the mental health sector identified a 
number of key differences, both in service structure, out-sourced dispensaries, typically 
increased length of stay and prevalence of electronic prescribing, and legislation 
documentation required under the Mental Health Act 2007, which rendered the timings 
and frequencies of tasks unrepresentative of their service.  The clinical task list however 
was agreed by these participants and it is therefore postulated that the approach could 
be repeated with a larger sample of staff from this setting to identify the activity 
standard for mental health pharmaceutical care.  However, this was outside the scope of 
this study. Objective one of this study has therefore been met by the identification of an 
activity standard for the delivery of pharmaceutical care in acute hospital settings. 
9.1.2. Objective 2: The identification of ‘unavailable’ time 
Objective two required the identification of ‘unavailable’ time inherent in the 
employment of staff i.e. that time when they are not available for direct patient care for 
whatever reason, so that the WISN method could be employed.  For each staff group 
this needed to be described; it is necessary to understand this variable as, without it, the 
staff resource would always be insufficient to deliver a sustainable service.  The 
participants identified very similar figures for the junior grades (Agenda for Change 
bands 2-7) but a wider variation in available time was seen for bands 8a and above.  This 
seems reasonable since the justification of a post at Agenda for Change 8a is often on 
the basis of the delivery of wider roles than just on routine ward service delivery.  This 
staff grade is generally involved in guideline development, governance issues, financial 
analysis of medicines expenditure and, increasingly,patient consultation in out-patient 
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clinics i.e. their work time is only partly based on delivery of ward services. For this 
reason the RSPWC utilises AfC Band 7 as its standard ward pharmacist grade.  There may 
be scenarios where lower or higher grades of staff can/need to be utilised(44) and these 
can be substituted in the calculator with the relevant ‘unavailable time’ by grade 
identified.  The validated version of the tool allows this modification to be made by the 
operator.   
The completion of these first two objectives i.e. the identification of an activity standard 
for clinical pharmacy and the ‘unavailable’ time inherent in employing pharmacy staff,  
allowed the derivation of the algorithm to drive the calculator to generate a resource for 
the delivery of an in-patient pharmaceutical care service.  All of the research questions 
posed (see page 60) were also addressed by the completion of these objectives.   
i. It has been demonstrated that the delivery of pharmaceutical care at other sites 
does appear to require the completion of the same task list as at RSUH.   
ii. In broad terms pharmaceutical care activities appear to take the same time at 
other sites, though there were some challenges as previously discussed.  The 
impact of automation on these processes was explored and it was demonstrated 
that use of electronic prescription and administration programmes is still not 
wide-spread.  Where they are employed, some tasks are reported to take longer 
(e.g. chart review ) but others reported to be quicker (e.g. MR).  Automated 
dispensing is more common, particularly amongst the teaching hospitals and the 
data here suggests that whilst the overall process of dispensing and checking is 
accelerated by use of automation, dispensing takes longer.  This seems illogical 
and so is discussed in more detail in the discussion of the limitations of the study 
(see section 9.4).  However, the implications of these technology developments 
are not yet sufficiently universal to require modification of the RSPWC at this 
time, though they will require review over the coming years.  
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iii. It has been demonstrated that the use of skill mixed teams to deliver services is 
common across different services, with many places utilising the skills of the 
pharmacy technician team in the same way as at RSUH. 
iv. The question as to how often the pharmaceutical care tasks are completed was 
more challenging to answer and this has already been discussed earlier in the 
chapter. Finally, it was demonstrated that consensus on the activity standard for 
pharmaceutical care was reached. 
 
The remaining objectives considered the place of this calculator within the context of 
current service delivery. 
9.1.3. Objective 3: Exploring current staffing levels at participant sites 
To demonstrate the transferability and applicability of the RSPWC to other healthcare 
settings, it was first necessary to understand the processes being used currently by 
pharmacy managers and the value (£) of the resource they would routinely request to 
deliver pharmacy services.  When asked to identify this necessary resource for specific 
scenarios a substantial variation was identified across the participant population 
(£15,000 to £150,000 – Table 7.11). This seems to be an example of ‘unwarranted 
variation’ as described by Carter(21), but why this should be remains unclear.  A simple 
answer could be that non-comparable services are being delivered, i.e. this data is 
comparing ‘apples with pears’ as pharmacy managers across the country have differing 
views on what service should be delivered and so ask for different levels of funding.   
However, the initial part of the study demonstrated, through strong consensus for the 
majority of components of the algorithm that all participants appear to have the same 
understanding of the service that should be delivered, but that this is not translated 
necessarily into the identification of the same level of resource with which to deliver it.  
A number of reasons may be postulated to explain this variation.  It might be that new 
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requests are based on historic agreements e.g. where funding has been low in the past, 
managers asking for what they think they might get, rather than what they actually 
need.  Alternatively, it may be simply that they perceive no way of objectively 
calculating the resource that is needed to deliver the service.  The best-guess ‘finger in 
the air’ technique of identifying staffing requirements was certainly recognised by the 
participants in the qualitative section of the study.  The reality of service provision 
seems to be that, whilst pharmacy managers largely agree on the standards of care that 
should be achieved, patients across the country will tend to experience different levels 
of service.  The challenge is how to standardise care to remove the ‘unwarranted 
variation’(21) against standards? The first step for this seems to be to set standards and 
then identify the gap or excess in the current models.  The values generated for a clinical 
pharmacy service using the RSPWC sit around two thirds of the way up the range (table 
7.11).  They are not excessive, but are substantially more than many sites currently 
request or receive, whatever the reason for that might be.  If the profession is being 
asked to standardise, then the RSPWC may be the first step in this process, though it 
might not be the final destination. 
9.1.4. Objective 4:  The transferability of the tool to different operators 
For the RSPWC to be part of the establishment of national standards, demonstrating the 
transferability of the tool between operators is required, i.e. completion of objective 
four.  This was not as straightforward as might have been expected or hoped since the 
‘right’ answer was not generated by all operators and differences in degree and cause of 
‘wrongness’ were found in each of the three scenarios.  This needs to be explored to 
understand the implications for the RSPWC in practice (see Table 7.28). One participant 
failed to follow the instructions in the questionnaire for any of the scenarios and only 
provided a narrative to their approach rather than a value that had been produced by 
using the calculator.  This participant appeared to have understood the scenarios as this 
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was demonstrated in the resource they identified in round 1 of the Delphi study, but 
reasons for not following the instructions in the questionnaire were not clear.  Their 
response might have been based on finding that ‘knowing’ how much resource was 
needed (in reality the calculator identifies substantially more than they requested in 
round 1) might in some way be too uncomfortable professionally or morally and so 
blissful ignorance was a better position to maintain i.e. they knew they did not have 
enough staff, but did not want to know the size of the gap.  This response was not 
explained during the course of the study and whilst recognising the need to ensure 
clarity in instruction in further issues of the RSPWC, this participant was considered an 
outlier in this section and is excluded for the purposes of this discussion.   
If we then consider the three scenarios separately, a number of different issues were 
identified (Table 7.28).  In the first scenario, which was the simplest – a ward, with a set 
number of beds and a specific length of stay – 80% (n=10) of operators generated the 
‘right’ number – the ‘wrong’ figure was because two operators chose to amend 
elements in the calculator that were not in the instructions (this will be discussed 
shortl). In scenario 2, a change of patient cohort with a reduced length of stay generated 
greater variability in answer. The ‘right’ answer was produced by 60% of operators, 
three did not complete the full process of calculation outside of the RSPWC and another 
made active changes to the data entered into the tool.  Finally the greatest variation in 
response was seen in Scenario 3.  This was the most challenging situation – the addition 
of a cohort of patients to an existing ward - and one which in the first round 
questionnaire generated the most diverse answers, based on diverse approaches to 
dealing with this question. Once more 60% (though different operators from Scenario 2) 
produced the ‘right’ answer, one operator did not follow the mathematical instructions, 
one changed the variables and two generated ‘wrong’ answers for which the error could 
not be explained.   The issue of not following the mathematical instructions in the user 
193 
 
guide suggests that greater clarity may be required prior to its wider release. A worked 
example might be helpful in demonstrating the ‘ball park’ figure – then ‘wrong’ answers 
could be more easily identified by users.  If one does not know what is ‘right’ then one is 
less likely to know when one is wrong.  These operators all demonstrated that they 
could use the calculator correctly and that it produced the same figures when they did 
so.  What they did not do was then use those figures correctly or fully to complete the 
calculation i.e. to identify the change in resource required (new service value minus old 
service value) rather than just calculating the post-change  figure.    
The diversity of response in Scenario 3 reflected that of the earlier stage.  This is a 
scenario with which pharmacy managers may not be comfortable with or clear on how 
to approach.  It is typically one where, historically, funding may not been considered for 
pharmacy.  Indeed managers may not have had the opportunity to ask for funding (see 
table 7.30 “we’d be expected to absorb into existing establishment”) as the impact for 
pharmacy only may be considered if the form of the service is clearly understood.  That 
pharmaceutical care is delivered to patients, not to beds and the bed numbers might be 
unchanged, but the numbers of patients in those beds over time has changed.  If this is 
not identified then there is a risk that pharmacy staff numbers may not grow alongside 
activity, although Fitzpatrick and Sanders(49) suggest that this has not happened in the 
NHS over the last five years, when they revisited their earlier benchmarking project.  
However, this validation study suggests that the diversity within pharmacy managers in 
responding to service developments within their organisations is another ‘unwarranted 
variation’(21). 
Finally the amendment of data input into the RSPWC by a number of operators serves to 
further highlight inconsistencies in service provision and the apparent desire by 
pharmacy managers to do things in their own way.  If this is so, these modifications were 
made because the RSPWC did not quite ‘fit’ their model, or in the words of one 
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participant “it didn’t take into consideration our local nuances”.  This raises the question 
of the balance to be struck between validity and adaptability, since it was recognised by 
Sim and Wright (see section 4.4) that to demonstrate the ‘equivalence’ element of 
reliability, a tool must produce the same results in the hands of different operators.  
They identify that ‘equivalence’ is improved when manipulation of the tool by the 
operator is limited.  This is demonstrated in these results of this study, where operators 
change more than is instructed, and the ‘wrong answer’ is generated and the tool’s 
validity is undermined.  This can be rectified by restricting modifications of input by 
operators to a minimal number of data sets for example, to number of beds and length 
of stay, but then the results might not reflect the service delivered in that locality and 
the tool is seen as lacking adaptability of application to services in transformation.  
Perhaps the more challenging question for pharmacy managers would be ‘is your service 
delivery model right?’  If one finds one’s service does not ‘fit’ a model, with service 
specification components that have been validated nationally by your peers, rather than 
amending the model, perhaps there is a need to review the service delivery model i.e. to 
reduce the ‘unwarranted variation’.  There is substantial evidence that clinical pharmacy 
improves outcomes for patients and has positive impact on finances of medicines 
use(5,8,9,126).  However, this evidence was based on delivery of specific clinical 
pharmacy services.  If the model of delivering that care is modified as per Wallestedt, 
Bladh and Ramsberg(54) then it cannot be presumed that the outcomes remain 
constant.   Pharmacy managers need to consider the impact on patient outcomes when 
they modify their service delivery approaches. Overall, this element of the study 
demonstrated that with appropriate instruction, participants are able to use the RSPWC 
to generate consistent values.   
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9.1.5. Objectives 5 and 6: To explore the utility of the tool in different 
healthcare settings and reasons for outlying data 
The applicability and utility of the RSPWC in other practice settings was further 
investigated through the qualitative stage of the study, which addressed objectives five 
and six. Most sites described the used of skill mixed teams of pharmacists, technicians 
and assistant technical staff working in co-located wards to deliver pharmaceutical care, 
including the supply components close to the patient.  The ‘unwarranted variation’(21) 
does not seem to be apparent here.  In Trusts with multiple smaller sites, in particular 
the mental health trusts, skill mixing was less apparent and this was driven by the 
practicalities of logistics, rather than by opinion on best practice. 
Across the whole sample it was identified that perceived insufficient staff resource was a 
challenge to all participants, regardless of size of Trust – again no apparent 
‘unwarranted variation’.   The cause of this insufficiency was multifaceted, with finances 
only one element of the problem.  Geographical location was reported as being 
problematic for attracting staff to work in some localities, in which instance even a fully 
funded service may be unlikely to solve this problem. Such instances tended to be in 
remote or isolated locations, or those in which too close a proximity to large teaching 
trusts that were reported to result in  pharmacy staff moving to the more ‘exciting’ or 
varied working environment of the large Trusts.  However, even participants from these 
larger organisations reported staffing challenges.  They identified that the rapid increase 
in extended roles for pharmacists(127), as their expertise is beginning to be recognised 
and exploited, seems to be generating a skills void which the profession is struggling to 
fill in a timely manner, and this appears to be at both ends of the spectrum.  Training of 
pharmacist independent prescribers does not appear to be keeping pace with the rate of 
expansion of roles and junior staff are not coming through quickly enough, with the right 
skill set to fill the gaps left behind.  This challenge is recognised by the profession and 
was discussed at a recent ‘Workforce Summit’ at the Royal Pharmaceutical Society(128).  
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The conclusion of that discussion was there is an urgent need for integration and 
collaboration across existing professional boundaries i.e. hospital pharmacy and 
community pharmacy, pharmacists and technicians, alongside the need for investment 
in funding and access to training of staff with the correct skills to deliver the service. 
The drive throughout the NHS to deliver a ‘7-day service’ to meet the standards for 
patient care set out in the Keogh report(129) appear to have brought substantial 
financial pressure to bear on hospital Trusts and several participants reported that they 
had been required to deliver these extended services within existing resource.  In such 
cases, existing staff resource is now being spread even more thinly across 7-days.  
Participants also reported that introduction of 7-day working, combined with the 
emergence of roles in GP practices, which may be attractive because usually they do not 
have the requirement for 7-day working, has resulted in the loss of  experienced hospital 
staff, which has added further to staffing pressures.  What therefore it is the place of the 
RSPWC in this context? 
 Participants identified the value of the tool being objective and based on “fact not 
feeling” (see Section 7.5.3) and that it required little data collection at a local level to 
allow staffing calculations to be made, which is supported by Hurst et al.(20) who 
identified the need for a simple to use tool, requiring minimum local data entry.  The 
pharmacy managers in the study identified applications both in identifying resource 
requirements for new business, but also in reviewing existing staffing levels against 
current activity to identify, objectively, where and how large the staffing gap was.  They 
recognised that this would in turn allow objective and tangible decisions to be made 
about what could or could not be achieved with the available staffing resource.  The 
ability to potentially use the tool ‘backwards’ was seen as a way of supporting this 
decision i.e. rather than identifying the resource needed for the number of patients, it 
could be used to identify the patients that could be managed with the available 
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resource.  This then leads on to the question, if you are not going to do the full ‘job’ for 
every patient, what jobs do you not do or which patients do you not see?  This is one 
area where consensus was not fully achieved and individuals often took diametrically 
opposed views.  It appears therefore from this study that some of the ‘unwarranted 
variation’ is not driven from disagreement amongst pharmacy leaders as to what care 
needs to be given to patients, but rather about how to deliver this care when you do not 
have enough staff to do deliver the same level of pharmaceutical care for every patient. 
Recognising that there may be insufficient resource to see every patient, every day, this 
research explored participants’ perspectives on what makes a patient a priority for a 
pharmacist and how one identifies those patients.  Pharmacists in this study 
independently identified the same patient characteristics included in a Scottish 
pharmacy prioritisation tool(46) and similarly reported that these patients should be 
reviewed daily by pharmacists.   If prioritisation of patients is to occur, the identification 
of those with greatest need within the hospital environment is the next challenge.  The 
recent work by Suggett and Marriott described earlier(45) identified that patient 
characteristics alone do not appear to be sufficient and that there seems to be need for 
some sort of ‘pharmacy triage’ of patients.  Hickson et al.’s work, however, suggests that 
a triage process will not always be consistently applied(47) because the patient is an 
individual and responds to illness and treatment individually i.e. the so called “squidgy 
human” effect.   Predicting which patients have to be seen is one element, knowing 
where they are in the Trust once they have been identified is another that was raised, 
and the need for electronic systems that allow these patients to be tracked though their 
hospital journey was identified.  Without this, services are likely to remain inherently 
inefficient, by using valuable manpower to add limited value to the patient care.   
Whilst many of the opinions expressed by participants supported the development of 
the RSPWC, a number of challenges to both its construct and application were made in 
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the qualitative stage of the research.  The issue of “it doesn’t take into account local 
nuances” has already been discussed, but another was the view that the ‘best guess’ 
approach to how long tasks take is based on the experience and training of a pharmacy 
manager and that these might not reflect the practice of junior members of the team. 
The inference being that the managers’ ‘best guess’ may underestimate the time 
pharmacists take to deliver the service in reality.  In response to this challenge, in the 
original development of the tool(12) the time and motion study which identified the 
times for the tasks was conducted across a range of wards and staff groups and 
represented a mean time for each task.  In this study, mixed data sources have been 
used including existing local data, where available, and with reference to published 
timings in the literature.  As such, this triangulation reduces the risk of under-estimate 
and associated under-resourcing of services. 
Another frequently mentioned challenge was the inclusion of dispensing activity in the 
RSPWC, which was expressed as dispensing activities not being ‘clinical’ and therefore 
not associated with pharmaceutical care and the issues around these being  
‘infrastructure’ tasks as defined by Carter(21).  A defence of the original inclusion of this 
activity in the RSPWC is based on the definition of pharmaceutical care(2) which 
focussed on the management or avoidance of ‘drug [medicines] related problems’ 
(DRPs).  These were outlined by Strand et al.(3) (see Table 9.1).  Of the 10 DRPs, one 
they identified was ‘the patient does not have a supply of the required medicine’.  This 
suggests that all the ‘clinical’ activity to optimise medicines in terms of evidence-based 
drug choice and titration of dose, will be to no avail if the medicine is not available to be 
administered.  
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Table 9.1 Drug related problems (adapted from Strand et al.(3)) and their management 
Drug related problems RSPWC tasks that facilitate management 
Untreated medical indication requiring drug 
therapy 
 
Review of medical notes 
 
Too little of correct drug prescribed 
 
Drug chart review 
Blood results 
Patient not receiving the prescribed drug 
 
Drug chart review 
Order of inpatient medicines 
Supply of discharge medicines 
 
 
Too much of the correct drug is prescribed 
 
Drug chart review 
Blood results 
Adverse Drug reaction  
 
Drug chart review 
Blood results 
Review of clinical notes 
Speaking to the patient 
Drug interaction 
 
Drug chart review 
Drug treatment with no valid indication 
 
Review of medical notes 
Wrong choice of drug 
 
Review of medical notes 
Review of drug chart 
Compliance with prescribed regimen Review of drug chart 
 
This view is further supported by the National Patient Safety Agency alert relating to 
missed doses(130) and with the move towards ‘near to patient’ supply of medicines as 
an accepted pharmacy service model it was deemed appropriate in this study to 
combine the pharmacy workforce requirements to deliver the whole patient-specific 
pharmacy service. 
The supply of medicines is, therefore, fundamental to the delivery of pharmaceutical 
care, but the Carter review(21) poses a different challenge that does not detract from 
the importance of efficient supply of medicines;  rather it questions who should be 
fulfilling that role.  The suggestion is that highly skilled hospital pharmacy staff should be 
focused on direct patient-facing care activities and that the supply function could be 
efficiently delivered by a third party supplier.  This might be through out-sourcing to a 
commercial partner or through greater use of pre-prepared patient packs, produced by 
a centralised manufacturing unit supporting a number of different sites.  This provides 
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an argument for removing the supply activities from the workforce calculator, but, on 
balance, it was considered appropriate to retain this element for the ‘validated’ RSPWC 
for a number of reasons 
 These are tasks that currently have to be delivered and so it remains important 
to identify the current resource required to do so 
 If this element of the service were to be ‘out-sourced’ then any commercial 
partner would need to understand the volume of workload involved for  
delivery of the business for which they are bidding 
 If this element were to be out-sourced then it would allow identification of the 
size of the workforce that could be released for other duties, which in turn may 
reduce the gap between resource and clinical pharmacy workload identified 
(assuming these staff were retained by the Trust) 
As such, it seems prudent that the staffing associated with the dispensing element of the 
calculation should be clearly identifiable to allow the above judgements to be made 
without the need for complex further calculation by individual managers. 
The final challenge to the RSPWC that was identified was that the increasing presence of 
pharmacist independent prescribers may impact on distribution of clinical tasks and 
therefore the resource needed to deliver them.  This seems largely dependent on the 
source of funding for these prescribers i.e. different models will have different impact. 
For example, a prescriber funded as a separate role by a clinical speciality, to replace a 
junior medic or advanced nurse practitioner, would be in addition to the ‘pharmacy 
team’ on the ward.  In this model it is unlikely that there would be a need to include any 
other clinical pharmacist time in addition to the prescriber for the medicines 
reconciliation and clinical review activities.  In this scenario you could redirect clinical 
pharmacist time to ward areas without a pharmacist prescriber and the algorithm for 
this model would then be different.  Alternatively, along Carter report principles, 
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removing the supply elements from the team may allow realignment of tasks to 
different staff groups, which then frees pharmacist time to undertake the prescribing.    
Other service delivery iterations are possible and so it is likely that the RSPWC will have 
to be revisited once the extent and shape of the impact of pharmacist prescribing and 
post-Carter service transformations are more fully understood.  This reflects the view of 
Gorin(98) that validation is an ongoing process and will never be a ‘job done’. 
 If the RSPWC is to remain relevant for more than a couple of years then the ability of 
operators to ‘bespoke’ the tool to explore the resource implications of different models 
will be necessary.  It is therefore proposed that there are two versions of the RSPWC 
published. The first will be the fully validated standard as described in Chapter 8.  All, 
but the essential local data entry fields of patient and bed numbers, length of stay and 
prescription size and type, will be locked and ‘un-editable’.  This then forms a baseline, a 
starting or reference point.  A second version of the RSPWC would have an increased 
number of editable fields but changes to service from this baseline would then be 
recognised as a departure from the validated version  and allow objective consideration 
of the potential service risks and benefits of doing so.  
However, since the definition of pharmaceutical care has remained unchanged for 
almost 30 years(2) and the delivery of pharmaceutical care is the primary objective then 
it would seem to follow that the elements of the RSPWC that are linked to that 
definition should remain fixed.  These are the tasks and the part of the tool which had 
the strongest consensus in the research (see Table 9.1).  The times, which are based on 
time and motion data, consensus and literature should remain constant. It is 
acknowledged, however, that as technology advancements are more widely 
implemented these too will in time require review.  It is, therefore , that the elements of 
the RSPWC that should be ‘editable’ are the staff group and grade to deliver the task, 
which will facilitate skill mix and, perhaps most importantly, the frequency with which 
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tasks are completed.  This is acknowledged throughout the profession and found in this 
study to be the greatest variable due to the patient acuity issues discussed previously.  
This would allow adaptation by patient groups relating to acuity and recognition of ‘out-
sourcing’ of specific functions by allowing the frequency to be zero.  This approach 
would be expected to allow sufficient flexibility for practical application in current 
service settings, whilst retaining the core elements on which consensus was reached.  
This will remind the manager that if a task is not to be done any longer, they need to 
consider either alternative options for service delivery, or identification and mitigation 
of risk. 
In summary, the aims and objectives of this study were achieved.  A validated workforce 
calculator has been developed, its transferability to other operators established and its 
applications identified.  The need for users to be able to make some modifications to the 
tool to ensure relevance to practice has been discussed. Finally, it is recognised that 
validation of the RSPWC is not a one-off activity and it will need to be reviewed in the 
light of changes to practice due to technological advancements and impact of the 
implementation of the Carter review.   
The final objective to be considered was that of the development of a validated tool 
which has been discussed fully in Chapter 8. 
The study results have been discussed in the context of the intended aims and 
objectives and this discussion now focuses on the consideration of their place in the 
published literature and their implications for pharmacy practice within the current 
political context. 
9.2 Discussion of study results in the context of the literature. 
Within the previous section the findings of this research were considered in the context 
of the fulfilment of study objectives and references were made to relevant literature as 
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part of that discussion.  A broader review of the results and their implications and place 
within the broader literature is now discussed.   
Across the wider healthcare workforce literature several parallels to this study can be 
found.  The methodology used has already been discussed in the context of WISN(23) 
and therefore the evidence-base nature of the approach used in the construction of the 
RSPWC has been demonstrated.  There is no published version of the application of 
WISN to the pharmacy workforce and, therefore, this study is novel in both its construct 
and findings.  Ghosh and Cruz(27) described their approach to workforce calculation in 
their work on nursing workforce in Oman.  As with the RSPWC, their calculator allowed 
the calculation of staffing requirements from a strategic perspective that could facilitate 
modelling of different workforce needs dependent on service structure, rather than a 
shift by shift, operational tool.  However, they have reported no evidence supporting 
validity or transferability of their calculator to different settings, which has been 
demonstrated for the RSPWC.  In addition the use of their calculator requires detailed 
data entry by individual users. 
Hughes et al.(30) demonstrated the impact of ‘admission, discharge and transfer’ (ADT) 
of patients on nursing workload.  Whilst their ‘multipliers’ for these activities are not 
fully evidenced, it was shown that nurses look after patients rather than beds and that 
increased numbers of ADTs were associated with increased workload.  Unlike Ghosh and 
Cruz(27) they built this into a tool to calculate operational staffing.  The impact of ADT 
on staff workload is reflected in the findings of the RSPWC study.  If the time required to 
deliver all tasks once for a single patient is considered, this amounts to 113 minutes.  Of 
this time 95 minutes (85%) are required for ADT activities (i.e. MR, POD check, initial 
review and endorsement of notes and drug chart, clinical check and supply of discharge 
medicines).  Each of the other tasks (subsequent review of notes, chart, patient 
counselling) would have to be completed five times to have the same impact.  Given the 
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average length of stay for in-patients in hospitals is falling(131) and that there is no 
agreement from UK  study participants as to the appropriate  frequency of patient 
review (see Tables 7.3 & 7.17-7.22)  it can be seen that the greatest consistent workload 
for pharmacists is also in ADT activities.  This adds to the justification of workload being 
calculated per patient admission, rather than by bed and,whilst there may be some 
value in perfecting the frequency of patient review figures in the RSPWC, the impact of 
this is unlikely to substantially change the overall value of resource identified 
The approach by the team led by Hurst(20) in the UK reflects that used in the 
development of the RSPWC;  their tool too has been demonstrated as applicable across 
multiple sites, although, unlike the RSPWC it can be used to calculate day to day 
resource requirements based on census and acuity measurements.  Of particular not, 
however, is the adoption of this work by the NHS Employers website as a standardised 
tool for identifying nursing workforce requirements(18).  This website does not have an 
equivalent for pharmacy yet and this may be a place for the RSPWC in the future. 
The approach recommended by Flynn, Kellagher and Simpson(31) also provides some 
direction on the possible applications of the RSPWC for the pharmacy profession.  Her 
paper suggested the triangulation of professional judgement with a calculator tool and a 
review of quality measures.  The RSPWC provides the tool, which can be used with the 
professional judgement of managers.  What is missing for pharmacy is agreed quality 
and outcome measures i.e. what does ‘good’ look like(21).  The risk as identified by 
Schoo et al.(32) is that if the development of these standard outcome measures is not 
established by the profession, sub-optimal measures will be externally imposed.   
Further consideration of this study in the light of the paper by Schoo(32) demonstrates 
that the priorities they identified for workforce calculation methods for AHPs have been 
addressed in the development of the RSPWC.  Namely, that it is simple to use, only 
requiring limited, available data to populate the calculator for individual settings.  It is 
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technically acceptable to the managers who will use it, i.e. it reflects the service they 
deliver.  It is comprehensible to lay users i.e. business managers can understand how it 
generates the values and, finally, it will be flexible in its application for this period of 
transformation. 
A key challenge for AHP workforce calculation identified by Schoo came back to the lack 
of consistency in service delivery models and, therefore, the belief that calculations have 
to be done at a local level which prohibits effective benchmarking, an opinion echoed by 
Rough(51,52).  This was reflected in the results of the qualitative part of this study, with 
participants suggesting that the RSPWC may not address the ‘nuances’ of a service.  
However, there is evidence that this challenge is unfounded and that clinical services are 
probably more alike than might at first be considered(36). 
The study by Onatade, Miller and Sanghera(36) ran concurrently with that of the 
validation of the RSPWC and they, therefore, describe a service provision that is 
contemporary to the development of the RSPWC.  This is important as much of the 
published literature are historical papers from the US, which may, therefore, not 
describe comparable services.   Their task list was independently compiled and matches 
the activities in the RSPWC, and the service they described in their introduction 
reflected that of contemporary practice at RSUH.  None of their participant sites were 
part of my study and so there is no ‘double counting’ of participants – their data could 
therefore further supports the results of the current study in terms of task/frequency 
consensus.  They demonstrated across three Trusts and seven different sites that the 
service description was consistent, but the staff resource to deliver it was widely 
different.  The statistically significant different elements they described were the 
frequency with which activities were completed, which reflects the data from my study.  
Reasons for these differences were not discussed, but the evidence presented identifies 
substantially higher staffing levels at those sites that delivered the activities most 
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frequently.  It therefore may be postulated that the higher frequencies of activity may 
be driven by already having the resource to deliver them.  A counter theory is that this is 
driven by patient need and maybe the different patient cohorts at their different sites 
warranted different levels of care, which has subsequently driven different staffing 
levels.  However, as demonstrated by Suggett and Marriott(45) and Hickson et al.(47), 
the means of consistently identifying patient specific pharmaceutical need has not been 
established and tools are not consistently applied.  The argument, once again, returns to 
demonstrating patient outcomes for the service provided.  This paper generates as 
many questions about the current delivery of pharmacy services in the UK as it provides 
answers; however, its results are supportive of those of the study validating the RSPWC, 
adding to its external validation.  
The work by O’leary, Stuchberry and Taylor(40) in the Australian pharmacy literature is 
closest to the development of the RSPWC in terms of tool construction and out-put.  
Once again the task list concurs with that in the RSPWC and many of the timings of these 
activities are aligned.  The frequency with which they complete these tasks is specified 
as daily in the Australian national standards(42) a level of clarity which is not found in 
the UK.  The RSPWC however extends this work to consider patient through-put (not just 
bed numbers) and the role of registered technical and support staff, as well as the 
delivery of medicines supply functions and allows calculation of staff for specific patient 
cohorts, as full wards or limited number business cases.   
When the literature relating to pharmacy productivity(35,48) is reviewed in the light of 
this study’s findings, a full comparison cannot be drawn.  The RSPWC effectively only 
provides one half of the equation, i.e. the workforce figures and not the output 
measures.  However, the basis of the productivity measures in both of these published 
studies(35,48) is the ‘budgeted staff costs’ and in neither paper is the method for the 
calculation of the baseline budget described or evidenced.  The RSPWC would, 
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therefore, allow a baseline staffing resource to be accurately calculated in a future 
productivity paper.  This would then need to be considered against an output data set to 
calculate productivity.  So whilst not adding to the literature in this field per se, the 
RSPWC may improve the quality of similar UK papers in the future.   
The validation of the RSPWC was a descriptive consensus study, conducted over 22 sites 
across the UK (excluding Northern Ireland) and consisted in the main part of acute 
hospital Trusts.  It was run in a parallel timeframe with the NHS benchmarking work(22) 
which allows a number of comparisons to be drawn and may result in a number of 
limitations.  Compared to the NHS benchmarking work mine was a smaller study (22 v 
157 participant sites).  The mean number of beds per participant site was larger in this 
study (1072 v 700 beds/trust).  This is a likely reflection of the prevalence in 
participation of acute and teaching hospitals. Of the evidence based pharmacy services 
described by Bond and Raehl(9) only medicines reconciliation is considered specifically 
in the NHS Benchmarking data, with a national average reported of 67% of patients 
receiving MR in 24 hours.  Of particular note is that, on average, trusts have 68 hours of 
pharmacist time per 100 beds each week.  If this is converted to beds/WTE pharmacist 
(AfC contracts 37.5 hours/week) this equates to 55 beds/pharmacist.  There is no 
indication of activity through these beds and this has already been discussed as being a 
methodology that underestimates resource(27,30).   
Accepting the inaccuracies in resource identification that is generated by the use of 
beds/pharmacist, comparison of this data across the literature and this study’s results is 
useful (see Table 8.2).  This serves to demonstrate the potential level of under 
resourcing in the pharmacy services across the NHS, the extent of the imbalance 
between London and the rest of the country and the relative place of the output from 
the RSPWC.  This also highlights the risks of using benchmarking data without robust 
outcome data with which to assess productivity.  .   
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Having discussed the study results in the context of the objectives and the broader 
literature it is also necessary to consider their implications for pharmacy practice within 
the current political climate. 
9.3 Discussion of implication of results for practice 
As has been previously described (see section 2.5) pharmacy practice literature suffers 
from a lack of consistency in service terminology and study methodology, making 
comparisons between results difficult.  The validation of the RSPWC has gathered, for 
the first time, a full set of time and motion data, from multiple sites, for the full scope of 
clinical pharmacy activities required to deliver pharmaceutical care to hospital in-
patients and, therefore, sets a benchmark for future comparison. 
The results of this study have been discussed in the context of its original aims and 
objectives, which have been demonstrated to be met.  Their place in and contribution to 
the body of literature on this subject has been considered, but what are the implications 
of these results in professional practice, within the current political context? 
Over the past four years there have been three key government reports into healthcare 
provision which set the backdrop for this research.  In 2013 the Francis Inquiry into the 
conduct of the Mid Staffordshire NHS Foundation Trust(132) identified many failings in 
care, resulting in over 400 preventable deaths at that hospital.  Identified causes of 
these failings were a focus on financial savings ahead of safe care, and a breakdown in 
the delivery of fundamental patient care.  Throughout this report the pharmacy 
profession is not mentioned at all, but there were several hundred references to the 
sub-optimal use of medicines.  The public inquiry was wide ranging and thorough and 
produced 290 recommendations to prevent similar events occurring at other 
organisations in the future.  The focus of these is patient care, which should be first and 
foremost in the mind of all healthcare staff.  There is consideration of the need for 
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strong leadership, governance and compliance with standards and recommendation 168 
specifies the need for ‘safe staffing levels’. 
Following that same year the Keogh report(129) was published on the investigations into 
the increased morbidity and mortality rates associated with reduced service levels at 
NHS hospitals at the weekends.  Amongst the ten standards of care that patients should 
expect, regardless of day or time of admission, two (Standards 3 & 9) related directly to 
pharmacy. Namely, patients should be reviewed by a multi-disciplinary team including 
pharmacy within 14 hours of admission and transfer of care should be efficient 
(admission and discharge supply of medicines).  The implementation of these standards 
was recommended by the end of the financial year 2016/17.  There were some early 
financial incentives for Trusts to establish the 7-day services through local 
commissioning projects, though the distribution of this funding varied from Trust to 
Trust.  Therefore, as reported in the results of this study, in some cases pharmacy 
service extension had to be implemented with no additional resource. 
Finally, in 2016, Lord Carter of Coles published his report into productivity within the 
NHS(21).  He identified many ‘unwarranted variations’ in practice and efficiency across 
the NHS generally and a number of specific work-streams were identified to address 
this, one of which focussed on hospital pharmacy services.  The basis of much of the 
evidence reviewed in this investigation was the data from the NHS Benchmarking 
Network’s Hospital Pharmacy project(22).  Staffing levels and service delivery metrics 
were considered and a benchmark (mean or mode depending on the criteria) was 
established.   
A pharmacy manager responsible for the safe use of medicines within a hospital 
environment, therefore, is faced with many challenges when identifying and deploying 
staff effectively, with limited national guidance on how to do so.  With the exception of 
medicines reconciliation requirements, there are no national standards which specify 
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the services that should be delivered, nor the frequency with which this should be done.  
As a consequence no staffing plan is identified for this service delivery. These decisions 
are based on local professional judgement and some sharing of practice, but 
fundamentally dependent on established budgets, many of which are historical.  How 
then do they ensure compliance with these three key reports – that pharmacy services 
are efficiently and productively delivered, in an equitable manner across the week, and 
that there are safe levels of staffing to ensure quality of care? The RSPWC could be seen 
as beginning to offer this structure to support managers. The RSPWC does not identify 
‘safe’ staffing levels as that was not within the scope of this study.  However, this is the 
first time that staffing levels to deliver the tasks associated with a modern clinical 
pharmacy service have been described.  The tasks required to deliver the service have 
been identified, how long they take has been reported and there is evidence from the 
literature that delivery of these tasks is associated with improved patient safety(9,10).  
This calculator allows a pharmacy manager to appraise their staffing levels against a 
validated tool.  In some cases this will identify a shortfall; the RSPWC will provide 
objective evidence to support requests for additional funding.  As Acres(37) identified 
this might not be forthcoming, but if the gap is known and credible, then informed 
conversations can begin regarding mitigating the risk associated with reduced staffing 
levels. In some cases this might identify apparent overstaffing of a department; the 
challenge to the pharmacy manager is then to demonstrate the productivity of their 
team or the increased acuity of the illness of the patients for whom they care.   
Whilst not disputing that unwarranted variations exist in the delivery of healthcare 
within the NHS the results of this study suggest the variation in pharmacy is not at the 
level of opinion on fundamental principles of pharmaceutical care, but on the delivery of 
this care with often insufficient staff resource.  The findings of this study and the 
validation of the RSPWC may not result in large increases in funding for hospital 
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pharmacy departments. They should, at a minimum, allow greater recognition of the 
issues of determining staffing levels and stimulate the profession into developing 
cohesive, evidenced-based approached to the delivery of safe and effective medicines 
use for the benefit of patients, within the staffing resource (both funding and personnel) 
available. 
9.4 Limitations of the study 
As with all research, limitations of the work can be identified.  When reflecting on this 
work, these limitations fall in to two areas; namely, the limitations of the study and its 
delivery and the limitations of the RSPWC.  These will be considered in turn, but first the 
presence of a non-UK participant will be discussed. 
9.4.1. Overseas participant 
As presented in the results (sections 7.1 and 5.3.2) there was one, non-UK participant 
included in the study population.  This is an apparent anomaly and requires explanation.  
The call for participants was issued through a number of professional forums including 
the UKCPA and RPS.  Whilst both of these organisations are UK based, both have 
international members.  As outlined in the Methods chapter (see 6.2.2), there were no 
exclusion criteria for this study, if inclusion criteria were met.  The participant from New 
Zealand responded to the call for participation during the feasibility study and was 
included as the inclusion criteria could be demonstrated.  At that time it was not known 
that there would only be one overseas participant.  Had others responded it may have 
validated the RSPWC internationally as well as nationally.  The consensus achieved was 
not influenced by the presence of this participant; they did not generate any outlying 
data.  Where the difference in their practice might have impacted on the development 
of the RSPWC, e.g. in mean timings calculated from participants’ data, they were 
excluded in the same way as the mental health trust was at this stage of the analysis, so 
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that the mean times were calculated from a homogenous (i.e. UK) population.  The 
strong parallels in the practice of clinical pharmacy between the UK and this site in New 
Zealand should be noted, though the fact that the participant is a UK ‘ex-pat’ pharmacist 
may have influenced this, along with the same challenges regarding frequency of activity 
being reported. In summary, this participant added to the population denominator, but 
did not adversely influence the results. 
9.4.2. Limitations of the study delivery 
Moving to the more common limitations associated with research projects, the most 
obvious limitation of the study is its sample size.  The study population was 22 sites, this 
compares to 156 in the NHS Benchmarking(22) work which ran concurrently with this 
research.  It might, therefore, not seem as ‘powerful’ data as the NHS benchmarking 
work to the casual observer.  The results and earlier discussion have demonstrated that 
this sample size is acceptable for the study methodology chosen and considers a 
different perspective on the delivery of pharmaceutical care from the benchmarking 
study. However, the parallel timeframes of the two projects might have impacted on 
participation in the RSPWC research.   Sites that were submitting data to the NHS 
benchmarking project might not have engaged with this study – there is something 
about ‘data fatigue’, that there is only so often individuals can summon the enthusiasm 
to participate in project work outside of the delivery of day to day services 
9.4.3. Limitations of the RSPWC 
The RSPWC has its own limitations and its use in practical situations needs to be made 
with due consideration of these limitations.  It has been tested only in the delivery of 
pharmaceutical care in general adult settings.  Applications to paediatrics and specialist 
settings such as renal or critical care have not been established.  The figures it generates 
are for all patients in ward settings across a full year period i.e. 24 hours per day, 7-days 
a week, and 52 weeks of the year.  As a consequence, the staff requirements may need 
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pragmatic pro rata modification by the user if services are not going to be delivered 
across the full 7 days, all year round.  This is of particular consideration when average 
length of stay for a patient cohort falls at 3 days or below (patients admitted on a Friday 
may have been discharged before Monday and so miss the pharmacy service).   
Justification of the tasks, times and frequencies which drive the algorithm behind the 
tool has been fully discussed already any user must therefore recognise that this is not 
an absolute answer to the question of staffing resource, but simply a justified starting 
point which provides an objective base for discussions around staffing levels.   
Another limitation to the RSPWC, which remains ill defined, is the impact of technology 
on service delivery.  The data gathered identifies a small number of trusts with 
implemented electronic prescribing and administration systems.  Despite many years of 
movement towards this aim, this remains a technology available to the few rather than 
the many(22).  Electronic prescribing and administration (ePMA) has two main effects 
on the delivery of pharmaceutical care.  It alters both how long it takes to deliver 
services and the model within which this is done.  From the data gathered here, some 
elements of practice may become more efficient, but some may take more time due to 
the nature of uploading the data into the electronic system and, therefore, the timings 
in the RSPWC will need to be reviewed against a future backdrop of ePMA being the 
‘norm’.  At this point the timings are a mean of those reported and so include both 
ePMA and non-ePMA sites.  Site numbers with ePMA were too small to produce an 
analysable subset.  The RSPWC is based on a ward-based pharmacy service, as 
described, where pharmacy staff work in skill mixed teams across geographical or 
specialist locations.  The widespread implementation of ePMA is likely to change that 
model as the technology will allow a more targeted service to be developed.  Gone may 
be the days of having to ‘trawl’ a ward of prescription charts to find the patients with 
newly prescribed or changed medicines, or for whom key medical parameters have 
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altered since the last review.  Some services may be able to be delivered remotely and 
others by dedicated, specialist teams with focussed activities e.g. discharge or 
therapeutic drug monitoring.  The tasks might not change, but how long they take and 
how often they are done and by whom will need to be re-calibrated in the light of 
mature ePMA systems.  
In addition, the impact of automated dispensing is not fully captured within this tool.  
Again, in this data set, only a small sample of sites with automated dispensing was 
described.  Analysis of dispensing times from these sites suggested a paradoxical 
increase in time to dispense a single item.  Automation should surely make it quicker.  
This was confirmed by local data collection at UHNM(133) where one site is automated 
and the other still wholly manual.  Of note, accuracy checking time was shorter on 
automated sites (again reflected in UHNM data), suggesting that the benefits of 
automation may be more about accuracy than speed.  This requires additional 
investigation across a larger sample size.  The data currently included is once again a 
mean time from across all respondents’ data and this will need to be revisited through 
larger sample sizes in the future, although the pressure of Carter may result in this being 
removed completely rather than being updated.  
Finally, a limitation of the tool which must be considered relates to the longevity of its 
validity.  The pharmacy profession and its delivery of pharmaceutical care is in the midst 
of a period of substantial change.  Many service models are changing in the light of the 
Lord Carter report(21) and in particular the impact of the increasing presence of 
pharmacist prescribers within in-patient services is as yet unknown.  The RSPWC will 
require re-validation in the ‘post-Carter’ era when the implications to the pharmacy 
workforce are better understood.   
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This study has been conducted in a ‘real-life’ setting and final considerations when 
discussing its findings are that of reflexivity and the implications of research conducted 
by a ‘researcher practitioner’.  These are considered in the following section. 
9.5 Reflexivity and the implications of a ‘researcher-practitioner’ 
The premise of professional doctorates, such as Doctor of Pharmacy is that knowledge is 
created from with practice and subsequently influences the future delivery of practice 
(134).  That being the case, it follows that research conducted in this manner is often by 
‘researcher-practitioners’ or ‘insider- researchers’ (134).  The implications of this on the 
outcomes of studies must be considered(135).  Strengths and weaknesses of research 
conduction in this manner exist(135) and are considered in the context of this study. 
Firstly with insider research there is the risk that one is too close to the subject and 
consequently cannot see the full picture, or that because one has too great an 
understanding at the start details are accepted as fact without further exploration. 
There is also the element that the desire for a positive outcome steers emphasis away 
from challenges which might suggest alternative or negative outcomes.  Moreover, the 
political influences within the workplace may drive the direction of research.  In the case 
of this study, had the tool been discredited then there might have been significant 
implications to staffing levels.  So the desire to 'prove at all costs' was mitigated by a 
transparent process and triangulation or corroboration of results from different 
independent sources. This removes the element of 'fix'. The 'closeness' issue was 
mitigated by the fact that although I was as the principal investigator of the study and a 
frequent user of the tool, I was not a principal developer. The early construction of the 
algorithm had been done by colleagues and in order to understand to tool in sufficient 
detail to validate all elements, I first had to unpick it and reconstruct it myself.  My 
assumptions weren't just made on historical knowledge but worked through from basic 
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principles.  
 
Another key challenge of being an ‘insider-researcher’ is that watching and observing 
your colleagues may, in itself, affect outcomes(135). In qualitative research this might 
well alter what people are saying to you. It is largely up to the reviewer to recognise this 
and draw their own conclusions. However, some active mitigation of this effect was 
taken in this study as the subjects of the investigation, whilst from the same profession, 
were not from the same organisation and so this effect was at a greater distance than 
when research is conducted from within a single department. 
 
There are however strengths in the ‘insider- researcher’ model.  Having an ‘expert’ 
researcher means that energy and time is not wasted in orientation or background -one 
'hits the ground running'. The ability to access subjects or data maybe greater than for 
an external researcher e.g. access to professional forums etc. and individuals  may be 
more willing to give time to a colleague that a stranger.  In my case, being part of the 
community of pharmacists gave me contacts for inviting participants which would have 
been difficult to identify from outside the profession for a small independent researcher.  
Finally the enthusiasm to deliver the project cannot be underestimated -in many ways 
the desire to succeed means that the job is completed  
A further consideration with regards to reflexivity in this study is borne from the 
ontological perspective taken that there was not one single reality and that the 
phenomenon of ‘delivery pharmaceutical care’ is subject to contextual influences.  The 
epistemological step is that data collection therefore had to be from the individuals 
involved in this phenomenon.  This led in turn to the methodological decision to use 
questionnaires and interviews to capture the data required.  These required a reflexive 
approach to this research and this is seen in both the development of the study 
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methods and in the results.  From a methods perspective reflexivity has run throughout 
the study, from concept to validation.  The RSPWC started as a calculator to simply 
identify pharmacy staff numbers to cover a ward, which progressed to its application to 
smaller discreet cohorts of patients to address the need to respond to business case 
submissions (this element is described in section 1.3).  From the feasibility study further 
modifications were made to both the RSPWC and the questionnaire design and this 
adaptation continued with the addition of the ‘exemplar patient’ section of the second 
round Delphi questionnaire, which was identified in an early qualitative interview.  As 
such this was an iterative process that it is wholly transparent and has added depth and 
quality to the results. 
The final reflexive strand is the socially contingent nature of the use of questionnaires 
and interviews.  There should be recognition that both participant response and 
researcher interpretation is driven by social contingency.  This means that the responses 
given will be subject to the participants’ personal views and experiences of the 
situations about which they are being questioned, including factors such as their 
perceptions about whom they thought they were speaking with and the potential use of 
the information they were sharing.  There be may a wish to present peer-acceptable 
views which may not fully reflect personal perspectives that might be articulated in 
other settings.    Their responses will also be affected by their views and opinions of the 
researcher asking the questions and the knowledge that this individual was associated 
with the site developing the calculator.  This might have made responses more positive 
than was really felt as it is always difficult to criticise children in front of their parents.  
Other factors such as the environment in which the interviews were conducted needs to 
be considered.  As telephone interviews, the researcher was unable to control this to 
the same extent for each participant.  Communication by telephone removes the non-
verbal communication which might have added additional insight in the researcher’s 
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notes, and the presence of colleagues in the room with the participant during the 
interview may have impacted on their answers to questions.  These considerations must 
be made when analysing the data in this type of study particularly in relation to the 
‘generalisability’ of the results.  However, the transparency of the reflexive approach to 
this work allows reviewers to judge the wider application of these findings for 
themselves. 
In summary, ‘insider’ or ‘practitioner’ research has inherent challenges based on social 
contingency and will be reflexive in nature.  In this research these have been 
acknowledged, mitigated where possible and presented in a transparent manner which 
allows a reviewer to consider the implications. 
 
9.6 Further work 
Results from this research have identified a number of future work streams for 
pharmacy.  These fall into three broad categories.   
Firstly those work-streams which might bring further clarification on the figures that 
drive the RSPWC algorithm and, therefore, its accuracy in calculating the resource 
required to deliver services.  This work could include further research on timings relating 
to the impact of ePMA and automated dispensing, but perhaps should first focus on the 
issue of how often tasks need to be done as this is the area with the least clarity from 
the existing study.  It is acknowledged that there probably never will be enough funding 
in the NHS for every patient to be reviewed in detail by the pharmacy team every day of 
their admission.  Accepting this reality, the need to identify those patients that need to 
be seen most appears to be a key challenge for the pharmacy profession and there 
appears to be a lack of clarity here about what is driving the ‘unwarranted variation’.  
The ‘need to be reviewed’ will be dependent on patient acuity, but also on the ‘value-
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added’ of the service, i.e. where are the greatest outcomes achieved.  The work by 
Suggett and Marriott(45) suggests that this might require a focus on more elderly 
patients (>80 years old) rather than on the more obviously critically ill on critical care 
units.  There is a need to establish, the ‘pharmaceutical’ acuity rather than medical 
acuity of patients and a greater understanding of how that changes during the course of 
an admission.    
 Secondly there is a need to explore the establishment of consistent, evidence based 
outcome measures for pharmaceutical care and reliable surrogate markers for these 
outcomes.  The work by Bond and Raehl(9,10) should be updated for modern UK 
services.  The definition of ‘what good looks like’(21) needs to be confirmed.  Linked to 
this is work to understand the outcomes of different models of care.  The variations in 
services have been postulated to be due to differences in delivery of care with limited 
resources.  Accepting that this is unlikely to change in the future, there is a need to 
identify which models of care are the most effective.   If we are to remove the 
‘unwarranted variation’ we want to choose the ‘right’ options, not just the ones that are 
cheapest or which receive greatest publicity. The Carter report has begun to define this 
with establishing certain ‘metrics’, though these are currently high-level organisational 
demographics, associating the numbers of staff and activities against 100 beds.  Is this 
really what should be defining ‘good’?  This has been challenged by professional leaders 
with suggestions made as to alternative measures(128) such as performance related to 
missed doses, patient experience and readmission.   Research to define, describe and 
measure this is needed. 
Finally, as identified by Gorin(98), validation is a continuum not a fixed point.  The 
RSPWC will need to be revisited when the impact of Carter and its resultant hospital 
pharmacy transformation is fully understood, recognising that hospital pharmacy is not 
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just about ward services, but with a greater understanding of how this and other 
elements will be delivered post Carter. 
In addition the transferability of this work to other allied health professions maybe 
should be explored as all these staff groups experience similar pressures and challenges.  
Initial steps to the sharing of this research with the AHPs at UHNM have begun. 
221 
 
10. Conclusions 
The RSPWC was developed to address a local need for an objective way to calculate 
staffing requirements for the delivery of pharmaceutical care to hospital in-patients. This 
study, through a ‘mixed-methods’ approach (including a two-round Delphi consensus 
study, an operator evaluation and qualitative interviews), across 21 independent 
hospital Trusts, UK-wide has demonstrated that this tool is both valid and transferable 
across different acute hospital settings.   
It captures for the first time, through strong consensus by participants, a description of 
the component tasks of a service to deliver pharmaceutical care.  The staff time required 
to deliver these was confirmed either through consensus or the identification of a 
‘national best representative’ figure.  In addition it re-affirms work of other teams 
relating to the challenges of how often these tasks should be done for individual 
patients.   For the purposes of the development and validation of this tool this was 
achieved through exploring practice using ‘exemplar patients’.  It is recognised not as 
perfection or the absolute answer to staffing calculation, but as a pragmatic and robust 
starting point on which future UK staffing decisions can be based. 
In addition to meeting the stated aims and objectives, results of this study have 
confirmed that ‘unwarranted variation’ exists within the NHS in the delivery of 
pharmaceutical care, particularly in relation to staffing levels.  It is proposed that this is 
not due to differences in opinion as to the service which should be delivered or how 
long they take, but rather to differences in how to do so when available staffing 
resources are insufficient to deliver the ideal service to all patients. 
The study has identified several future research work-streams. Firstly, these include the 
need to explore the current limitations of the RSPWC. This includes the impact of 
automation and electronic prescribing on productivity, its application to non-acute 
222 
 
hospital settings and the future impact of pharmacist prescribing activities.  In addition 
the need has been identified to demonstrate the patient benefit outcomes associated 
with the delivery of pharmaceutical care in the 21st century in the UK. 
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Appendix 1: Glossary of terms and abbreviations 
AfC Agenda for Change – the NHS employment framework which specifies terms 
and conditions of employment including a 9-point pay-scale against which all 
non-medical posts are graded. 
AHP Allied Health Professions. A term used to refer to registered health 
professionals who are not doctors or nurses e.g. physiotherapists, pharmacists, 
occupational therapists, pathologists etc. 
AKI Acute kidney injury.  The temporary reduction in kidney function in response to 
illness or drug use. 
ATC Adjusted treatment cost. An expression used in the Lord Carter report to 
identify the cost of delivering care for one WAU. 
Benchmarking A process by which an organisation compares elements of its service with those 
of a peer to understand its relative place in terms of performance or 
productivity. 
CD Controlled Drug.  A medicine, the storage, prescribing, supply and 
administration of which is controlled under the Misuse of Drugs Act 1971. 
 
Clinical 
interventions 
When used in the context of clinical pharmacy practice these are activities 
conducted by a pharmacist which results in amendment of prescribed 
medicines to improve safety or efficacy of their use. 
Clinical 
Pharmacy 
The science and practice of rational medicines use – ensuring that it is safe, 
effective and cost-effective. 
Clinical 
verification of 
prescribed 
medicines 
This is the process by which a pharmacist reviews a medicine prescribed for a 
patient to ensure that the dose, form, administration is appropriate and that 
the prescription meets legal and local prescribing standards. 
Consensus General or widespread agreement. 
 
CQUIN Commissioning for Quality and Innovation.  A process whereby a health 
commissioner associates a portion of funding with the achievement of specified 
quality or innovation metrics. 
Delphi 
technique 
A method of generating consensus amongst a group of experts.  First used by 
the Rand corporation in the 1950s, but now accepted in to social and health 
research. 
De-prescribing The act of stopping medicines deemed to no longer demonstrate a positive 
benefit v risk ratio for an individual patient. 
Drug related 
problem 
Problems experienced by patients when using medicines for health 
improvement. 
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ELD Existing local data.  Service activity data which is routinely collected by a 
pharmacy manager to describe their staff activity. 
ePMA Electronic prescriptions and medicine administration.  A computer system 
designed to facilitate the paperless prescribing and administration of medicines.  
These facilitate improved safety, quality of records, information access in the 
use of medicines within an organisation. 
Foundation 
Trust 
An NHS trust which has met the required criteria for independence from  
Department of Health control and given the freedom to conduct business 
outside of NHS restrictions, though regulated by an independent regulator 
‘Monitor’. 
Frailty The degree of vulnerability of patients to ill health.  Commonly associated with 
old age. 
 
High risk 
medicines 
Those medicines considered to be high risk for the occurrence of adverse drug 
reactions. 
 
LOS Length of stay – the time a typical patient in a cohort will spend in hospital per 
admission. 
 
MDS Monitored dosage system.  A method of dispensing medicines into container 
with compartments allowing identification of medicines that should be taken at 
specified times and days to facilitate administration of medicines by lay 
individuals. 
MMT Medicines Management Technicians.  Registered pharmacy technicians 
employed to work at ward level, to engage with patients and ward staff to 
ensure that medicines are available for safe and timely administration.  Their 
role includes completion of MR on admission, ordering of medicines for in-
patient and discharge use, educating patients on the use of their medicines and 
supporting the ward team in the safe use and storage of medicines. 
MR Medicines reconciliation – this is the process of ensuring that information 
relating to the medicines required by a patient for managing their health 
conditions is accurately transferred between health professionals when a 
patient moves setting i.e. on admission to or discharge from hospital. 
Multi-morbid 
patients 
Patients with three or more concomitant illnesses. 
 
‘National best 
representative 
figure’ 
The value identified for how long a pharmaceutical care task takes to takes to 
complete. This is based on triangulation of data from a number of sources 
identified through the research. 
 
NBM Nil by mouth. The required state of a patient who is unable to tolerate oral 
intake of food, drink, medicines for surgical or medical reasons. 
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NHS Trust The legal body employing staff and delivering commissioned health care in a 
specific locality – these may be hospital or community based organisations. 
NICE National Institute of Health & Care Excellence.  A UK organisation tasked with 
reviewing the use of medicines and medical technology to ensure cost effective 
practice and equity in access to such products across the UK.  They conduct 
appraisals of products, assess their place in practice and issue guidance to 
support best practice. 
OSCE Objective Structured Clinical Examination.  A method of assessing competence 
of practitioners in practical activities/skills required for the effective delivery of 
a service. 
Patient flow The movement of patients through a hospital from arrival at the emergency 
department, transfer to in-patient ward and subsequent discharge back into the 
community.  
 
Pharmaceutical 
acuity 
The degree to which a patient is in need of the specialist in-put of a clinical 
pharmacy team, determined by the combination of their underlying health 
status and the complexity of the medicines they are prescribed. 
 
Pharmaceutical 
care 
Ensuring the safe use of medicines, specific to individual patient situations with 
the purpose of achieving specified health outcomes. 
PODs Patient’s Own Drugs.  Those medicines which the patient has brought into 
hospital from home, or has been dispensed for the use of a specific named 
patient. 
Post-take ward 
rounds 
The consultant-led ward round which occurs in the first 12 hours after a patient 
has been admitted to hospital. 
 
RAG Red, amber, green.  A rating system used in common practice to identify areas 
which require improvement (red), those which meet standards (green) and 
those which either is on route to improvement or failure depending on the 
direction of movement in successive ratings, amber. 
Reflexivity The phenomenon of human behaviour being influenced by individuals 
experience, culture, education and environment and the consideration of how 
this impacts on the conduct of research activities. 
RPS 
 
 
Royal Pharmaceutical Society – a professional representative body for 
pharmacists, regardless of sector of employment.  Establishes national 
standards for practice and practitioners. 
 
 
RSPWC Royal Stoke Pharmacy Workforce Calculator 
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RSUH Royal Stoke University Hospital – the acute hospital provider in.  Linked with 
Keele University as a teaching hospital.  Part of UHNM NHS Trust. 
Shelford Group A representative body comprising of the ten leading NHS multi-specialty 
academic healthcare organisations. They aim to achieve excellence in clinical 
research, education and patient care and provide system-wide leadership for 
the benefit of patients. 
SHPA Society of Hospital Pharmacists of Australia.  A professional representative body 
for hospital pharmacists in Australia 
SSU Short stay unit. A hospital in-patient ward with an length of stay for patients 
typically less than 48 hours. 
STP Strategic Transformation Partnerships – geographical grouping of healthcare 
organisations, working collaboratively to improve quality and efficiency of 
health services for their local populations. 
TDM Therapeutic drug monitoring.  The monitoring of blood levels of drugs whose 
action or toxicity is dependent or predicted by the achievement of specific 
concentrations of the drug in the blood system. 
TTO To take out – medicines dispensed for a patient to take home with them on 
discharge (interchangeable with TTA -to take away or TTH- to take home). 
UHNM University Hospitals of North Midlands NHS Trust.  The NHS Trust delivering 
healthcare in North Staffordshire and neighbouring counties, includes RSUH and 
County Hospital (CH), Stafford. 
UKCPA United Kingdom Clinical Pharmacy Association – a membership organisation for 
pharmacists working in ‘clinical pharmacy’.  These practitioners work in both 
hospital and community settings and the Association provides peer support, 
education and training and opportunities for establishing and sharing best 
practice. 
WAU Weighted activity unit.  An expression used in the Lord Carter report to identify 
one in-patient admission. 
WHO World Health Organisation. An international organisation committed to 
improving global healthcare delivery. 
Winter 
pressures 
The increased use of health care by a local community during the winter 
months, caused by increased levels of illness due to influenza, norovirus or falls 
due to icy ground conditions. 
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WTE Whole time equivalent.  A term referring to the employment of a member of 
staff for hours equivalent to the expected full time employee.  Part time 
employee hours are expressed as a decimal of this i.e. 1.0WTE = 37.5 
hours/week an employee working 15 hours/week = 0.4WTE. 
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Appendix 2: Original version of the RSPWC 
 
beds
Average length of stay 
Extra number of patients per year based on beds and length of stay #DIV/0! per year
0 per year 0.00 per week
0 per year 0.00 per week
#DIV/0! per year ##### per week
CLINICAL ACTIVITY
ACTIVITY
STAFF GROUP 
REQUIRED TO 
PERFORM ACTIVITY
TIME TAKEN 
ON AVERAGE 
(per 
prescription in 
mins)
ESTIMATED NUMBER OF 
OCCASIONS  ACTIVITY 
TAKES PLACE PER 
ADMISSION
TOTAL TIME 
REQUIRED FOR 
ADDITIONAL 
CASES PER 
WEEK (mins)
TOTAL TIME 
REQUIRED FOR 
ADDITIONAL 
CASES PER 
WEEK (hrs)
Obtaining Drug History  MMT 8 1 #DIV/0! #DIV/0!
Check of Drug History Pharmacist 2 1 #DIV/0! #DIV/0!
Check of PODs MMT 5 2 #DIV/0! #DIV/0!
Clinical Review of Notes Pharmacist 5 2 #DIV/0! #DIV/0!
Review of Blood results Pharmacist 1 2 #DIV/0! #DIV/0!
Initial review of Chart Pharmacist 5 1 #DIV/0! #DIV/0!
Initial endorsing of Chart Pharmacist 2 1 #DIV/0! #DIV/0!
Interventions Pharmacist 5 1 #DIV/0! #DIV/0!
Subsequent review of  Chart Pharmacist 2 2 #DIV/0! #DIV/0!
Subsequent endorsing of Chart Pharmacist 0.5 2 #DIV/0! #DIV/0!
Completion of Paperwork Pharmacist 2 2 #DIV/0! #DIV/0!
Ordering of Non Stocks Pharmacist 2 2 #DIV/0! #DIV/0!
Counselling Pharmacist or MMT 5 1 #DIV/0! #DIV/0!
Transcription of TTOs Pharmacist 5 0 #DIV/0! #DIV/0!
Clinical Check of TTO Pharmacist 5 1 #DIV/0! #DIV/0!
TOTAL #DIV/0! #DIV/0!
Booking in ATO 2.5 1 #DIV/0! #DIV/0!
Dispensing ATO or Technician 20 1 #DIV/0! #DIV/0!
Checking ACT 8 1 #DIV/0! #DIV/0!
TOTAL #DIV/0! #DIV/0!
Booking in ATO 2.5 1 #DIV/0! #DIV/0!
Triage Pharmacist 5 1 #DIV/0! #DIV/0!
Dispensing ATO or Technician 20 1 #DIV/0! #DIV/0!
Checking ACT 8 1 #DIV/0! #DIV/0!
TOTAL #DIV/0! #DIV/0!
GRAND TOTAL #DIV/0! #DIV/0!
REQUIRED STAFF GROUP
GRADE  REQUIRED 
(According to 
speciality needs)
TOTAL TIME 
REQUIRED 
FOR 
ADDITIONAL 
BEDS PER 
WEEK (mins)
TOTAL TIME 
REQUIRED FOR 
ADDITIONAL BEDS 
PER WEEK (hrs)
WTE REQUIRED 
FOR 
ADDITIONAL 
ACTIVITY
MID POINT OF 
GRADE (+22% 
oncost)
ATO 2 #DIV/0! #DIV/0! #DIV/0! 19338
TECHNICIAN 4 #DIV/0! #DIV/0! #DIV/0! 25178
MMT/PHARMACIST 5 #DIV/0! #DIV/0! #DIV/0! 29066
PHARMACIST 7 #DIV/0! #DIV/0! #DIV/0! 43354
CLINICAL STAFF TOTAL
#DIV/0!
Template for Pharmacy Time for  Business Cases
 © University Hospital of North Staffordshire NHS Trust. All rights reserved 2014.
Extra number of beds opening as a result of business case
TOTAL COST FOR CLINICAL PHARMACY SERVICE
AT DISCHARGE
INITIAL
Extra number of elective patients per year as a result of business case:
Extra number of emergency admissions per year as a result of business case
Extra number of elective patients & emergency admissions per year as a result of 
business case
CLINICAL ACTIVITIES
DISPENSING
#DIV/0!
WTE REQUIRED 
FOR ADDITIONAL 
ACTIVITY
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
COST
#DIV/0!
#DIV/0!
#DIV/0!
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Appendix 3:  Feasibility study questionnaire 
Pharmacy Staffing Questionnaire  
This has 4 sections; please complete each one to the best of your knowledge.  If you do not have data on a particular aspect please complete as 
‘no data available’. 
Section 1:  Tasks performed for delivery of pharmaceutical care 
This section identifies the key tasks completed during the provision of pharmaceutical care.  For each task identified below please complete the 
following grid using the key and the sample answer below 
Tasks: 
Direct patient care activities completed 
for each patient admission 
Identify if this 
task is 
completed by 
your Pharmacy 
Team for each 
patient  
 
 
 
 
Identify staff 
group required 
to perform task 
at your Trust 
 
Pharmacist (P) 
MMT 
ATO 
Technician (T) 
ACT 
How long do you think this 
activity takes to complete 
on average (per prescription 
in mins)? 
 
NB This data can be: 
1. Existing local data (ELD) 
2. Data collected specifically 
in response to questionnaire 
(DC)  
3. Best Guess (BG) 
4. Not Known (NK) 
Please estimate number of 
occasions the task is 
completed per admission. 
 
Please identify if this is 
dictated by personal practice 
(PP) or by departmental 
SOP (SOP) 
 
 
 
Sample Answer: 
Medicines Reconciliation (pharmacy 
completed and signed off by pharmacist 
√ P and MMT ELD 10 SOP 1 
 242 
 
Direct patient care activities completed 
for each patient admission 
Identify if this activity  
is completed by your 
Pharmacy Team for 
each patient  
Identify staff 
group required 
to perform 
activity at your 
Trust 
How long do you think this 
activity takes on average 
(per prescription in mins)? 
Please estimate 
number of occasions 
activity takes place per 
admission. 
Medicines Reconciliation (pharmacy 
confirmed and signed off) 
    Check of PODs 
    Clinical Review of Notes 
    Review of Blood results 
    Initial review of Drug Chart 
    Initial endorsing of Drug Chart 
    Subsequent review of Drug Chart 
    Subsequent endorsing of Drug Chart 
    Completion of Paperwork 
    Ordering of Non Stocks 
    Clinical Check of TTO 
    Talking to patient about their medicines 
    Making interventions on patient care 
    DISPENSARY BASED 
Booking on to tracker system 
    Dispensing 
    Checking 
    TTO (ward or dispensary based) 
Booking onto tracker system 
    Triage (Clinical Check) 
    Dispensing 
    Checking 
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If you think pharmacy teams should routinely complete additional direct patient care tasks that are not identified above, please note them here 
and provide the same detail about them using the grid below 
Additional activities routinely performed but not listed above 
Direct patient care activities completed 
for each patient admission 
Identify if this activity  
should be completed 
by your Pharmacy 
Team for each patient  
Identify staff 
group required 
to perform 
activity at your 
Trust 
How long do you think this 
activity should take on 
average (per prescription 
in mins)? 
Please estimate 
number of occasions 
activity should take 
place per admission. 
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Section 2:  Pharmacy resource to deliver ward pharmacy service 
If faced with the following scenarios please identify what resource you would request to deliver your ward service in full time equivalents (fte) of 
different staff grades eg 1.0 fte Band 6 pharmacist, 0.5 fte band 5 technician and what issues you would take into consideration 
1. A new general medical ward is planned to open. This will have 28 beds and an average length of stay of 5 days.  You have to identify the pharmacy 
staff (fte) required to deliver your standard ward based service. 
 
 
2. An existing 28 bed general medical ward with average length of stay of 4 days is being converted to a short stay (48 hour) unit.  What impact will this 
have on your pharmacy service and what if any additional staff would you request? 
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Section 3: ‘Non-operational Time’ 
 In most roles, pharmacy staff will not be engaged in direct patient care for the entirety of their working day- a certain amount of non-
operational ( ie other than ward and dispensary) activities are required  to maintain staff employment and need to be recognised within a whole 
time equivalent exists.  This section is identifying the average non operational commitment for each fte.  
Staff grade under Agenda 
for Change (AfC) 
Travel time ie 
department-ward 
(mins/day) 
Mandatory 
training 
(minutes/ 
MONTH) 
Professional 
training eg 
diploma 
(Mins/week) 
Departmental or 
MDT meetings 
(mins/week) 
Rest time  
due to on-call 
Other (please 
specify) 
Pharmacist AfC 8a (& above)       
Pharmacist AfC 7       
Pharmacist AfC 6       
Technician Band 5       
Technician Band 4       
ATO Band 3 &2       
 246 
 
Section 4:  Now we would like some information about your hospital to put the other data into context 
a) Please tick which of the following describes your hospital (please tick all that apply)  ⃝ Foundation Hospital Trust    
⃝ Non Foundation Hospital Trust ⃝ Private Hospital  ⃝ Prison Hospital         ⃝ Tertiary referral unit   ⃝ Teaching Hospital     
⃝ District General Hospital    ⃝ Intermediate Care ⃝ Mental Health Unit  
b) Which specialities are practiced at your Trust? 
 
⃝ Acute Medicine  ⃝ General Medicine ⃝ Respiratory  ⃝ Gastroenterology  ⃝ Endocrinology  ⃝ Neurology  
⃝ Stroke  ⃝ Frail Elderly   ⃝ Cardiology  ⃝ Renal    ⃝ Paediatrics  ⃝ Orthopaedic   
⃝ Critical Care    ⃝ Neurosurgery  ⃝ CT Surgery      ⃝ General surgery ⃝ Gynaecology  ⃝ ENT   
⃝ Vascular Surgery   ⃝ GI surgery  ⃝ Obstetrics  ⃝ Rehabilitation  ⃝ Long stay elderly ⃝ Psychiatry 
 
c) How many in-patient beds in your Trust ............................................... 
 
d) How many pharmacy staff employed at Trust:  Pharmacists ......  Technicians  ......  ATO ........ 
 
e) Location  of your Trust  - UK Home Nation  ⃝ Yes  ⃝ No       
If yes please specify  ⃝ Wales  ⃝ England   ⃝ Scotland ⃝ Northern Ireland    
If no please specify ................................................................................. 
Please now save a copy of this for your records and return a copy to r.bednall@nhs.net.  Thank you for your participation in Part 1 of this study.  
You will shortly receive a copy of the Royal Stoke Pharmacy Workforce Calculator as Part 2 of this project.  You will also be asked to confirm or 
amend your responses to parts 1 and 3 of this questionnaire in the light of the data presented once all first round results are available. 
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Appendix 4: Feasibility study participant information sheet  
Participant Information Sheet 
Study title: Evaluation of the Royal Stoke Workforce Calculator – Feasibility Study 
Invitation 
You are being invited to take part in a research study. You do not have to take part 
but before you decide, it is important for you to understand why the research study is 
being done and what it will involve. Please take time to read the following information 
carefully and discuss it with others if you wish. My name is Ruth Bednall, I am 
Doctorate in Pharmacy student at Keele University and I am doing this research 
study as part of this degree. Ask me (ruth.bednall@uhns.nhs.uk) if there is anything 
that is not clear or if you would like more information. Take time to decide whether or 
not you wish to take part.  
What is the purpose of the study? 
The Royal Stoke Pharmacy Workforce Calculator (RSPWC) was developed by the 
Pharmacy Department at the Royal Stoke University Hospital.  Locally this tool has 
proved an effective method of identifying the pharmacy resource required to deliver 
pharmaceutical care and securing funding through the business case process to 
employ the necessary staff.   This study seeks to assess its reliability and usability 
when applied to the ward pharmacy services of other hospital sites. 
Why have I been chosen? 
You are being invited to take part in this research study because you responded to 
the invitation issued through a professional forum, expressing an interest to be part 
of the study. 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you choose to take part you will 
first be asked to confirm your consent and you can still withdraw at any time. You do 
not have to give a reason.  
What will happen to me if I take part and what do I have to do? 
If you decide to take part you will be invited to contribute in three parts. 
Part 1: This is a questionnaire that identifies  
a) tasks that are performed by your staff in the course of their provision of 
pharmaceutical care 
b) what resource you currently request to deliver specific services 
c) ‘down time’ in an average working week 
d) Demographic information about your hospital 
You will be required to complete and return this questionnaire by email. 
Part 2: On receipt of the completed questionnaire you will be sent a copy of the 
RSPWC and asked to use it to calculate the pharmacy resource that would be 
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required to deliver services in 3 different scenarios.  Once calculated this information 
will be emailed to the investigator and you are then free to continue using the 
RSPWC for your own purposes. 
 
Part 3: On receipt of your calculations, if you have identified an interest in continued 
participation, we will send you a final questionnaire to appraise your views of the use 
of the RSPWC and its perceived or actual benefits/disadvantages to your 
department. 
What are the possible disadvantages and risks of taking part? 
We are not aware of any disadvantages or risks to you in taking part in the study.  
What are the possible benefits of taking part? 
You will have access to the RSPWC tool to use for your own workforce planning 
purposes. 
What if there is a problem or something goes wrong? 
You can contact me (ruth.bednall@uhns.nhs.uk) if you wish to complain, or have any 
concerns about any aspect about any way you have been approached or treated 
during the course of this study. I will consider such reports promptly and take 
appropriate action immediately. If you feel that your complaint has not been handled 
to your satisfaction you can contact my supervisor (Dr Simon White]) at 
(s.j.white@keele.ac.uk).  Alternatively, you can contact the Chair of the School of 
Pharmacy Research Ethics and Governance Committee (Dr Judith Rees) at 
j.a.rees@keele.ac.uk.  
Who will have access to information about me or my department? 
All the information that we collect about you during the course of the research will be 
kept strictly confidential and no one outside the project will be allowed access to it. 
Electronic data containing personally identifiable information about you will only be 
stored on password-protected media that only I and my supervisor (Dr Simon White) 
have access to. Hardcopies of data and other documentation containing personally 
identifiable information about you will be kept secure in a locked cupboard that only 
my supervisor and I have access to. At the end of the study all data and documents 
containing personally identifiable information about you will be destroyed. You will 
not be able to be identified in any reports or publications. You will have access to 
your data benchmarked against other participant sites. 
How will information about me be used? 
The results (including anonymised short direct quotes) will be included in a research 
report as part of my doctoral degree in pharmacy at Keele University, and may 
subsequently be published as research papers in academic journals and presented 
at conferences. No individual person or organisation will be identifiable in any direct 
quotes, reports, papers, presentations or summaries. The results of the study might 
also be used for additional or subsequent research. 
Who is organising and funding the research? 
The study is being organised and funded by the School of Pharmacy at Keele 
University and the University Hospitals of North Midlands (UHNM) NHS Trust. 
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Who has reviewed the study? 
The research study has been approved by Keele University School of Pharmacy 
Research Ethics and Governance Committee and the UHNM Research and 
Governance team. The study will be registered with the Clinical Audit Departments at 
participating Trusts 
  
Further Information and Contact Details  
If you have any questions or require any further information, either now or at any 
time during the study, please contact me (Ruth Bednall) at 
ruth.bednall@uhns.nhs.uk  Alternatively, you can contact me in writing at the 
Pharmacy Department, Royal Stoke University Hospital, Newcastle Road, Stoke on 
Trent, ST4 6QG 
 Thank you for taking time to read this 
information. 
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Appendix 5: Feasibility Consent Form 
Consent Form 
Title of Project:  
Evaluation of the Royal Stoke Workforce Calculator – Feasibility Study 
Name of Principal Investigator: Ruth Bednall      
Please tick box 
1 I confirm that I have read and understand the information sheet for the above 
study and have had the opportunity to ask questions. 
□ 
2 I understand that my participation is voluntary and that I am free to withdraw at 
 any time. 
 
□ 
3 I agree to take part in this study 
□ 
4 I understand that data collected about me during this study will be anonymised  
before it is submitted for publication. 
□ 
5 I agree to allow the data collected to be used for future research projects 
□ 
___________________ 
Name of participant 
________________ 
Date 
__________________ 
Signature 
Ruth Bednall________________  
Researcher 
27/2/15________ 
Date 
Ruth M Bednall 
Signature 
1 copy for participant, 1 copy for researcher 
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Appendix 6:  Research and Ethics approvals 
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Email trail from Dr D Clements, R&D Manager UHNM 
Some advice please pharmacy workforce calculator project 
 
> On 11 Feb 2016, at 14:44, Clement, Darren (RJE) UHNS <Darren.Clement@uhns.nhs.uk> 
wrote: 
> 
> Hi Ruth 
> Based on what you described to me this is not a piece of research and as such does not 
require NHS R&D Approval. 
> 
> In terms of the IP side of things I've cc'd our Commercial Development Manager who 
will  pick this up with you. 
> 
> Regards 
> Darren 
> 
> 
> Dr Darren Clement 
> Research and Development Manager 
> Honorary Senior Research Fellow - Keele University 
> 
> 
> Research and Development Department 
> Academic Research Unit 
> Courtyard Annexe - C Block 
> Royal Stoke University Hospital 
> University Hospitals of North Midlands NHS Trust Newcastle Road, 
> Staffordshire, ST4 6QG 
> Tel: 01782 675379 
> PA: louise.barlow@uhns.nhs.uk 
> 
 
> -----Original Message----- 
> From: Bednall, Ruth (RJE) UHNS 
> Sent: 11 February 2016 14:39 
> To: Clement, Darren (RJE) UHNS 
> Cc: s.j.white@keele.ac.uk; e.r.mills@keele.ac.uk 
> Subject: RE: Some advice please pharmacy workforce calculator project 
> 
> Hi Darren 
> 
> Thanks for your time to discuss this project - your advice was very much appreciated. 
> 
> Please could I ask you to confirm the outcome of our discussion in writing/email for my 
records ie that the nature of the project is service evaluation and as such does not require 
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NHS management approval through the R&D process. 
> On final query, please can you advise if there is a specific template or document I need to 
complete to clarify the intellectual property rights on this work - in discussion with my tutors 
we have agreed that the calculator tool, developed at RSUH 'belongs' to UHNM but the 
research to validate 'belongs' to Keele University.  Can you advise how I formalise this 
agreement please? 
> 
> 
> Best Regards 
> 
> Ruth 
> 
> Ruth Bednall MSc MRPharmS 
> Pharmacy Team Leader, Specialised Division 
> 
> 
> Pharmacy Department 
> Main Building 
> Royal Stoke University Hospital 
> University Hospitals of North Midlands NHS Trust Newcastle Road, 
> Stoke-on-Trent, Staffordshire, ST4 6QG 
> Tel: 01782 67451501782 674515 
> Email: ruth.bednall@uhns.nhs.uk 
> 
> -----Original Message----- 
> From: Bednall, Ruth (RJE) UHNS 
> Sent: 07 February 2016 21:42 
> To: Clement, Darren (RJE) UHNS 
> Subject: Some advice please pharmacy workforce calculator project 
> 
> 
> Hi Darren 
> 
> I  am aware that Kate Ford has discussed this project with you, but I would appreciate a 
little of your time to discuss it in person.  My problem lies with the fact that the project 
doesn't fit into a 'typical' type if research an so the 'normal' processes for authorisation don't 
really work. I'd like to discuss my options with you to see if there's any alternate to the IRAS 
or audit process. 
> 
> Can you let me know when might be convenient? Telephone conversation is fine. 
> 
> Best Regards 
> 
> Ruth 
> Ruth Bednall MSc MRPharmS 
> Pharmacy Team Leader, Specialised Division 
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Appendix 7: Main study Part 1: Questionnaire 1 
Pharmacy Staffing Questionnaire  
This has 4 sections; please complete each one to the best of your knowledge.  If you do not have data on a particular aspect please complete as 
‘no data available’. 
 
Section 1:  Tasks performed for delivery of pharmaceutical care 
 
This section identifies the key tasks completed during the provision of pharmaceutical care.  For each task identified below please complete the 
following grid using the key and the sample answer below 
 
Tasks: 
Direct patient care activities completed 
for each patient admission 
Identify if this 
task is 
completed by 
your Pharmacy 
Team for each 
patient  
 
 
 
 
Identify staff 
group required 
to perform task 
at your Trust 
 
Pharmacist (P) 
MMT 
ATO 
Technician (T) 
ACT 
How long do you think this 
activity takes to complete 
on average (per prescription 
in mins)? 
 
NB This data can be: 
1. Existing local data (ELD) 
2. Data collected specifically 
in response to questionnaire 
(DC)  
3. Best Guess (BG) 
4. Not Known (NK) 
Please estimate number of 
occasions the task is 
completed per admission. 
 
Please identify if this is 
dictated by personal practice 
(PP) or by departmental 
SOP (SOP) 
 
 
 
Sample Answer: 
Medicines Reconciliation (pharmacy 
completed and signed off by pharmacist 
√ P and MMT ELD 10 SOP 1 
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Direct patient care activities completed 
for each patient admission 
Identify if this activity  
is completed by your 
Pharmacy Team for 
each patient  
Identify staff 
group required 
to perform 
activity at your 
Trust 
How long do you think this 
activity takes on average 
(per prescription in mins)? 
Please estimate 
number of occasions 
activity takes place per 
admission. 
Medicines Reconciliation  
    Check of PODs 
    Clinical Review of Notes 
    Review of Blood results 
    Initial review of Drug Chart 
    Initial endorsing of Drug Chart 
    Subsequent review of Drug Chart 
    Subsequent endorsing of Drug Chart 
    Completion of Paperwork 
    Ordering of Non Stocks 
    Clinical Check of TTO 
    Talking to patient about their medicines 
    Making interventions on patient care 
    DISPENSARY BASED 
In-patient Medicine Supply (whether that as non-stock or as one stop dispensing) 
Booking on to tracker system 
    Dispensing 
    Checking 
    TTO (ward or dispensary based) 
Booking onto tracker system 
    Triage (Clinical Check) 
    Dispensing 
    Checking 
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If you think pharmacy teams should routinely complete additional direct patient care tasks that are not identified above, please note them here 
and provide the same detail about them using the grid below 
Additional activities routinely performed but not listed above 
Direct patient care activities completed 
for each patient admission 
Identify if this activity  
should be completed 
by your Pharmacy 
Team for each patient  
Identify staff 
group required 
to perform 
activity at your 
Trust 
How long do you think this 
activity should take on 
average (per prescription 
in mins)? 
Please estimate 
number of occasions 
activity should take 
place per admission. 
     
          
     
     
     
     
     
Does your Trust have automated dispensing? (Please circle) Yes No 
Does your Trust have electronic prescribing? (Please circle) Yes No 
What is the average number of items on an in-patient prescription at your Trust?  
 Standard item CD item Monitored dosage item 
How long does it take to dispense 1 item at your Trust?(mins)    
How long does it take to  accuracy check 1 item at your Trust?(mins)    
What percentage of your discharge medicines are in the above categories    
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Section 2:  Pharmacy resource to deliver ward pharmacy service 
 
If faced with the following scenarios please identify what resource you would request to deliver your ward service in full time equivalents (fte) of 
different staff grades eg 1.0 fte Band 6 pharmacist, 0.5 fte band 5 technician and what issues you would take into consideration 
 
1. A new general medical ward is planned to open. This will have 28 beds and an average length of stay of 5 days.  You have to identify the pharmacy 
staff (fte) required to deliver your standard ward based service. 
 
 
 
 
 
2. An existing 28 bed general medical ward with average length of stay of 4 days is being converted to a short stay (48 hour) unit.  What impact will this 
have on your pharmacy service and what if any additional staff would you request? 
 
 
 
 
 
 
3. Finally, you are approached by a directorate manager about to submit a business case for 200 new Bariatric Surgical patients.  No new beds will be 
opened, these cases will go through and existing 28 bed surgical ward with a length of stay of 3 days.  He asks what resource implications this will have 
for you and what he should include in the business case 
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Section 3: ‘Non-operational Time’ 
 
 In most roles, pharmacy staff will not be engaged in direct patient care for the entirety of their working day- a certain amount of non-
operational ( ie other than ward and dispensary) activities are required  to maintain staff employment and need to be recognised within a whole 
time equivalent exists.  This section is identifying the average non operational commitment for each fte.  
 
Staff grade under Agenda 
for Change (AfC) 
Travel time ie 
department-ward 
(mins/day) 
Mandatory 
training 
(minutes/ 
MONTH) 
Professional 
training eg 
diploma 
(Mins/week) 
Departmental or 
MDT meetings 
(mins/week) 
Rest time  
due to on-call 
Other (please 
specify) 
Pharmacist AfC 8a (& above)       
Pharmacist AfC 7       
Pharmacist AfC 6       
Technician Band 5       
Technician Band 4       
ATO Band 3 &2       
 
  
  
261 
 
Section 4:  Now we would like some information about your hospital to put the other data into context 
 
a) Please tick which of the following describes your hospital (please tick all that apply)   
 
⃝ Foundation Hospital Trust  ⃝ Non Foundation Hospital Trust ⃝ Private Hospital   ⃝ Prison Hospital          
⃝ Tertiary referral unit    ⃝ Teaching Hospital     ⃝ District General Hospital    ⃝ Intermediate Care  
⃝ Mental Health Unit  
 
b) Which specialities are practiced at your Trust? 
 
⃝ Acute Medicine  ⃝ General Medicine ⃝ Respiratory  ⃝ Gastroenterology  ⃝ Endocrinology  ⃝ Neurology  
 
⃝ Stroke  ⃝ Frail Elderly   ⃝ Cardiology  ⃝ Renal    ⃝ Paediatrics  ⃝ Orthopaedic   
 
⃝ Critical Care    ⃝ Neurosurgery  ⃝ CT Surgery      ⃝ General surgery ⃝ Gynaecology  ⃝ ENT   
 
⃝ Vascular Surgery   ⃝ GI surgery  ⃝ Obstetrics  ⃝ Rehabilitation  ⃝ Long stay elderly ⃝ Psychiatry 
 
c) How many in-patient beds in your Trust ............................................... 
 
d) How many pharmacy staff employed at Trust:  Pharmacists ......  Technicians  ......  ATO ........ 
 
e) Location  of your Trust  - UK Home Nation  ⃝ Yes  ⃝ No       
If yes please specify  ⃝ Wales  ⃝ England   ⃝ Scotland ⃝ Northern Ireland    
If no please specify ................................................................................. 
Please now save a copy of this for your records and return a copy to r.bednall@nhs.net.  Thank you for your participation in Part 1 of this study.  
You will shortly receive a copy of the Royal Stoke Pharmacy Workforce Calculator as Part 2 of this project.  You will also be asked to confirm or 
amend your responses to parts 1 and 3 of this questionnaire in the light of the data presented once all first round results are available. 
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Appendix 8: Main study Part 1: Questionnaire 2 
Pharmacy Staffing Questionnaire –Data Summary & Review 
Data Summary 
Thank you for your participation in this study.  Data was submitted from 21 sites across the 
UK and summarised below for your review.  The purpose of this part of the study is to 
identify if consensus can be achieved on the tasks required to deliver pharmaceutical care, 
the time these take and how often these should be completed for one patient.  Very high 
levels of consensus (>90%) were achieved on the tasks required for the delivery of care 
(data set A).  Some sites identified additional tasks on which you are now asked to 
comment.   
For the staff delivering the tasks (B) and the time taken to complete (C) there is broad 
agreement amongst participants – though consensus is not to the same level as for the tasks 
themselves.  Please review this data – your own site’s data is shown alongside. For category 
B all sites responded and the % agreement on staff groups is shown.  For data set C, the ‘N’ 
number refers to the number of sites which submitted data on each element.  The first 
figure is the ‘mode’ ie the most common response given followed in brackets by the 
percentage of participants who returned this response  - this represents the percentage 
agreement achieved so far.  Finally in this section the range of responses is shown to give 
you some context.  If you wish to amend your data in the light of the information provided–
please complete the blank data set which follows the data summary.  If you don’t wish to 
amend data, explanation as to any differences from the mode would be a useful insight and 
again should be documented in the blank data set provided.  Only amendments and 
explanations need to be recorded here – a full copy of your data is not required on this 
occasion.  
The same principle has been applied to the display of data set D – how often the task should 
be completed.  You will note that there is a level of consensus achieved here which suggests 
not a numerical value but a dependency on patient characteristics.  Please pay particular 
attention to the questions relating to this which follow. 
If you have any questions relating to this summary please don’t hesitate to contact me 
r.bednall@nhs.net . 
Please now review the data summarised below.  
  
Data Summary 
Key: *Data was bimodal Depends = depends on the patient   D-3 = ranges from depends on patient to 3 times during admission 
Direct patient care activities completed 
for each patient admission 
A 
Agreement with task 
necessity 
B 
Staff group required to deliver 
task 
C 
Time task takes 
(on average in 
minutes) 
D 
Frequency which task 
should be done for each 
patient admission 
 
% 
Participants’ 
agreement 
N=21 
Your 
Site Data 
%  
Participants’ 
response/ 
Category 
N= 21 
Your 
Site Data 
Mode of 
Participants’ 
Response 
(% in 
agreement) 
Range 
Your
Site 
Data 
Mode of 
Participants’ 
Response 
(% in 
agreement) 
Range 
Your Site 
Data 
Medicines Reconciliation (pharmacy 
confirmed and signed off) 
100  P & MMT = 81%  N= 21* 
10 (29%) & 20 
(29%) 
6-30 
 N=21 
1(85%) 
1-2 
 
Check of Patients Own Drugs (PODs) 95  P&MMT= 43% 
MMT= 48% 
 N=17 
5 (58%) 
4-15 
 N=20 
1(65%) 
1-2 
 
Clinical Review of Notes 90  P=81%  N=18 
5 (66%) 
2-10 
 N=20 
Depends (45%) 
D-7 
 
Review of Blood results 90  P=81%   N=17 
5 (35%) 
1-5 
 N=19 
Depends (52%) 
D-3 
 
Initial review of Drug Chart 100  P=38% 
P&MMT=57% 
 N=18 
5 (50%) 
2-5 
 N=19 
1 (79%) 
D-1 
 
Initial endorsing of Drug Chart 95  P=43% 
P&MMT=48% 
 N=17 
 5 (40%) 
1-10 
 N=17 
1 (82%) 
D-1 
 
Subsequent review of Drug Chart 95  P=33% 
P&MMT=57% 
 N=17 
5 (41%) 
1-5 
 N=18 
Depends (44%) 
D-Daily 
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Direct patient care activities completed 
for each patient admission 
A 
Agreement with task 
necessity 
B 
Staff group required to deliver 
task 
C 
Time task takes 
(on average in 
minutes) 
D 
Frequency which task 
should be done for each 
patient admission 
 
% 
Participants’ 
agreement 
N=21 
Your 
Site Data 
%  
Participants’ 
response/ 
Category 
N=  
Your 
Site Data 
Mode of 
Participants’ 
Response 
(% in 
agreement) 
Range 
Your
Site 
Data 
% 
Participants’ 
response 
Your Site 
Data 
Subsequent endorsing of Drug Chart 90  P=38% 
P&MMT=47% 
 N=17 
2(30%) 
0-5 
 N=17 
Depends (41%) 
D-daily 
 
Completion of Paperwork 
(Pharmacy handover/care plans etc) 
86  P=14% 
P&MMT=47% 
MMT=5% 
Not reported 
=33% 
 N=9 
5 (66%) 
1-5 
 N=11 
Depends (27%) 
D-Daily 
 
Ordering of Non Stocks 90  P&MMT=43% 
MMT=29% 
 N=16 
5(44%) 
1-5 
 N=17 
Depends (47%) 
D-3 
 
Clinical Check of Discharge prescription 100  P=76%  N=21 
5(38%) 
2-17 
 N=21 
1 (100%) 
 
Talking to patient about their medicines 95  P&MMT=81%  N=17 
5 (47%) 
1-15 
 N=17 
1 (40%) 
D-2 
 
Making interventions on patient care 100  P=33% 
Discharge =67% 
 N=16 
5 (56%) 
1-10 
 N=19 
Depends (57%) 
D-Daily 
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Direct patient care activities 
completed for each patient 
admission 
A 
Agreement with task 
necessity 
B 
Staff group required to 
deliver task 
  
 
% 
Participants’ 
agreement 
N=21 
Your 
Site 
Data 
%  
Participants’ 
response/ 
Category 
N=  
Your 
Site Data 
    
In patient Booking on to tracker 
system 
67  (N=9) 
ATO 100% 
     
In patient Dispensing 
100 
 ATO=29% 
ATO&TECH=48
% 
Not reported= 
19% 
     
In patient Checking 100  ACT=38% 
P&ACT=43% 
     
     
Discharge booking onto tracker 
system 
76  (N=13) ATO 
100% 
      
Discharge Dispensing 
100 
 ATO=14% 
ATO&TECH=57
5% 
NR=19% 
      
Discharge Checking 76  P&MMT=64% 
MMT/ACT=29% 
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Data Review  
If you wish to amend your data set please make changes to the relevant category using the example answer below 
Tasks: 
Direct patient care activities completed 
for each patient admission 
A 
Identify if you 
think this task 
should be 
completed by 
your Pharmacy 
Team for each 
patient  
 
 
 
 
B 
Identify staff 
group required 
to perform this 
task  
 
Pharmacist (P) 
MMT 
ATO 
Technician (T) 
ACT 
C 
How long do you think this 
activity should take to 
complete on average (per 
prescription in mins)? 
 
NB This data can be: 
1. Existing local data (ELD) 
2. Data collected specifically 
in response to questionnaire 
(DC)  
3. Best Guess (BG) 
4. Not Known (NK) 
D 
Please estimate number of 
occasions the task should 
be completed per 
admission. 
 
Please identify if this is 
dictated by personal practice 
(PP) or by departmental 
SOP (SOP) 
 
 
 
Sample Answer: 
Medicines Reconciliation (pharmacy 
completed and signed off by pharmacist 
√ P and MMT ELD 10 SOP 1 
Key for abbreviations: MMT – Medicine Management Technician, ATO – Assistant Technical Officer, ACT – Accredited Checking Technician  
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Revised Data Set – please use this section to amend your site’s data in the light of the results above.  
Direct patient care activities completed for 
each patient admission 
A 
Identify if you think 
this activity  should 
be completed by your 
Pharmacy Team for 
each patient  
B 
Identify staff 
group required 
to perform this 
task 
C 
How long do you 
think this activity 
should take on 
average (per 
prescription in mins)? 
D 
Please estimate 
number of occasions 
you think the activity 
should place per 
admission. 
Comments 
Medicines Reconciliation  
    
 
Check of Patients Own Drugs (PODs) 
    
 
Clinical Review of Notes 
    
 
Review of Blood results 
    
 
Initial review of Drug Chart 
    
 
Initial endorsing of Drug Chart 
    
 
Subsequent review of Drug Chart 
    
 
Subsequent endorsing of Drug Chart 
    
 
Completion of Paperwork 
    
 
Ordering of Non Stocks 
    
 
Clinical Check of Discharge prescription 
    
 
Talking to patient about their medicines 
    
 
Making interventions on patient care 
    
 
DISPENSING ACTIVITY  
In-patient Medicine Supply (whether that as non-stock or as one stop dispensing)  
Booking on to tracker system 
    
 
Dispensing 
    
 
Checking 
    
 
Discharge Prescription (ward or dispensary based)  
Booking onto tracker system 
  Thank you for your support and contribution to this study.  You will be 
sent a copy of the Executive Summary when it is prepared at the end of 
the research. 
 
Triage (Clinical Check) 
  Dispensing 
  Checking 
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Please consider in particular data set D.  If you answered ‘depends on the patient’ for this category in the previous round of data collection 
or have changed your response to ‘depends on the patient’ in this round. Please describe below the patient characteristics which would 
result in you reviewing this patient more frequently. 
 
 
 
 
 
If these characteristics exist how often would you review the patient? 
 
 
 
 
 
 
 
 
Does your service delivery model include different levels of clinical review?  YES  NO 
For example 
Level 1 – chart review only, basic safety review doses, interactions, allergies, formulary  
Level 2 -  above and in addition review of medical notes, blood results, fluids etc 
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Using the example below to guide you please identify when during the course of a patient stay you would expect to complete 
certain clinical tasks for a ‘typical’ patient in each category below. 
Key: MR – medicines reconciliation, L1-Level 1 review, L2 – level 2 review, TTO – clinical check, PODs- POD check 
Patient type Admission day 
1 2 3 4 5 6 7 8 9 10 
Example patient MR & L2 
& POD 
L2  L1 & 
TTO 
POD  
Respiratory patient 
with CAP  
          
Elective ‘gynae’ 
surgical patient  
          
Longer stay elderly 
patient 
          
Short stay medical 
patient 
          
Vascular surgical 
patient 
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During the initial questionnaire, some of your colleagues identified additional tasks, which they believed should be routinely delivered in 
pharmaceutical care.  Please complete the following grid with your consideration of these tasks 
Additional activities routinely performed but not listed above 
Direct patient care activities completed 
for each patient admission 
Identify if you think 
this activity  should be 
completed by your 
Pharmacy Team for 
each patient  
Y=yes  N=no 
 
Identify staff 
group required 
to perform 
activity at your 
Trust 
 
How long do you think this 
activity should take on 
average (per prescription 
in mins)? 
Please estimate 
number of occasions 
activity should take 
place per admission. 
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Appendix 9: Main study Part 2: Operator evaluation 
Royal Stoke Pharmacy Workforce Calculator – Operator 
Evaluation 
Thank you for returning your workforce questionnaire.  Attached to this email is a copy of 
the RSPWC tool with instructions for use.  Following the instructions provided please 
calculate the workforce required for the following scenarios and then cut and paste the 
bottom section of the tool with your answers in each section. For the purposes of the study,  
please do not alter the  percentages of the different types of prescription items – these 
answer s are intended only to confirm the transferability of the tool between different 
operators.  It is accepted that these numbers may differ between sites and patient groups 
ie 
 
 
1. A new general medical ward is planned to open. This will have 28 beds and an average 
length of stay of 5 days. The average number of items on an in-patient prescription is 8. You 
have to identify the pharmacy staff (WTE) required to deliver your standard ward based 
service. 
 
2. An existing 28 bed general medical ward with average length of stay of 4 days (average 
items 8) is being converted to a short stay (48 hour) unit.  What impact will this have on your 
pharmacy service and what if any additional staff would you request? 
 
3. Finally, you are approached by a directorate manager about to submit a business case for 
200 new Bariatric Surgical patients.  No new beds will be opened, these cases will go through 
and existing 28 bed surgical ward with a length of stay of 3 days.  These patients have an 
average of 6 items on their prescription.  He asks what resource implications this will have 
for you and what he should include in the business case 
REQUIRED STAFF GROUP
GRADE  REQUIRED 
(According to 
speciality needs)
TOTAL TIME 
REQUIRED 
FOR 
ADDITIONAL 
BEDS PER 
WEEK (mins)
TOTAL TIME 
REQUIRED FOR 
ADDITIONAL BEDS 
PER WEEK (hrs)
WTE REQUIRED 
FOR ADDITIONAL 
ACTIVITY
MID POINT OF 
GRADE (+22% 
oncost)
ATO 2 #DIV/0! #DIV/0! #DIV/0! 19338
TECHNICIAN 4 #DIV/0! #DIV/0! #DIV/0! 25178
MMT/PHARMACIST 5 #DIV/0! #DIV/0! #DIV/0! 29066
PHARMACIST 7 #DIV/0! #DIV/0! #DIV/0! 43354
CLINICAL STAFF TOTAL #DIV/0!
COST
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
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Now use the RSPWC  for your own purposes and apply it to situations that arise in your 
setting.  When you have familiarised yourself with the tool , please answer the following 
questions 
 
1. Do you think the RSPWC generates the workforce resource required to deliver 
pharmaceutical care in your setting? 
Yes   No 
If  ‘No’ please explain: 
 
2. How did the value generated compare with what you would have requested without using 
it? (please circle) 
More      The same   Less 
 
3. Were the instructions easy to understand? (please circle) 
Yes   No   Other (please explain) 
 
4. How long did it take you to use the RSPWC to calculate the answers? (please circle) 
<10 minutes  10-20 minutes  21-30 minutes  >30 
minutes 
 
5. Would you be willing to participate in a semi-structured telephone interview about the 
application of the RSPWC in practice? (please circle) NB you will be contacted by email in the 
first instance to arrange a convenient time/date. 
Yes         No thanks 
Name:     
email: 
 
Thank you for taking the time to complete this questionnaire.  You are now free to use the 
RSPWC in your practice.  Regardless of your answer to question 5, we would be interested in 
hearing about your experience of using it.  Please email r.bednall@nhs.net with any other 
feedback as you use this tool in practice. 
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Please note that a final, fully validated version will be issued at the end of the evaluation 
project.  For this reason we ask therefore that this version is not further shared but 
retained for your department’s use. Please direct any interested parties to the researcher. 
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Appendix 10: Main Study Participant Information Sheet 
Study title: Pharmacy workforce - validation of a staff resource 
calculation tool. 
Invitation. You are being invited to take part in a research study. You do not have to take 
part but before you decide, it is important for you to understand why the research study is 
being done and what it will involve. Please take time to read the following information 
carefully and discuss it with others if you wish. My name is Ruth Bednall, I am Doctorate in 
Pharmacy student at Keele University and I am doing this research study as part of this 
degree. Take time to decide whether or not you wish to take part.  
What is the purpose of the study? The Royal Stoke Pharmacy Workforce Calculator 
(RSPWC) was developed by the Pharmacy Department at the Royal Stoke University 
Hospital.  Locally this tool has proved an effective method of identifying the pharmacy 
resource required to deliver pharmaceutical care. This study seeks to assess its reliability 
and usability when applied to the ward pharmacy services of other hospital sites. 
Why have I been chosen? You are being invited to take part in this research study either 
because you responded to the invitation issued through a professional forum, or to a 
personal invitation to participate and expressed an interest to be part of the study. 
Do I have to take part? It is up to you to decide whether or not to take part. If you choose to 
take part you will first be asked to confirm your consent and you can still withdraw at any 
time. You do not have to give a reason.  
What do I have to do to take part?  If you decide to take part you will be invited to 
contribute in 4 parts. 
Part 1: This is a questionnaire that you will be required to complete and return by email. It 
identifies tasks that are performed by your staff in the course of their provision of 
pharmaceutical care, what resource you currently request to deliver specific services, ‘down 
time’ in an average working week and demographic information about your hospital The time 
required to complete this questionnaire will be dependent on the availability of data at your 
site. To fully complete some local data collection may be required, but this is not compulsory 
and incomplete data sets are acceptable where local data for specific criteria are not easily 
available. You may need to complete aspects of this questionnaire during working hours. 
Your Chief Pharmacist should be aware and approve of your participation in this study. 
Part 2: On return of your response to the first questionnaire you will be sent a copy of the 
RSPWC and asked to use it to calculate the pharmacy resource that would be required to 
deliver services in 3 different scenarios and complete a feedback form. This should be 
emailed to the investigator and you are then free to continue using the RSPWC for your own 
purposes  
Part 3:.Results from the first questionnaire will be returned to you.  You will be only be able 
to identify your data in the tables provided, other data will be anonymised.  The second 
questionnaire will ask you to confirm or amend your responses in the light of the information 
presented.  You will be required to return this questionnaire by email. 
Part 4: On receipt of your calculations, if you have identified an interest in continued 
participation, you may be contacted by the investigator to participate in a semi-structured 
telephone interview to appraise your views of the use of the RSPWC and its perceived or 
actual benefits/disadvantages to your department. 
What are the possible disadvantages and risks of taking part? We are not aware of any 
disadvantages or risks to you in taking part in the study. 
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What are the possible benefits of taking part? You will have access to the RSPWC tool to 
use for your own workforce planning purposes. 
 
Can I withdraw from the study? Yes, any participant can choose to withdraw their data 
from the study with no explanation required up to the point when the data collection for Part 2 
is complete and the results compiled.  If a participant chooses to withdraw, their data will be 
destroyed and not included in the report.  Withdrawal rate of participants will be included in 
the degree report but this will be anonymous. 
What if there is a problem or something goes wrong? You can contact me 
(r.bednall@nhs.net) if you wish to complain, or have any concerns about any aspect about 
any way you have been approached or treated during the course of this study. I will consider 
such reports promptly and take appropriate action immediately. If you feel that your complaint 
has not been handled to your satisfaction you can contact my supervisor (Dr Simon White]) 
at (s.j.white@keele.ac.uk).  Alternatively, you may contact the Head of the School of 
Pharmacy (Professor Nigel Ratcliffe n.ratcliffe@keele.ac.uk ).  If you remain unhappy about 
the research and/or wish to raise a complaint about any aspect of the way in which you have 
been approached or tyreated during the course of the study please write to Nicola Leighton, 
who is the University contact for complaints regarding research at Research & Enterprise 
Services, Keele University, ST5 5BG n.leighton@keele.ac.uk telephone 01782 733306.  
Who will have access to information about me or my department? All the information 
that we collect about you during the course of the research will be kept strictly confidential 
and no one outside the project will be allowed access to it. Electronic data containing 
personally identifiable information about you will only be stored on password-protected media 
that only I and my supervisor (Dr Simon White) have access to. Hardcopies of data and other 
documentation containing personally identifiable information about you will be kept secure in 
a locked cupboard that only my supervisor and I have access to. At the end of the study all 
data and documents containing personally identifiable information about you will be 
destroyed. You will not be able to be identified in any reports or publications. You will have 
access to your data benchmarked against other participant sites. 
How will information about me be used? The results (including anonymised short direct 
quotes with your consent) will be included in a research report as part of my doctoral degree 
in pharmacy at Keele University, and may subsequently be published as research papers in 
academic journals and presented at conferences. The participating Trust names will be listed 
within the degree report and may be included in any publication to demonstrate the 
population within which consensus has been achieved. It will not be possible to associate any 
data with any individual in any direct quotes, reports, papers, presentations or summaries.  
Who is organising and funding the research? The study is being organised and funded by 
the School of Pharmacy at Keele University and the University Hospitals of North Midlands 
(UHNM) NHS Trust. 
Who has reviewed the study? The research study has been approved by Keele University 
Ethical Review Panel and has received NHS Management permission (R&D approval).  
Further Information and Contact Details If you have any questions or require any further 
information, either now or at any time during the study, please contact me (Ruth Bednall) at 
r.bednall@nhs.net.  Alternatively, you can contact me in writing at the Pharmacy Department, 
Royal Stoke University Hospital, Newcastle Road, Stoke on Trent, ST4 6QG 
Thank you for taking time to read this information. 
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Appendix 11: Main Study Consent Form 
Consent Form 
Title of Project: Pharmacy workforce - validation of a staff resource calculation 
tool. 
Name of Principal Investigator: Ruth Bednall      
Please tick box 
 
I confirm that I have read and understand the information sheet for the above study 
and have had the opportunity to ask questions 
 
I have informed the relevant authority within my Trust that I am submitting data to 
this project (eg Chief Pharmacist) and they are happy with the content of that 
submission 
 
I agree to take part in this study and I understand that my participation is voluntary  
and that I am free to withdraw at any time up to the conclusion of Part 2 of the study. 
 
 
I understand that data collected about me during this study will be anonymised 
before it is submitted for publication, this includes anonymised short direct quotes if I  
participate in Part 4 
 
 
Name of participant  _____________________ 
 
Signature  ______________________ 
 
Date   ______________________ 
 
 
 
Researcher   Ruth Bednall________________  
 
Signature  __Ruth M Bednall_______ 
 
Date   27/2/15________ 
 
1 copy for participant, 1 copy for researcher 
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Appendix 12: Study Prototype RSPWC with instructions for use 
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Appendix 13: Main Study Part 3: Interview Guide 
Introduction: 
Thank you for agreeing to have this conversation with me today.  I anticipate that it will take 
no longer than 30 minutes.  I am digitally recording our discussions so that it can be 
accurately transcribed for analysis purposes.  The data generated will remain confidential 
and reported anonymously, no comments will be directly attributed to you in any report or 
paper produced. You are able to stop the conversation at any point today and withdraw 
your data from the analysis within the next 4 weeks. 
 
If you are happy then we can start? 
 
I’d like to first understand a little about your site and the service you deliver. 
 
Perhaps you could start by describing for me the trust in which you work in terms of status, 
beds, and specialities? 
 
Can you describe how your pharmacy department is structured and the way in which your 
ward based clinical pharmacy service is delivered? 
 
What are the challenges that face you currently in terms pharmacy staffing? 
 
Prompts: recruitment, retention, CIP, productivity 
 
Having used the RSPWC what do you think might be its application if any in your practice? 
 
What do you think might be the benefits or disadvantages of this tool? 
 
 
What are the limitations of its application? 
 
 
 
During the course of the study it has become apparent that the consensus on how often a 
task has to be done is that ‘it depends on the patient’.  What do you think would be patient 
characteristics that would require additional or priority input and how do you manage this 
at your Trust? 
 
 
 
 
 279 
 
Appendix 14: Main Study Part 3: Participant Information Sheet 
Study title:  
Pharmacy workforce - validation of a staff resource calculation tool. 
Invitation: You are being invited to take part in a research study. You do not have to take 
part but before you decide, it is important for you to understand why the research study is 
being done and what it will involve. Please take time to read the following information 
carefully and discuss it with others if you wish. My name is Ruth Bednall, I am Doctorate in 
Pharmacy student at Keele University and I am doing this research study as part of this 
degree. Take time to decide whether or not you wish to take part.  
 
What is the purpose of the study? The Royal Stoke Pharmacy Workforce 
Calculator (RSPWC) was developed by the Pharmacy Department at the Royal Stoke 
University Hospital.  Locally this tool has proved an effective method of identifying the 
pharmacy resource required to deliver pharmaceutical care. This study seeks to assess its 
reliability and usability when applied to the ward pharmacy services of other hospital sites. 
 
Why have I been chosen? You are being invited to take part in this research study 
because you responded to an invitation issued through a professional forum or a direct 
personal invitation and expressed an interest to be part of the study and have already 
completed the first 3 parts of the research.   
 
Do I have to take part? It is up to you to decide whether or not to take part. If you 
choose to take part you will first be asked to confirm your consent and you can still withdraw 
at any time. You do not have to give a reason.  
 
What do I have to do to take part?  If you decide to take part you will be contacted 
to participate  in a conversation about pharmacy staffing requirements generally and your 
views of the RSPWC in particular and its perceived or actual benefits/disadvantages to your 
department. This conversation is not expected to take more than 30 minutes and will be 
digitally recorded to ensure accurate transcription of the conversation for analysis purposes. 
The timing of this interview will be arranged for your convenience and it may/may not be 
during your working hours. Your Chief Pharmacist should be aware and approve of your 
participation in this study. 
 
What are the possible disadvantages and risks of taking part? We are not 
aware of any disadvantages or risks to you in taking part in the study. 
 
What are the possible benefits of taking part? You will have opportunity to 
express your views and opinions on the potential applications of the RSPWC and influence 
the future development of this tool. 
 
Can I withdraw from the study? Yes, any participant can choose to withdraw their 
data from the study with no explanation required up to the point when all the conversations 
have been completed and the results compiled.  If a participant chooses to withdraw, their 
data will be destroyed and not included in the report.  Withdrawal rate of participants will be 
included in the degree report but this will be anonymous. 
 
What if there is a problem or something goes wrong? You can contact me 
(r.bednall@nhs.net) if you wish to complain, or have any concerns about any aspect about 
any way you have been approached or treated during the course of this study. I will consider 
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such reports promptly and take appropriate action immediately. If you feel that your complaint 
has not been handled to your satisfaction you can contact my supervisor (Dr Simon White]) 
at (s.j.white@keele.ac.uk).  Alternatively, you may contact the Head of the School of 
Pharmacy(Professor Nigel Ratcliffe n.ratcliffe@keele.ac.uk ).  If you remain unhappy about 
the research and/or wish to raise a complaint about any aspect of the way in which you have 
been approached or tyreated during the course of the study please write to Nicola Leighton, 
who is the University contact for complaints regarding research at Research & Enterprise 
Services, Keele University, ST5 5BG n.leighton@keele.ac.uk telephone 01782 733306.  
 
Who will have access to information about me or my department? All the 
information that we collect about you during the course of the research will be kept strictly 
confidential and no one outside the project will be allowed access to it. Electronic data 
containing personally identifiable information about you will only be stored on password-
protected media that only I and my supervisor (Dr Simon White) have access to. Hardcopies 
of data and other documentation containing personally identifiable information about you will 
be kept secure in a locked cupboard that only my supervisor and I have access to. At the end 
of the study all data and documents containing personally identifiable information about you 
will be destroyed. You will not be able to be identified in any reports or publications.  
 
How will information about me be used? The results (including anonymised short 
direct quotes with your consent) will be included in a research report as part of my doctoral 
degree in pharmacy at Keele University, and may subsequently be published as research 
papers in academic journals and presented at conferences. The participating Trust names 
will be listed within the degree report and may be included in any publication to demonstrate 
the population within which consensus has been achieved. It will not be possible to associate 
any data with any individual in any direct quotes, reports, papers, presentations or 
summaries.  
 
Who is organising and funding the research? The study is being organised and 
funded by the School of Pharmacy at Keele University and the University Hospitals of North 
Midlands (UHNM) NHS Trust. 
 
Who has reviewed the study? The research study has been approved by Keele 
University Ethical Review Panel and has received NHS management permission (R&D 
approval).  
 
Further Information and Contact Details If you have any questions or require any 
further information, either now or at any time during the study, please contact me (Ruth 
Bednall) at r.bednall@nhs.net.  Alternatively, you can contact me in writing at the Pharmacy 
Department, Royal Stoke University Hospital, Newcastle Road, Stoke on Trent, ST4 6QG  
 
Thank you for taking time to read this information. 
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Appendix 15: Main Study Part 3: Consent form 
Consent Form 
Title of Project: Pharmacy workforce - validation of a staff resource calculation 
tool. 
 
Name of Principal Investigator: Ruth Bednall   
    
Please tick box 
I confirm that I have read and understand the information sheet for the above study  
and have had the opportunity to ask questions. 
 
I have informed the relevant authority within my Trust that I am submitting data to 
this project (eg Chief Pharmacist) and they are happy with the content of that 
submission. 
 
 
 I agree to take part in this study and I understand that my participation is voluntary 
and  that I am free to withdraw at any time up to the conclusion of Part 2 of the study. 
 
 
I understand that data collected about me during this study will be anonymised 
before it is submitted for publication 
 
 
I am willing for anonymised direct quotes to be included in a reports produced 
 relating to this study 
 
 
 
___________________________ 
Name of participant 
_____________ 
Date 
_________________________ 
Signature 
Ruth Bednall________________  
Researcher 
27/2/15________ 
Date 
__Ruth M Bednall_______ 
Signature 
 
 
1 copy for participant, 1 copy for researcher 
  
 282 
 
Appendix 16: List of participant sites 
The following sites submitted data as part of this nationwide consensus study. 
Bradford Teaching Hospitals NHS Foundation Trust 
County Durham and Darlington NHS Foundation Trust 
Dudley Group NHS Foundation Trust 
East Kent University Hospitals NHS Foundation Trust 
Guys' & St. Thomas' NHS Foundation Trust 
Hutt Valley District Health Board, NZ 
Morriston Hospital, Abertawe Bro Morgannwg University Health Board 
Neville Hall Hospital, Aneurin Bevan University Health Board 
Newcastle upon Tyne Hospitals NHS Foundation Trust 
NHS Fife 
North Bristol NHS Trust 
North Cumbria University Hospitals NHS Trust 
Northampton General Hospital NHS Trust 
Northumbria Healthcare NHS Foundation Trust 
Nottingham University Hospitals NHS Trust 
Nottinghamshire Healthcare NHS Foundation Trust 
Royal Gwent Hospital, Aneurin Bevan University Health Board 
South Tees Hospitals NHS Foundation Trust 
Tee, Esk and Wear Valleys NHS Foundation Trust 
The Leeds Teaching Hospitals NHS Trust 
The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust 
University Hospitals Coventry and Warwickshire NHS Trust 
University Hospitals of Leicester NHS Trust 
University Hospitals of North Midlands NHS Trust 
 
